1510 |
Book
AHFS Formulary service 2000 Bethesda - 3546 p |
|
2000 |
3291 |
Journal
Acta Pol Pharm 2012 ; 69, 1: 95-105. |
Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A, Bilski P, Domanska A, Lukasz Helminiak, Jablonska M, Jachymska A. |
2012 |
795 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2338-2339. |
21-day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a cassette.
Henderson F. |
1996 |
3316 |
Journal
Chem Pharm Bull 2012 ; 60, 1: 86-93. |
A 5% Glucose Infusion Fluid Provokes Significant Precipitation of Phenytoin Sodium Injection via Interruption of the Cosolvent Effect of Propylene Glycol.
Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K. |
2012 |
3958 |
Journal
J Infect Dis 1988 ; 157, 3: 600-601. |
A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities .
Henrickson K.J; . Powell K.R; . Schwartz C.L. |
1988 |
2242 |
Journal
Int J Pharm 1998 ; 167, 1-2: 223-228. |
A note on the solution chemistry of carboplatin in aqueous solutions.
Lederer M, Leipzig-Pagani E. |
1998 |
1232 |
Journal
Br J Pharm Pract 1987 ; 9: 223-226, 236. |
A physical compatibility study of furosemide & flucloxacillin injections.
Beatson C, Taylor A. |
1987 |
3847 |
Journal
J Pain Palliat Care Pharm 2016 ; 29, 4: 370-373. |
A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution.
Raphael C.D, Zhao F, Hughes S.E, Juba K.M. |
2016 |
401 |
Journal
Aust J Hosp Pharm 1991 ; 21: 115-118. |
A preliminary study of the stability of midazolam in polypropylene syringes.
Peterson GM, Khoo BHC, Galloway JG, Paterson J. |
1991 |
2203 |
Journal
J Oncol Pharm Practice 2007 ; 13: 119-126. |
A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'.
Kaestner S, Sewell G. |
2007 |
2560 |
Journal
Aust J Hosp Pharm 1994 ; 24: 312-316. |
A short-term stability study of an oral solution of dexamethasone.
Accordino A, Chambers R, Thomson B. |
1994 |
3279 |
Journal
J Clin Pharm Ther 2012 ; 37, 1: 71-73. |
A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care.
Al-Tannak N.F, Cable C.G, McArthur D.A, Watson D.G |
2012 |
3817 |
Poster
Gerpac Congress, Giens, France 2015 |
A stability study of 25 mg/mL phenylephrine hydrochloride and 5 mg/mL tropicamide eye drops.
Stordeur F, Chanat C, Brandely M.L, Chast F. |
2015 |
3685 |
Journal
EJHP 2017 ; 24:4 : 235-241 |
A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements.
Pfeifer C, Noll S, Gerecke H, Fassauer G, Jira T, Remane Y , Vogel J, Frontini R, Reinhardt R. |
2017 |
3438 |
Journal
J Pharm Biomed Anal 2013 ; 83 : 164-170. |
A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids.
Respaud R, Quenum L, Plichon C, Tournamille J.F, Gyan E, Antier D, Viaud-Massuard M.C. |
2013 |
554 |
Journal
J Parenter Sci Technol 1991 ; 45: 212-217. |
A study of the interaction of selected drugs and plastic syringes.
Speaker TJ, Turco SJ, Nardone DA, Miripol JE. |
1991 |
525 |
Journal
Int J Pharm 1990 ; 65: 49-56. |
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
De Vroe C, De Muynck C, Remon JP, Samsom M. |
1990 |
2894 |
Journal
J Dermatolog Treat 2004 ; 15: 295-302. |
A topical azythromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC, Sangha ND, Mc Carty MA et al. |
2004 |
4045 |
Journal
J Pharm Biomed Anal 2016 ;124:365-373 |
A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor.
Sestak V, Roh J, Klepalova L, Kovarikova P. |
2016 |
1332 |
Journal
J Clin Hosp Pharm 1981 ; 6: 209-211. |
Absorption of isosorbide dinitrate by PVC infusion bags and administration sets.
Lee MG, Fenton-May V. |
1981 |
3595 |
Manufacturer
Hospira 2009 |
Aciclovir - Summary of Product Characteristics
|
2009 |
3933 |
Manufacturer
Teva Laboratoire 2015 |
Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
|
2015 |
576 |
Journal
Drug Intell Clin Pharm 1980 ; 14: 353-357. |
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Holmes CJ, Ausman RK, Walter CW, Kundsin RB. |
1980 |
1624 |
Journal
Am J Health-Syst Pharm 2000 ; 57: 760-762. |
Activity of dalteparin sodium in polypropylene syringes.
Louie S, Chin A, Gill MA. |
2000 |
811 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1296-1298. |
Activity of enoxaparin sodium in tuberculin syringes for 10 days.
Charland SL, Davis DD, Tillman DJ. |
1998 |
466 |
Journal
Am J Hosp Pharm 1991 ; 48: 2172-2175. |
Activity of octreotide acetate in a total nutrient admixture.
Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM. |
1991 |
375 |
Journal
Am J Hosp Pharm 1991 ; 48: 1511-1514. |
Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
Patel JP, Tran LT, Sinai WJ, Carr LJ. |
1991 |
156 |
Journal
Anticancer Drugs 1995 ; 6: 163-164. |
Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions.
Barberi-Hayob M, Merlin JL, Vigneron M, Conroy T. |
1995 |
4567 |
Journal
Pharmaceutics 2021 ;13, 458. |
Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study.
Henry H, Lannoy D, Maboudou P, Seguy D, Dine T, Pigny P, Odou P. |
2021 |
64 |
Journal
Am J Hosp Pharm 1992 ; 49: 1672. |
Additional data on visual compatibility of foscarnet sodium with morphine sulfate.
DiStefano JE, Outman WR. |
1992 |
1242 |
Journal
Pharm Weekbl [Sci] 1988 ; 10: 213-216. |
Adsorption of human and porcin insulins to intravenous administration sets.
Tol A, Quik RFP, Thyssen JHH. |
1988 |
2119 |
Journal
Eur J Anaesthesiol 2003 ; 20: 124-126. |
Adsorption of sufentanil to epidural filters and catheters.
Westphal M, Hohage H, Buerckle H, Van Aken H, Ermert T, Brodner G. |
2003 |
167 |
Journal
Int J Pharm 1994 ; 103: 87-92. |
Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters.
Francomb MM, Ford JL, Lee MG. |
1994 |
3508 |
Manufacturer
Sanofi Aventis Group 2013 |
Aflibercept (Zaltrap®) - Summary of Product characteristics
|
2013 |
3635 |
Manufacturer
Novartis Pharmaceuticals UK Ltd 2015 |
Aldesleukine (Proleukin®) - Summary of Product Characteristics
|
2015 |
3417 |
Poster
ADKA Congress, Dresden, Germany 2013 |
Aliquotierte Levosimendanlösungen - stabil ?
Trittler R, Hecklinger J. |
2013 |
3616 |
Manufacturer
Boehringer Ingelheim 2012 |
Altéplase (Actilyse®) - Résumé des caractéristiques du produit
|
2012 |
4471 |
Manufacturer
Kyowa Kirin Pharma 2019 |
Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
|
2019 |
3598 |
Manufacturer
Clinigen Healthcare Ltd 2016 |
Amifostine (Ethyol®) - Résumé des caractéristiques du produit
|
2016 |
3549 |
Manufacturer
B Braun 2012 |
Amikacine B Braun - Résumé des caractéristiques du produit.
|
2012 |
3524 |
Manufacturer
Sanofi 2013 |
Amiodarone hydrochloride (Cordarone®) - Summary of Product Characteristics.
|
2013 |
3527 |
Manufacturer
Glaxo Smith Kline 2018 |
Amoxicillin (Amoxil®) – Summary of Product Characteristics
|
2018 |
3545 |
Manufacturer
Mylan SAS 2009 |
Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit
|
2009 |
265 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1463-1464. |
Amphotericin B does not mix with fat emulsion.
Trissel LA. |
1995 |
1498 |
Journal
Ann Pharmacotherapy 1996 ; 30: 409-412. |
Amphotericin B formulated in a lipid emulsion.
Cleary JD. |
1996 |
2043 |
Journal
Antimicrob Agents Chemother 1998 ; 42: 762-766. |
Amphotericin B in lipid emulsion : stability, compatibility, and in vitro antifungal activity.
Walker S, Tailor SAA, Lee M, Louie L, Louie M, Simor AE. |
1998 |
793 |
Journal
J Antimicrob Chemother 1996 ; 37: 1165-1169. |
Amphotericin B intralipid formulation: stability and particule size.
Ranch?re JY, Latour JF, Fuhrmann C, Lagallarde C, Loreuil F. |
1996 |
984 |
Journal
Ann Pharmacotherapy 1996 ; 30: 298. |
Amphotericin B is incompatible with lipid emulsions.
Ericsson O, Hallmen AC, Wikstrom I. |
1996 |
3398 |
Manufacturer
Gilead Science (France) 2013 |
Amphotéricine B (Ambisome®) - Résumé des caractéristiques du produit
|
2013 |
3591 |
Manufacturer
Bristol Myers Squibb 2011 |
Amphotericine B (Fungizone®) - Résumé des caractéristiques du produit
|
2011 |
1758 |
Journal
Can J Hosp Pharm 1999 ; 52: 90. |
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donelly RF. |
1999 |
1392 |
Journal
Can J Hosp Pharm 1999 ; 52: 90. |
Ampicillin and ciprofloxacin incompatibility.
Lewis GM, Donnelly RF. |
1999 |
3528 |
Manufacturer
Essential generics 2012 |
Ampicillin sodium – Summary of Product Characteristics
|
2012 |
3576 |
Manufacturer
Prostrakan 2012 |
Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit
|
2012 |
805 |
Journal
Hosp Pharm 1997 ; 32: 1013-1020. |
An automated process for determining the physical compatibility of drugs.
Oskroba DM, Leissing NC, Trissel LA. |
1997 |
3760 |
Journal
J Oncol Pharm Practice 1996 ; 2: 107-112. |
An evaluation of the stability of granulocyte colony stimulating factor on the short-term storage and delivery from an elastomeric infusion system.
Tivnann H, Gaines-Gas R, Thorpe R et al. |
1996 |
4681 |
Journal
Hosp Pharm 2022 ; 57, 1: 69-75. |
An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding.
Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F. |
2022 |
124 |
Journal
Int Pharm J 1993 ; 7: 14-19. |
An in vitro interaction between promethazine hydrochloride and chloroquine phosphate.
Abubakar AA, Mustapha A, Wambebe OC. |
1993 |
3725 |
Journal
Dysphagia 2014 |
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D. |
2014 |
3190 |
Journal
Advance in Haematology 2009 Article ID 704928, 5 page |
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions.
Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M, |
2009 |
4736 |
Journal
J Pharm Biomed Anal 2023 |
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions.
Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. |
2023 |
1895 |
Journal
J Pharm Biomed Anal 2004 ; 35: 57-64. |
Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phtalate released by multilayer infusion tubing.
Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J. |
2004 |
1917 |
Journal
J Pharm Biomed Anal 1997 ; 15: 537- 543. |
Analysis of gentamicin sulfate and a study of its degradation in dextrose solution.
Graham AE, Speicher E, Williamson B. |
1997 |
2148 |
Journal
Anal Biochem 2002 ; 309: 117-126. |
Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J. |
2002 |
3567 |
Manufacturer
Pfizer 2020 |
Anidulafungin (Ecalta®) - Summary of Product Characteristics.
|
2020 |
3006 |
Journal
J Am Acad Dermatol 1987 ; 16: 984-988. |
Anthralin stability in various vehicles.
Green PG, Kennedy CT, Forbes DR. |
1987 |
1230 |
Journal
Br J Pharm Pract 1986 ; 8: 218-220. |
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Regnard C, Pashley S, Westrope F. |
1986 |
1893 |
Journal
Ann Pharmacotherapy 2004 ; 38: 569-573. |
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC. |
2004 |
4445 |
Journal
Chemotherapy 1979 ; 25: 336-345. |
Antibiotic compatibility and stability in a parenteral nutrition solution.
Reed M.D, Perry E.B, Fennell S.J, Brissie E.O, Ball W.D. |
1979 |
1386 |
Journal
Pharm J 1983 ; 231- 233. |
Antibiotic interactions.
Gove L. |
1983 |
3952 |
Journal
Hemodial Int 2010 ; 14, 3 : 322-326. |
Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C.
Battistella M,. Vercaigne L.M, Cote D,. Lok C.E. |
2010 |
3951 |
Journal
Hemodial Int 2009 ; 13, 3: 322-328. |
Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C
Battistella M, Walker S, law S, Lok C. |
2009 |
1103 |
Journal
J Pediatr 1988 ; 112: 813-817. |
Antibiotic stability in a pediatric parenteral alimentation solution.
Fox AS, Boyer KM, Sweeney HM. |
1988 |
1760 |
Journal
Pharmacotherapy 2000 ; 20: 394-399. |
Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter.
Vercaigne LM, Sitar DS, Penner B, Bernstein K, Wang GQ, Burczynski FJ. |
2000 |
2268 |
Journal
Ann Pharmacotherapy 2008 ; 42, 4: 511-515. |
AntiXa stability of diluted dalteparin for pediatric use.
Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J. |
2008 |
3615 |
Manufacturer
Archimeded Pharma 2012 |
Apomorphine (Apomorphine Archimedes®) - Résumé des caractéristiques du produit
|
2012 |
3227 |
Journal
Braz J Pharm Sci 2014 ; 50, 3 : 521-527. |
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Simon B, Hancu G, Gy?resi A. |
2014 |
4579 |
Journal
Processes 2021 , 9, 453. |
Application of the HPLC Method in Parenteral Nutrition
Assessment: Stability Studies of Ondansetron
Tomczak S, Radwan V, Jelinska A, Stawny M. |
2021 |
3295 |
Manufacturer
LFB Biom?dicaments 2018 |
Argatroban - Résumé Caractéristiques du Produit
|
2018 |
2277 |
Manufacturer
GlaxoSmithKline 2008 |
Argatroban - Summary of Product Characteristics
|
2008 |
4726 |
Manufacturer
Mylan 2023 |
Arsenic trioxide Mylan - Résumé des caractéristiques du produit
|
2023 |
3445 |
Journal
Krankenhauspharmazie 2013 ; 34, 8: 410-411. |
Aseptische Herstellung applikationsfertiger Adrenalin-Dauerinjektionen 20 µg/ml.
Heeb R.M, Thiesen J, Krämer I. |
2013 |
1160 |
Journal
Int J Pharm 1986 ; 32: 123-131. |
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM. |
1986 |
4292 |
Journal
Drugs R D 2019 19: 127–140. |
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion.
Vimpolsek M, Gottar-Guillier M, Rossy E. |
2019 |
4676 |
Poster
EAHP Congress Vienna 2022 |
Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days.
Borišek R, Šmid I. |
2022 |
4645 |
Journal
JAC Antimicrob Resist 2021 |
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Jamieson C, Drummond F, Hill T, Ozolina L, Gilchrist M, Seaton R.A, Santillo M, Wilkinson A-S, Allwood M.C. |
2021 |
2139 |
Journal
EJHP Science 2006 ; 12,5: 96-99. |
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. |
2006 |
2815 |
Journal
EJHP 2009 ; 15, 4: 30-32. |
Assessment of stability in extemporaneously prepared venlafaxine solutions.
Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE. |
2009 |
4434 |
Journal
Clin Ther 2019 ; 41, 10: 2162-2170. |
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. |
2019 |
4512 |
Journal
EJHP 2020 2020;0:1-5. |
Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements
Jamieson C,Ozolina L,Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS. |
2020 |
4218 |
Journal
EJHP 2020 ; 27, 2: 90-94. |
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Allwood M.C,Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C, |
2020 |
1873 |
Journal
Clin Ther 2003 ; 25: 1219-1224. |
Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study.
Laposata M, Johnson SM. |
2003 |
1608 |
Journal
Int J Pharm Compound 2001 ; 5: 397-400. |
Assessment of the stability of teicoplanin in intravenous infusions.
Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J. |
2001 |
4532 |
Manufacturer
Roche Products Limited 2021 |
Atezolizumab (Tecentriq®) - Summary of Product Characteristics
|
2021 |
3629 |
Manufacturer
Actavis UK 2014 |
Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
|
2014 |
3676 |
Manufacturer
Hospira 2014 |
Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
|
2014 |
711 |
Journal
Am J Hosp Pharm 1980 ; 37: 492-496. |
Avaibility of diazepam from plastic containers.
Cloyd JC, Vezeau C, Miller KW. |
1980 |
177 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2213-2216. |
Avaibility of lorazepam after simulated administration from glass and polyvinyl chloride containers.
Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR. |
1995 |
1102 |
Journal
Eur J Clin Pharmacol 1981 ; 19: 181-185. |
Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems.
Cossum PA, Roberts MS. |
1981 |
4467 |
Manufacturer
Roche Products Limited 2020 |
Avastin - Summary of Product Characteristics
|
2020 |
4474 |
Manufacturer
Merck 2023 |
Avelumab (Bavencio®) - Summary of Product Characteristics
|
2023 |
3236 |
Manufacturer
Celgene 2011 |
Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
|
2011 |
3547 |
Manufacturer
Sanofi-Aventis France 2011 |
Aztréonam (Azactam®) - Résumé des caractéristiques du produit
|
2011 |
94 |
Journal
Am J Hosp Pharm 1990 ; 47: 1970. |
Aztreonam-vancomycin incompatibility.
Chandler SW, Folstad J, Trissel LA. |
1990 |
3683 |
Manufacturer
Aguettant 2014 |
Baclofen - Résumé des caractéristiques du produit
|
2014 |
2729 |
Journal
J Pharm Clin 1995 ; 14, 2: 106-111. |
Bains de bouche antifongiques: études de stabilité.
Vincent I, Schmit B, Houze S, benhaiem N, Jacques L, Taburet AM. |
1995 |
3261 |
Manufacturer
Bristol Myers Squibb 2011 |
Belatacept (Nulojix®) – Résumé des caractéristiques du produit
|
2011 |
3936 |
Manufacturer
GlaxoSmithKline Laboratoire 2016 |
Bélimumab (Benlysta®) – Résumé des caractéristiques du produits
|
2016 |
3721 |
Manufacturer
Spectrum Pharmaceuticals 2014 |
Belinostat (Beleodaq®) - Summary of Product Characteristics
|
2014 |
3158 |
Manufacturer
Astellas Pharma GmbH 2014 |
Bendamustine (Levact®) - Summary of Product Characteristics
|
2014 |
2288 |
Manufacturer
Cephalon 2008 |
Bendamustine hydrochloride (Treanda®) – Summary of Product Characteristics
|
2008 |
3585 |
Manufacturer
Genus Pharmaceuticals 2008 |
Benzylpenicillin sodium - Summary of Product Characteristics
|
2008 |
4582 |
Journal
J Pharm Technol 2021 |
Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules.
Brun D, Curti C, Lamy E, Jean C, Bertault-Përez P, Broggi J, Tintori G, Vanelle P. |
2021 |
3978 |
Journal
Am J Health-Syst Pharm 2017 ; 74,9: 202-210 |
Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations.
Kirk L.M, Brown S.D, Luu Y, Ogle A, Huffman J, O. Lewis P.O. |
2017 |
1269 |
Journal
J Clin Pharm Ther 1988 ; 13: 335-340. |
Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units.
DeMuynck C, De Vroe C, Remon JP, Colardyn F. |
1988 |
857 |
Journal
Am J Hosp Pharm 1983 ; 40: 1323-1328. |
Binding of selected drugs to a “treated” inline filter.
Kanke M, Eubanks JL, DeLuca PP. |
1983 |
3696 |
Journal
Braz J Pharm Sci 2012 ; 48, 4: 691-698. |
Biological and physicochemical stability of ceftazidime and aminophylline on glucose parenteral solution.
Santos C.A.D, Oliveira-Nascimento L, Knirsch M.C, Stephano M.A, Pessoa J?nior A, Penna T.C.V. |
2012 |
3539 |
Manufacturer
The Medecines Company 2013 |
Bivalirudin (Angiox®) - Summary of Product Characteristics.
|
2013 |
4154 |
Manufacturer
Accord Health Care 2018 |
Bleomycin sulfate- Summary of Product Characteristics
|
2018 |
3646 |
Manufacturer
Sanofi Aventis France 2013 |
Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
|
2013 |
3774 |
Manufacturer
Amgen 2016 |
Blinatumomab - (Blincyto®) - Summary of Product Characteristics
|
2016 |
1911 |
Manufacturer
Janssen-Cilag Ltd 2016 |
Bortezomib (Velcade®) - Summary of Product Characteristics
|
2016 |
3537 |
Journal
Krankenhauspharmazie 2013 ; 34,11: 500-505. |
Bortezomib zur subkutanen Applikation.
Lipp HP, Gfrörer W, Riedmüller S. |
2013 |
3495 |
Manufacturer
Takeda 2013 |
Brentuximab (Adcetris®) - Summary of Product Characteristics
|
2013 |
705 |
Journal
Am J Hosp Pharm 1981 ; 38: 183-187. |
Bretylium tosylate admixture compatibility. II : Dopamine, lidocaine, procainamide, and nitroglycerin.
Lee YC, Malick W, Amann AH, Baaske DM, Shah JJ, Wagenknecht DM, Carter JE. |
1981 |
743 |
Journal
Am J Hosp Pharm 1980 ; 37: 803-808. |
Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM. |
1980 |
2878 |
Journal
Can J Hosp Pharm 2009 ; 62, 5: 375-380. |
Buffered Lidocaine Hydrochloride Solution With and Without Epinephrine: Stability in Polypropylene Syringes.
Pascuet E, Donnelly RF, Garceau D, Vaillancourt R. |
2009 |
3653 |
Manufacturer
Laboratoire Léo 2013 |
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
|
2013 |
3684 |
Manufacturer
Laboratoire Léo 2012 |
Bumétanide (Burinex®) - Résumé des caractéristiques du produit
|
2012 |
181 |
Journal
Med Sci Monit 2015 ; 21:1138-1145. |
Butorphanol and Ketamine Combined in Infusion Solutions for Patient-Controlled Analgesia Administration: A Long-Term Stability Study.
Fuchao Chen, Hui Xiong, Jinguo Yang, Baoxia Fang, Jun Zhu, Benhong Zhou. |
2015 |
3237 |
Manufacturer
Sanofi Aventis France 2011 |
Cabazitaxel (Jevtana®) - Résumé des caractéristiques du produit.
|
2011 |
3644 |
Manufacturer
Hameln Pharmaceuticals 2010 |
Calcium gluconate® - Summary of Product Characteristics
|
2010 |
4689 |
Journal
Braz J Pharm Sci 2022 ;58: e19175 |
Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo.
Dysarz L.P, Tavares M, Viçosa A.L, Ribeiro M.F, Teixeira R.G.S, Elias S.C, Márcio R. M. |
2022 |
4345 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 |
Carbidopa Capsules for Insulinoma Diagnostic: Compounding and Stability Study.
Curti C, Mathias F, Savelli M, Garrigue P, Lamy E, Guillet B, Vanelle P. |
2019 |
2253 |
Journal
J Synchrotron Rad 2001 ; 8: 716-718. |
Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.
Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S. |
2001 |
2254 |
Journal
New J Chem 2000 ; 24: 1003-1008. |
Carboplatin decomposition in aqueous solution with chloride ions monitored by X-ray absorption spectroscopy.
Curis E, Provost K, Nicolis I, Bouvet D, B?nazeth S, Crauste-Manciet S, Brion F, Brossard D. |
2000 |
3348 |
Manufacturer
Amgen 2016 |
Carfilzomib (Kyprolis®) - Résumé des caractéristiques du produit
|
2016 |
3314 |
Manufacturer
Bristol Myers Squibb 2011 |
Carmustine (Bicnu®) – Résumé des caractéristiques du produits
|
2011 |
3167 |
Journal
Farm Hosp 2010 ;34:293-7. |
Carvedilol stability in paediatric oral liquid formulations.
Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA. |
2010 |
4067 |
Journal
Pharmazie 2017 ;72:197-199 |
Caspofungin infusion solutions (50 mg/mL): chemical stability and antifungal activity against Candida spp.
Pinder N, Pelzl L.H; Walther G, Backhaus J, Kurzai O, Hoppe-Ticky T. |
2017 |
1519 |
Manufacturer
Merck Sharp Dohme 2015 |
Caspofungine (Cancidas®) - Summary of Product Characteristics
|
2015 |
2343 |
Manufacturer
Fresenius Biotech 2009 |
Catumaxomab (Removab®)
|
2009 |
3546 |
Manufacturer
Panpharma SA 2007 |
Cefamandole Flavelab - Résumé des caractéristiques du produit
|
2007 |
1479 |
Journal
Krankenhauspharmazie 1995 ; 1: 9-12. |
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Digel S. |
1995 |
3548 |
Manufacturer
Bristol Myers Squibb 2007 |
Cefepime (Maxipime®) - Summary of Product caracteristics.
|
2007 |
2093 |
Manufacturer
Shionogi B.V. 2020 |
Cefiderocol (Fetcroja®)- Summary of Product Characteristics
|
2020 |
3544 |
Manufacturer
Pfizer 2006 |
Cefoperazone (Cefobid®) - Summary of Product Characteristics
|
2006 |
1206 |
Journal
Am J Hosp Pharm 1983 ; 40: 564. |
Cefoperazone-aminoglycoside incompatibility.
Frear RS. |
1983 |
3677 |
Manufacturer
Sanofi Aventis France 2008 |
Cefpirome (Cefrom®) - Résumé des caractéristiques du produit
|
2008 |
2902 |
Manufacturer
Forrest Pharmaceuticals 2015 |
Ceftazidime - avibactam (Avycaz®) - Summary of Product Characteristics
|
2015 |
3883 |
Manufacturer
Arrow 2016 |
Ceftazidime - Résumé des caractéristiques du produit
|
2016 |
273 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1302-1305. |
Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir.
Van Doorne V, Bernaards J, DeJonge P. |
1996 |
697 |
Journal
Can J Hosp Pharm 1988 ; 41: 65-71. |
Ceftazidime stability in normal saline and dextrose in water.
Walker SE, Dratnitsaris G. |
1988 |
3543 |
Manufacturer
Wockhardt 2013 |
Ceftazidime – Summary of Product Characteristics
|
2013 |
4650 |
Manufacturer
Advanz Pharma 2021 |
Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.
|
2021 |
3803 |
Manufacturer
Laboratoires Merck Sharp & Dohme Chibret 2020 |
Ceftolozane / tazobactam (Zerbaxa®) - Summary of Product Characteristics
|
2020 |
3828 |
Poster
ASHP Midyear 2015 |
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
Thabit A.K, Hamada Y, Nicolau D.P. |
2015 |
3523 |
Manufacturer
Roche 2018 |
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
|
2018 |
2302 |
Manufacturer
Lettre AFFSAPS 30 November 2008 2008 ; 61, 5: 356-357. |
Ceftriaxone et incompatibilités physico-chimiques, particulièrement avec les solutions contenant des sels de calcium.
|
2008 |
3687 |
Manufacturer
Stravencon 2013 |
Cefuroxime sodium - Summary of Product Characteristics
|
2013 |
275 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1461-1462. |
Cephalosporin-pentamidine isethionate incompatibilities.
Lewis JD, El-Gendy A. |
1996 |
674 |
Journal
Can J Hosp Pharm 1992 ; 45: 237-242. |
Cephalotin stability in normal saline, five percent dextrose in water, and Dianeal* solutions.
Walker SE, Paton TW, Oreopoulos DG. |
1992 |
2220 |
Manufacturer
Merck Serono 2015 |
Cétuximab (Erbitux®) - Dossier scientifique
|
2015 |
2389 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 69-74. |
Characterization of an extemporaneous liquid formulation of lisinopril
Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL. |
2003 |
410 |
Journal
Am J Hosp Pharm 1991 ; 48: 1500-1506. |
Characterization of cisplatin degradation as affected by pH and light.
Zieske PA, Koberda M, Hines JL, Knight CC, Sriram R, Raghavan NV, Rabinow BE. |
1991 |
2723 |
Journal
J Ped Hematol Oncol 2004 ; 26: 179-184. |
Chemical and functional analysis of hydroxyurea oral solutions.
Heeney MM, Whorton MR, Howard TA. |
2004 |
3898 |
Journal
EJHP 2016 ;23:288-293 |
Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients
Bonacucina G, Logrippo S, Cespi M, Ganzetti R, Casettari L, Sestili M, Perinelli D.R, Ricciutelli M, Marziali A, Polidori C, Pa |
2016 |
3622 |
Journal
Int J Pharm Compound 2014 ; 18, 2 : 152-158. |
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride.
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L. |
2014 |
2803 |
Journal
Respiratory Care 2008 ; 683, 12: 1716-1722. |
Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium.
Bonasia PJ, McVicar WK, Williams B, Ong S. |
2008 |
2201 |
Journal
EJHP Science 2007 ; 13, 3: 55-59. |
Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers.
Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. |
2007 |
2188 |
Journal
EJHP Science 2007 ; 13, 2: 40-47 |
Chemical and physical stability of diluted busulfan infusion solutions.
Karstens A, Krämer I. |
2007 |
482 |
Journal
J Parenter Sci Technol 1991 ; 45: 108-112. |
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM. |
1991 |
436 |
Journal
Am J Hosp Pharm 1991 ; 48: 2635-2637. |
Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4°C for 35 days.
Mitrano FP, Outman WR, Baptista RJ, Palombo JD. |
1991 |
903 |
Journal
J Parenter Sci Technol 1993 ; 47: 35-39. |
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J. |
1993 |
4428 |
Journal
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132. |
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. |
2004 |
380 |
Journal
Crit Care Med 1995 ; 23: 1061-1066. |
Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system.
Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B. |
1995 |
1730 |
Journal
Act Pharm Nord 1991 ; 3: 251. |
Chemical compatibility of mitoxantrone and etoposide (VP-16).
Björkman S, Roth B. |
1991 |
1461 |
Journal
J Pharm Pharmacol 1994 ; 46: 951-955. |
Chemical incompatibility between procainamide hydrochloride and glucose following intravenous admixture.
Sianipar A, Parkin JE, Sunderland VB. |
1994 |
585 |
Journal
J Clin Pharm Ther 1988 ; 13: 199-205. |
Chemical stabilities of cefaperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections.
Das Gupta V, Bethea C, Dela Torre M. |
1988 |
961 |
Journal
J Clin Pharm Ther 1990 ; 15: 187-196. |
Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion.
Barnes AR. |
1990 |
693 |
Journal
J Clin Pharm Ther 1988 ; 13: 329-334. |
Chemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixtures.
Das Gupta V, Parasrampuria J, Bethea C. |
1988 |
631 |
Journal
J Parenter Sci Technol 1985 ; 39: 145-148. |
Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion.
Das Gupta V, Stewart KR. |
1985 |
2986 |
Journal
J Clin Pharm Ther 1988 ; 13: 165-169. |
Chemical stabilities of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy.
Gupta VD, Parasrampurian J, Gardner SN. |
1988 |
1331 |
Journal
J Clin Hosp Pharm 1986 ; 11 : 449-452. |
Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.
Das Gupta V, Steward KR. |
1986 |
657 |
Journal
J Clin Pharm Ther 1996 ; 21: 173-175. |
Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes.
Pramar YV, Loucas VA, Word D. |
1996 |
667 |
Journal
J Clin Pharm Ther 1994 ; 19: 195-198. |
Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes.
Pramar YV, Moniz D, Hobbs D. |
1994 |
2173 |
Journal
EJHP Science 2006 ; 12, 6: 135-139. |
Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care.
Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P. |
2006 |
1813 |
Journal
Int J Pharm Compound 2003 ; 7, 4: 310-312. |
Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Gupta VD. |
2003 |
2875 |
Journal
Can J Hosp Pharm 2004 ; 57, 5: 283.287. |
Chemical Stability of 4-Aminopyridine Capsules.
Donnelly RF. |
2004 |
2319 |
Journal
EJHP Science 2009 ; 15, 1: 11-14. |
Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump.
Janssen K, Wisselo R, Geerlings C, Schouten J.P. |
2009 |
2586 |
Journal
Br Assoc Dermatol 1998 ; 139 (suppl 52): 8-1. |
Chemical stability of adepalene and tretinoin when combined with benzoyl peroxyde in presence and in absence of visible light and ultraviolet radiation.
Martin B, Meunier C, Montels D. |
1998 |
2252 |
Journal
Neuromodulation 2007 ; 10, 1: 1-5. |
Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J. |
2007 |
2249 |
Journal
Neuromodulation 2007 ; 10, 1: 12-17. |
Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
Shields D, Montenegro R, Aclan J. |
2007 |
2280 |
Journal
Int J Pharm Compound 2008 ; 12, 5: 463-466. |
Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
Shields DE, Aclan J, Szatkowski A. |
2008 |
2251 |
Journal
Neuromodulation 2005 ; 8, 4: 257-263. |
Chemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration.
Shields D, Montenegro R, Ragusa M. |
2005 |
2298 |
Journal
Int J Pharm Compound 2008 ; 12, 6: 553-557. |
Chemical stability of admixtures containing ziconotide 25 mcg/ml and morphine sulfate 10 mg/ml or 20 mg/ml during simulated intrathecal administration.
Shields D.E, Aclan J, Szatkowski A. |
2008 |
647 |
Journal
Int J Pharm Compound 1997 ; 1: 347-348. |
Chemical stability of amiodarone hydrochloride in intravenous fluids.
Pramar YV. |
1997 |
2877 |
Journal
Int J Pharm Compound 2009 ; 13, 5: 445-446. |
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms.
Das Gupta V. |
2009 |
2737 |
Journal
J Pharm Pharmacol 1996 ; 48, 1: 22-26. |
Chemical stability of artesunate injection and proposal for its administration by intravenous infusion.
Batty KT, Ilett KF, Timothy Davis ME. |
1996 |
3534 |
Journal
Am J Health-Syst Pharm 2013 ; 70:2137-2142 |
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D. |
2013 |
3418 |
Journal
Int J Pharm Bio Sci 2013 ; 3, 1: 449-458. |
Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C.
Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C |
2013 |
3349 |
Journal
Int J Pharm Bio Sci 2012 ; 2, 3: 344-350. |
Chemical stability of bortezomib solutions in original manufacturer vials.
Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M. |
2012 |
3180 |
Journal
Int J Pharm Compound 2011 ; 15, 1: 78-80. |
Chemical stability of brompheniramine maleate in an oral liquid dosage form.
Gupta VD, Gupta VS. |
2011 |
3086 |
Journal
Anaesthesia 2000 ; 55, 9: 853-858. |
Chemical stability of bupivacaine, lidocaine and epinephrine in pH-adjusted solutions.
Robinson, J, Fernando, R, Sun Wai, W.Y., Reynolds, F. |
2000 |
1814 |
Journal
Int J Pharm Compound 2003 ; 7, 2: 152-154. |
Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene suyringes for padiatric use.
Gupta VD. |
2003 |
4244 |
Poster
2019 |
Chemical Stability of Cloxacillin in Sterile Water for Injection (SWFI) Stored in Polypropylene (PP) Syringes (50 and 100 mg/mL) and Glass Vials (250 mg/mL) at 4°C and 25°C.
Perks W, Marchensano R, Law S, Iazetta J, Walker SE. |
2019 |
1229 |
Journal
Br J Pharm Pract 1990 ; 12: 53-54, 60. |
Chemical stability of cytarabine and vinblastine injections.
Weir PJ, Ireland DS. |
1990 |
1372 |
Journal
Int J Pharm Compound 2007 ; 11, 1: 79-81. |
Chemical Stability of Desonide in Ear Drops.
Gupta,VD. |
2007 |
1701 |
Journal
Int J Pharm Compound 2002 ; 6: 395-397. |
Chemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Gupta VD. |
2002 |
1806 |
Journal
Can J Hosp Pharm 2002 ; 55, 5: 307-312. |
Chemical stability of dimenhydrinate in minibags and polypropylene syringes.
Donnely RF. |
2002 |
1277 |
Journal
Can J Hosp Pharm 1999 ; 52: 150-155. |
Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes.
Donnelly RF. |
1999 |
4393 |
Poster
Sunnybrook Health Sciences Centre 2020 |
Chemical Stability of Epinephrine Diluted in 0.9% Sodium Chloride and Stored in Polypropylene (PP) Syringes at 4°C and 25°C.
Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E. |
2020 |
2886 |
Journal
Int J Pharm Compound 2009 ; 13, 3: 250-253. |
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. |
2009 |
4418 |
Journal
J Pediatr Pharmacol Ther 2004 ; 9, 4: 254-258. |
Chemical Stability of Extemporaneously Prepared Lorazepam Suspension at Two Temperatures.
Ellaria Lee W-M, Lugo R.A, Rusho W.J, MacKay M, Sweeley J. |
2004 |
2031 |
Journal
Int J Pharm Compound 2005 ; 9: 482-483. |
Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags.
Donnelly RF. |
2005 |
1680 |
Journal
Int J Pharm Compound 2002 ; 6: 468-470. |
Chemical stability of furosemide in minibags and polypropylene syringes.
Donnelly RF. |
2002 |
2367 |
Journal
Int J Pharm Compound 2005 ; 9, 5: 399-401. |
Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion.
Gupta V.D. |
2005 |
2835 |
Journal
Int J Pharm Compound 2007 ; 11, 3: 259-261. |
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Das Gupta V. |
2007 |
2659 |
Journal
Int J Pharm Compound 2010 ; 14, 2: 160-164. |
Chemical stability of hydromorphone hydrochloride in patient-controlled analgesia injector.
Khondkar D, Chopra P, McArter JP, Rosen JA, Li SK. |
2010 |
2837 |
Journal
Int J Pharm Compound 2005 ; 9, 2: 165-166. |
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form
Das Gupta V, Sood A. |
2005 |
1750 |
Journal
Int J Pharm Compound 1998 ; 2: 463-465. |
Chemical stability of meperidine hydrochloride in polypropylene syringes.
Donelly RF, Bushfield TL. |
1998 |
2843 |
Journal
Int J Pharm Compound 2004 ; 8, 6: 489-491. |
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly R. |
2004 |
1627 |
Journal
Int J Pharm Compound 2001 ; 5: 148-150. |
Chemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes.
Das Gupta V. |
2001 |
1957 |
Journal
Int J Pharm Compound 2005 ; 9, 1: 72-74. |
Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature.
Gupta VD. |
2005 |
2376 |
Journal
J Sep Sci 2007 ; 30, 12: 1233-1238. |
Chemical stability of midazolam injection by high performance liquid chromatography.
de Diego M, Godoy G, Mennikent S. |
2007 |
3998 |
Journal
Int J Pharm Compound 2017 ; 21:4 :347-351 |
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
Robert J, Sorrieul J, Rossignol E, Beaussart H, Kieffer H, Folliard C, Dupoiron D, Devys C. |
2017 |
154 |
Journal
Pharm Res 1990 ; 7: 452-460. |
Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent.
Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ. |
1990 |
3278 |
Journal
Int J Pharm Compound 2012 ; 16, 1: 80-81. |
Chemical Stability of Pentoxifylline in a Topical Cream.
Gupta Vishnu D |
2012 |
2849 |
Journal
Int J Pharm Compound 2005 ; 9, 6: 484-486. |
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Das Gupta V. |
2005 |
1631 |
Journal
Int J Pharm Compound 2008 ; 12, 4: 372-374. |
Chemical stability of perphenazine in two commercially available vehicles for oral liquid dosage forms
Gupta VD. |
2008 |
1891 |
Journal
Int J Pharm Compound 2004 ; 8, 2: 153-155. |
Chemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusion.
Gupta VD. |
2004 |
2876 |
Journal
Int J Pharm Compound 2009 ; 13, 5: 438-439. |
Chemical Stability of Scopolamine Hydrobromide Nasal Solution.
Das Gupta V. |
2009 |
684 |
Journal
Ann Pharmacotherapy 1990 ; 24: 1056-1058. |
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM. |
1990 |
3835 |
Journal
Current Ther Res 2015 ; 77: 99-104. |
Chemical Stability of Telavancin in Elastomeric Pumps.
Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C. |
2015 |
1933 |
Journal
Int J Pharm Compound 2004 ; 8, 5: 404-406. |
Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags.
Gupta VD. |
2004 |
1827 |
Journal
J Parenter Sci Technol 1990 ; 44: 332-335. |
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM. |
1990 |
381 |
Journal
J Parenter Sci Technol 1993 ; 47: 166-171. |
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R. |
1993 |
527 |
Journal
J Clin Pharm Ther 1987 ; 12: 339-342. |
Chemical stability of thiopental sodium injection in disposable plastic syringes.
Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR. |
1987 |
172 |
Journal
J Parenter Sci Technol 1992 ; 46: 111-116. |
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM. |
1992 |
2248 |
Journal
Neuromodulation 2007 ; 10, 1: 6-11. |
Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
Shields D, Montenegro R. |
2007 |
4412 |
Journal
J Pediatr Pharmacol Ther 2014 ;19,1:25–29. |
Chiral Stability of an Extemporaneously Prepared Clopidogrel Bisulfate Oral Suspension.
Tynes C.R, Livingston B, Patel H, Arnold J.J. |
2014 |
3326 |
Journal
J Pharm Pract and Res 2012 ; 42, 2: 106-110. |
Chiral stability study of oral liquid clopidrogel formulations for infants.
Mihaila B, Ellis D, Rozek T, Milne R. |
2012 |
3507 |
Manufacturer
AbbVie 2013 |
Chirocaine - Summary of Product Characteristics
|
2013 |
2199 |
Manufacturer
Mundipharma 2007 |
Chlorhydrate d'oxycodone (Oxynorm®)– Résumé des caractéristiques du produits
|
2007 |
3596 |
Manufacturer
Sanofi 2014 |
Chlorpromazine (Largactil®) - Summary of Product Characteristics
|
2014 |
3520 |
Manufacturer
Sanofi 2011 |
Cidomycin - Summary of product Chracteristics.
|
2011 |
3592 |
Manufacturer
Sandoz 2008 |
Cimetidine - Résumé des caractéristiques du produit
|
2008 |
1201 |
Journal
Am J Hosp Pharm 1981 ; 38: 1919-1922. |
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG. |
1981 |
1203 |
Journal
Am J Hosp Pharm 1981 ; 38: 1173-1174. |
Cimetidine hydrochloride compatibility with preoperative medications.
Yuhas EM, Lofton FT, Baldinus JG, Mayron D. |
1981 |
747 |
Journal
Am J Hosp Pharm 1980 ; 37: 390-392. |
Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
Rosenberg HA, Dougherty JT, Mayron D, Baldinus JG. |
1980 |
268 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1850-1851. |
Ciprofloxacin and sodium phosphate not compatible during actual Y-site injection.
Benjamin BE. |
1996 |
1393 |
Journal
Pharm J 1987 ; 238: 290. |
Ciprofloxacin lactate infusion.
Lyall D, Blythe J. |
1987 |
3529 |
Manufacturer
Hospira 2013 |
Ciprofloxacin – Summary of Product Characteristics
|
2013 |
1500 |
Journal
Ann Pharmacotherapy 1996 ; 30: 87. |
Ciprofloxacin-ampicillin sulbactam incompatibility.
Melonakos TK. |
1996 |
3601 |
Manufacturer
Actavis 2012 |
Cisatracurium Actavis - Résumé des Caractéristiques du Produit
|
2012 |
4769 |
Journal
Pharmaceutics 2023 ;15,1404 |
Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products.
Roche M, Danel C, Simon N, Kouach M, Bouchfaa M, Berneron C, Odou P, Lannoy D. |
2023 |
3578 |
Manufacturer
Accord Healthcare 2011 |
Cisplatin - Summary of Product Characteristics
|
2011 |
4084 |
Manufacturer
Accord Health Care 2017 |
Cisplatine - Résumé des caractéristiques du produits
|
2017 |
3579 |
Manufacturer
Janssen Cilag 2005 |
Cladribine Janssen Cilag - Résumé des caractéristiques du produit
|
2005 |
3526 |
Manufacturer
Pharmacia 2010 |
Clindamycin (Dalacin®) - Summary of Product Characteristics
|
2010 |
2238 |
Manufacturer
Baxter 2018 |
Clinomel - Résumé des caractéristiques du produit
|
2018 |
2272 |
Manufacturer
Genzyme 2006 |
Clofarabine (Evoltra®) – Résumé des caractéristiques du produits
|
2006 |
4515 |
Journal
Pharmaceutics 2020 |
Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice.
Tomczak S, Stawny M, Jelinska A. |
2020 |
4178 |
Journal
EJHP 2017 ; 25, e2 |
Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration.
Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E. |
2017 |
1974 |
Journal
J Pain Symptom Manage 1996 ; 12, 3: 168-171. |
Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
Chandler SW, Trissel LA, Weinstein SM |
1996 |
1978 |
Journal
Clin Ther 1992 ; 14, 2: 192-195. |
Comparative sorption of clomipramine, viloxazine and maprotiline hydrochlorides in polyvinylchloride bags and glass vials.
Airaudo C, Bianchi C, Verdier M, Gayte-Sorbier A. |
1992 |
4317 |
Journal
J Pharm Technol 2019 ;35,3:105-109 |
Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes.
Lawson S, Lewis P, Peacock G, Brown S. |
2019 |
4140 |
Journal
Int J Pharm Compound 2018 ;22,4:340-344 |
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes.
Huffman J, Brown S, Lewis P, Lawson S, Ogle A, Peacock G. |
2018 |
2042 |
Journal
Antimicrob Agents Chemother 2002 ; 46: 2327-2332. |
Comparative stability studies of antipseudomonal ß-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
Viaene E, Chanteux H, Servais H, Mingeot-Leclerq MP, Tulkens PM. |
2002 |
4279 |
Journal
Bio Drugs 2019 ; 33: 193–205. |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. |
2019 |
1651 |
Journal
J Clin Pharm Ther 2002 ; 27: 205-209. |
Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions.
Ars?ne M, Favetta P, Favier B, Bureau J. |
2002 |
1246 |
Journal
Pharm Weekbl [Sci] 1990 ; 12: 188-189. |
Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings.
Hooymans PM, Janknegt R, Lohman JJHM. |
1990 |
4642 |
Poster
SEFH Congress (Virtual) October 2021 2021 |
Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia.
Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner |
2021 |
3464 |
Journal
Enferm Clin 2011 21:25-29. |
Compatibilidad física de la amiodarona en perfusión continua
Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau. |
2011 |
3466 |
Journal
Enferm Intensiva 2011 ;22:78-82. |
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau. |
2011 |
3212 |
Journal
Enferm Intensiva 2011 ;22:78-82. |
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos.
Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M. |
2011 |
3134 |
Journal
Enferm Intensiva 2010 ; 21: 96-103. |
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM. |
2010 |
3465 |
Journal
Enferm Intensiva 2010 ;21:96-103. |
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
E. P?rez Juan, M. Maqueda Palau, M. Ar?valo Rubert, B. Ribas Nicolau, S.M. Amor?s Cerd?. |
2010 |
4332 |
Poster
JFSPH 2019 2019 |
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI).
Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI) |
2019 |
2109 |
Journal
Pharmactuel 2006 ; 39: 71-75. |
Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels.
Pelletier E, Forest JM, Hildgen P. |
2006 |
3766 |
Journal
Pharmactuel 2014 ; 47, 3 : 161-165. |
Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels
Forrest J.M, Hildgen P. |
2014 |
3964 |
Journal
Pharmactuel 2017 ; 50,1 : 27-33. |
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. |
2017 |
3176 |
Poster
16èmes JFSPH, Sion, 18-19 novembre 2010 |
Compatibilité du Remifentanil avec d'autres médicaments injectables : influence du soluté.
Humbert Delaloye V, Berger M, Voirol P, Pannatier A. |
2010 |
2879 |
Poster
GSASA Congress - Lucerne - Switzerland 2008 |
Compatibilité entre amiodarone, catecholamines et/ou nitroprussiate de sodium, administré en continu par voie veineuse aux soins intensifs adultes.
Imesch G., Humbert-Delaloye V., Berger M., Pannatier A. |
2008 |
1909 |
Journal
J Pharm Clin 2000 ; 19: 248-251. |
Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche.
Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A. |
2000 |
3767 |
Journal
Pharmactuel 2014 ; 47, 3 : 167-172. |
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Legris M.E, Lavoie A, Forrest J.M, Hildgen P. |
2014 |
4742 |
Journal
Pharmactuel 2022 ; 55, 4: 247-255. |
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Macoviciuc M, Nguyen C, Forest J-M, Leclair G. |
2022 |
3823 |
Journal
Pharmactuel 2015 ; 48, 3 : 146-152. |
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. |
2015 |
4389 |
Journal
Pharmactuel 2019 ;52,4:206-213 |
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. |
2019 |
3985 |
Poster
Hopipharm Congress 2017 - Nancy 2017 |
Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro.
Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. |
2017 |
3216 |
Journal
Pharmactuel 2011 ; 44, 1 : 14-18 |
Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y.
Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G. |
2011 |
4354 |
Poster
GERPAC Congress 2019 2019 |
Compatibilité visuelle du Vyxeos lors d'administration en Y avec une sélection de médicaments injectables.
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. |
2019 |
4654 |
Poster
Communication personnelle 2021 |
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. |
2021 |
3177 |
Poster
16èmes JFSPH, Sion, 18-19 novembre 2010 2010 |
Compatibilités physico-chimique entre catécholamines, amiodarone, et/ou nitroprussiate de sodium intraveineux.
Humbert-Delaloye V, Berger M, Pannatier A. |
2010 |
36 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2423-2426. |
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. |
1995 |
311 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 167-169. |
Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.
Newborn AL, Kessler JM, Joyner KA. |
1996 |
3498 |
Journal
Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424. |
Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M |
2008 |
2787 |
Journal
Am J Health-Syst Pharm 2005 ; 62, 8: 828-833. |
Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
Lee TY, Chen CM, Lee CN, Chaing YC. |
2005 |
310 |
Journal
Am J Hosp Pharm 1991 ; 48: 510-514. |
Compatibility and pH variability of four injectable phenytoin sodium products.
Markowsky SJ, Kohls PR, Ehresman D, Leppik I. |
1991 |
1932 |
Journal
Int J Pharm Compound 2004 ; 8,5: 398-403. |
Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
Trissel LA, Zhang Y. |
2004 |
284 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2560-2564. |
Compatibility and stability of aztreonam and vancomycin hydrochloride.
Trissel LA, Xu QA, Martinez JF. |
1995 |
3159 |
Journal
Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121. |
Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution.
Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z. |
2010 |
695 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 873-875. |
Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutions.
Zbrozek AS, Marble DA, Bosso JA. |
1988 |
3125 |
Journal
Int J Pharm Compound 2010 ; 14, 4: 346-349. |
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin.
Baker D S, Waldrop Bruce, Arnold John. |
2010 |
1943 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1924-1927. |
Compatibility and stability of ceftazidime sodium and tenoxicam in 5% dextrose injection.
Wang DP, Chiou AHJ, Lee DKT. |
2004 |
639 |
Journal
Drug Intell Clin Pharm 1987 ; 21: 806-810. |
Compatibility and stability of clindamycin phosphate - aminoglycoside combinations within polypropylene syringes.
Zbrozek AS, Marble DA, Bosso JA, Bair JN, Townsend RJ. |
1987 |
566 |
Journal
Am J Hosp Pharm 1983 ; 40: 91-94. |
Compatibility and stability of clindamycin phosphate with intravenous fluids.
Porter WR, Johnson CA, Cohon MS, Gillespie W. |
1983 |
2022 |
Journal
J Pain Symptom Manage 2005 ; 30: 80-86. |
Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes.
Watson DG, Lin M, Morton A, Cable CG, McArthur DA. |
2005 |
4431 |
Journal
Medicine 2018 ; 97:50(e13698) |
Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.
Chen P, Chen F, Zhou B-H. |
2018 |
731 |
Journal
Am J Hosp Pharm 1978 ; 35: 669-672. |
Compatibility and stability of diazepam injection following dilution with intravenous fluids.
Morris ME. |
1978 |
1058 |
Journal
Am J Hosp Pharm 1983 ; 40: 1690-1691. |
Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives.
Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ. |
1983 |
1405 |
Journal
J Clin Pharm Ther 1998 ; 23: 67-72. |
Compatibility and stability of fentanyl admixtures in polypropylene syringes.
Peterson GM, Miller KA, Galloway JG, Dunne PF. |
1998 |
2205 |
Journal
Arzneimittel Forschung 2006 ; 56, 10: 714-720. |
Compatibility and stability of furosemide and dexamethasone combined in infusion solutions.
Negro S, Rendon AL, Azuara ML, S?nchez Y, Fern?ndez-Carballido A, Barcia E. |
2006 |
29 |
Journal
J Pharm Sci 1995 ; 84: 267-268. |
Compatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutions.
Pinguet F, Rouanet P, Martel P, Fabbro M, Salabert D, Astre C. |
1995 |
9 |
Journal
Can J Hosp Pharm 1992 ; 45: 187-192. |
Compatibility and stability of hyaluronidase and hydromorphone.
Walker SE, Lau DWC. |
1992 |
1194 |
Journal
Am J Hosp Pharm 1983 ; 40: 1007-1009. |
Compatibility and stability of labetolol hydrochloride in commonly used intravenous solutions.
Yuen PHC, Taddei CR, Wyka BE, Chaudry IA. |
1983 |
1658 |
Journal
J Am Pharm Assoc 2000 ; 40: 520-524. |
Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
Zhang Y, Xu QA, Trissel LA, Willimas KY. |
2000 |
1659 |
Journal
J Am Pharm Assoc 2000 ; 40: 509-514. |
Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
Xu QA, Trissel LA, Williams KY. |
2000 |
1668 |
Journal
Ann Pharmacotherapy 2000 ; 34: 996-1001. |
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Zhang Y, Xu QA, Trissel LA, Williams KY. |
2000 |
2353 |
Journal
Int J Pharm Compound 2000 ; 4, 6: 476-479. |
Compatibility and stability of linezolid injection admixted with gentamicin sulfate and tobramycin sulfate.
Xu Q.A, Trissel L.A, Zhang Y, Williams K.Y. |
2000 |
4034 |
Journal
Afr J Pharm Pharmacol 2012 ;27,6:2055-2060 |
Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions.
Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y. |
2012 |
1866 |
Journal
Int J Pharm 1998 ; 174: 157-177. |
Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone.
Vermeire A, Remon JP. |
1998 |
3434 |
Journal
Can J Hosp Pharm 2013 ; 66, 3 : 167-170. |
Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection.
Kistner C, Ensom M.H.H, Decarie D, Lauder G, Carr R.R. |
2013 |
4310 |
Journal
Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16. |
Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.
Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. |
2017 |
6 |
Journal
Am J Hosp Pharm 1994 ; 51: 2138-2142. |
Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22 and 32°C.
Trissel LA, Xu QA, Martinez JF, Fox JL. |
1994 |
25 |
Journal
Am J Hosp Pharm 1993 ; 50: 1410-1414. |
Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
McGuire TR, Narducci WA, Fox JL. |
1993 |
872 |
Journal
Ann Pharmacotherapy 1997 ; 31: 1465-1470. |
Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F. |
1997 |
1286 |
Journal
Ann Pharmacotherapy 1998 ; 32: 1013-1016. |
Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Trissel LA, Xu QA, Gilbert DL. |
1998 |
2312 |
Journal
Int J Pharm Compound 2009 ; 13, 1: 78-80. |
Compatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administration.
Trissel L.A, Trusley C, Kupiec T.C, Ben M. |
2009 |
2227 |
Journal
Int J Pharm Compound 2008 ; 12, 2: 156-160. |
Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA. |
2008 |
2228 |
Journal
Int J Pharm Compound 2008 ; 12,2: 170-173. |
Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration.
Kupiec T, Ben M, Trusley C, Trissel LA. |
2008 |
2281 |
Journal
Int J Pharm Compound 2008 ; 12, 5: 460-462. |
Compatibility and stability of palonosetron hydrochloride with lactated Ringer's, Hetastarch in lactated electrolyte, an mannitol injections during simulated Y-site administration.
Ben M, Kupiec T, Trusley C, Trisel LA. |
2008 |
3075 |
Journal
EJHP Science 2009 ; 15, 4: 78-82. |
Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia
Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J. |
2009 |
3366 |
Journal
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403 |
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. |
2012 |
925 |
Journal
Can J Hosp Pharm 1998 ; 51: 55-57. |
Compatibility and stability of propafenone hydrochloride with five critical-care medications.
Dupuis LL, Trope A, Giesbrecht E, Wong B. |
1998 |
934 |
Journal
Int J Pharm Compound 1998 ; 2: 318-321. |
Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration.
Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M. |
1998 |
3927 |
Journal
Int J Pharm Compound 2017 ; 21, 1 : 66-75. |
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate.
Wu G,Yeung S,Chen F. |
2017 |
3928 |
Journal
Int J Pharm Compound 2017 ; 21, 1: 76-82. |
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
Wu G, Yeung S, Chen F. |
2017 |
3327 |
Journal
Am J Health-Syst Pharm 2012 ; 69:1405-1409 |
Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
LaPlante K.L, Woodmansee S, Mermel L.A. |
2012 |
4693 |
Journal
Drug Design Dev Ther 2022 ;16:1433-1440. |
Compatibility and Stability of Ten Commonly Used Clinical Drugs in Pediatric Electrolyte Supplements Injection.
Shen H, Fu Y, Chen Y, Xia W, Jia Z, Yu Q, Zhang L, Han L. |
2022 |
3132 |
Journal
J Palliat Med 2010 ; 13, 3: 273-277. |
Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine.
Negro S, Martin A, Azuara L, Sanchez Y, Barcia E. |
2010 |
2211 |
Journal
J Clin Pharm Ther 2007 ; 32: 441-444. |
Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B. |
2007 |
1671 |
Journal
Int J Pharm 1996 ; 139: 243-247. |
Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC. |
1996 |
4061 |
Journal
Int J Pharm Compound 2018 ; 22,1 :86-94 |
Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride.
Wu George, Powers Dan, Yeung S, Chen F, Neelon K. |
2018 |
4062 |
Journal
Int J Pharm Compound 2018 ;22,1:76-85 |
Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection.
Wu George, Powers Dan, Yeung S, Chen F, Neelon K. |
2018 |
1033 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 985-989. |
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK. |
1999 |
1606 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 594-598. |
Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK. |
2001 |
1325 |
Journal
JPEN 1982 ; 6: 163-165. |
Compatibility of 5-fluorouracil and total nutrition solutions.
Hardin TC, Clibon U, Page CP, Cruz AB. |
1982 |
4435 |
Journal
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27. |
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Hanifah S, Nugroho B.H, Chabib L. |
2020 |
307 |
Journal
Am J Hosp Pharm 1994 ; 51: 1792-1799. |
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. |
1994 |
3 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2208-2212. |
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. |
1995 |
390 |
Journal
Am J Hosp Pharm 1986 ; 43: 1482-1485. |
Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Craft DA, Lizer MH. |
1986 |
364 |
Journal
Am J Hosp Pharm 1989 ; 46: 97-100. |
Compatibility of aminophylline and verapamil in intravenous admixtures.
Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ. |
1989 |
1259 |
Journal
Am J Hosp Pharm 1981 ; 38: 900-901. |
Compatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injection.
Jhunjhunwala VP, Bhalla HL. |
1981 |
1172 |
Journal
Am J Hosp Pharm 1981 ; 38: 377-378. |
Compatibility of amphotericin B with certain large-volume parenterals.
Jurgens RW, DeLuca PP, Papadimitriou D. |
1981 |
2900 |
Journal
EJHP 2009 ; 15, 5: 32-38. |
Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration.
Hines S, Pleasance S. |
2009 |
2125 |
Journal
Hospital Pharmacist 2003 ; 10: 354-361. |
Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration.
Gardiner PR. |
2003 |
1982 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 834-837. |
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Trissel LA, Ogundele AB. |
2005 |
1055 |
Journal
Can J Hosp Pharm 1983 ; 36: 43-52. |
Compatibility of antibiotics and other drugs in total parenteral nutrition solutions.
Faragos S. |
1983 |
431 |
Journal
Am J Hosp Pharm 1975 ; 33: 1010-1013. |
Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures.
McRae MP, King JC. |
1975 |
3019 |
Journal
Curr Med Res Opin 2007 ; 23: 2477-2483. |
Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs.
Bonasia P, Cook C, Cheng Y et al. |
2007 |
3764 |
Journal
Am J Health-Syst Pharm 2014 2014; 71: 1831-1832. |
Compatibility of argatroban injection with select antiarrhythmic drugs
Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S. |
2014 |
2004 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1381-1384. |
Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
Patel K, Hursting MJ. |
2005 |
1963 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 2415-2418. |
Compatibility of argatroban with selected cardiovascular agents.
Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS. |
2004 |
1260 |
Journal
Am J Hosp Pharm 1981 ; 38: 871-875. |
Compatibility of azathioprime sodium with intravenous fluids.
Johnson CA, Porter WA. |
1981 |
4456 |
Journal
Scientific reports 2020 10:1788 |
Compatibility of aztreonam in four commercial peritoneal dialysis fluids.
Tobudic S, Prager I, Kussmann M, Obermüller M, Ursli M, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G. |
2020 |
99 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1086-1090. |
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. |
1995 |
4177 |
Journal
Int J Pharm Compound 2018 ;22,6:516-526 |
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide,
Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. |
2018 |
2774 |
Journal
Ann Pharmacotherapy 2004 ; 38: 967-972. |
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions.
McKenzie J.E, Mario Cruz-Rivera M. |
2004 |
529 |
Journal
Pharm Weekbl [Sci] 1991 ; 13: 254-256. |
Compatibility of bupivacaine and iohexol in two mixtures for paediatric regional anaesthesia.
Van Asten P, Glerum JH, Spaanderman ER, Van Niekerk J, Van Dijk A. |
1991 |
220 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 61-64. |
Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE, Christen C, Perez MM, Ma M. |
1997 |
221 |
Journal
Am J Hosp Pharm 1992 ; 49: 2149. |
Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate.
Neels JT. |
1992 |
3378 |
Journal
Am J Health-Syst Pharm 2013 ; 70:515-519. |
Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection
Chen F-C, Fang B-X, Li P, Yang J-G, Zhou B-H. |
2013 |
3805 |
Journal
Am J Health-Syst Pharm 2015 ; 72:1374-1378. |
Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags.
Chen F.C, Xiong H, Liu H.M, Fang B.X, Li P. |
2015 |
3910 |
Journal
EJHP 2016 ; 23: 352-358. |
Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.
Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O. |
2016 |
4732 |
Journal
Am J Health-Syst Pharm 2023 80, 3;164–170 |
Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration.
Kenneally A, Agbana P, Gardner B, Bae Y, Mitchell T, Beckman E. |
2023 |
2247 |
Journal
Int J Pharm Compound 2008 ; 12, 3: 276-278. |
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Chan P, Heatherly K, Kupiec T.C, Trissel L.A. |
2008 |
3542 |
Journal
Am J Health-Syst Pharm 2015 ; 72:390-395 |
Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion
Berti A.D, Hutson P.R, Schulz L.T, Webb A.P, Rose W.E. |
2015 |
93 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2185-2188. |
Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
Hutchings SR, Rusho WJ, Tyler LS. |
1996 |
79 |
Journal
Am J Hosp Pharm 1991 ; 48: 111-113. |
Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection.
Lee DKT, Wang DP, Lee A. |
1991 |
87 |
Journal
Am J Hosp Pharm 1991 ; 48: 108-110. |
Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection.
Lee DKT, Lee A, Wang DP. |
1991 |
1670 |
Journal
Pharmazie 1998 ; 53: 112-116. |
Compatibility of cefpirome and cephalotin with PVC bags during simulated infusion and storage.
Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC. |
1998 |
3249 |
Journal
Am J Health-Syst Pharm 2011 ; 68: 2163-2169. |
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. |
2011 |
900 |
Journal
Ann Pharmacotherapy 1992 ; 26: 1221-1226. |
Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
Pleasants RA, Vaughan LM, Williams DM, Fox JL. |
1992 |
3984 |
Journal
Hosp Pharm 2017 ,52;3 : 221-228 |
Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
Meyer K, Santarossa M, Danziger L.H, Wenzler E. |
2017 |
2269 |
Journal
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551. |
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. |
2008 |
3846 |
Journal
Pharmazie 2016 71: 185?191. |
Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions.
Polonini HC, Silva SL, Cunha CN, Brand?o MAF, Ferreira AO. |
2016 |
434 |
Journal
Am J Hosp Pharm 1991 ; 48: 2166-2171. |
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Goodwin SD, Nix DE, Heyd A, Wilton JH. |
1991 |
14 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1193-1195. |
Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
Gilbert DL, Trissel LA, Martinez JF. |
1997 |
4460 |
Journal
Scientific reports 2019 9:6512 |
Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.
Kussmann M, Ferth A, Obermüller M, Pichler P, Zeitlinger M, Wiesholzer , Burgmann H, Poeppl W, Reznicek G. |
2019 |
299 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1735-1741. |
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF, Gilbert DL. |
1997 |
413 |
Journal
Am J Hosp Pharm 1990 ; 47: 1373-1377. |
Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection.
Stewart CF, Fleming RA. |
1990 |
565 |
Journal
Drug Intell Clin Pharm 1986 ; 20: 960-963. |
Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions.
Marble DA, Bosso JA, Townsend RJ. |
1986 |
644 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 54-57. |
Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles.
Marble DA, Bosso JA, Townsend RJ. |
1988 |
421 |
Journal
Am J Hosp Pharm 1985 ; 42: 839-843. |
Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures.
Foley PT, Bosso JA, Bair JN, Townsend RJ. |
1985 |
3012 |
Journal
Hosp Pharm 2015 ; 50, 3: 214-220. |
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Sullivan T, Forrest J.M, Leclair G. |
2015 |
549 |
Journal
Int J Pharm Compound 1997 ; 1: 121-122. |
Compatibility of common respiratory therapy drug combinations.
Owsley HD, Rusho WJ. |
1997 |
132 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 181-184. |
Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.
Najari Z, Rusho WJ. |
1997 |
3715 |
Journal
Am J Health-Syst Pharm 2014 ; 71:1534-1535 |
Compatibility of conivaptan injection with select cardiovascular medications.
Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D. |
2014 |
227 |
Journal
Am J Hosp Pharm 1994 ; 51: 2292. |
Compatibility of cyclizine lactate and haloperidol lactate.
Fawcett JP, Woods DJ, Munasiri B, Becket G. |
1994 |
3981 |
Journal
EJHP 2017 ;24:162?166 |
Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D. |
2017 |
389 |
Journal
Am J Hosp Pharm 1991 ; 48: 2161-2166. |
Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
Walker SE, DeAngelis C, Iazzetta J, Eppel JG. |
1991 |
712 |
Journal
Am J Hosp Pharm 1980 ; 37: 496-500. |
Compatibility of diazepam with intravenous fluid containers and administration sets.
Parker WA, MacCara ME. |
1980 |
2087 |
Journal
Pharmactuel 2004 ; 37: 17-20. |
Compatibility of dimenhydrinate injectable by Y administration.
Ferreira E, Forest JM, Hildgen P. |
2004 |
250 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 566-569. |
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P. |
1997 |
1754 |
Journal
Int J Pharm Compound 1999 ; 3: 241-244. |
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Wolkin AC. |
1999 |
2262 |
Journal
Am J Health-Syst Pharm 2008 ; 65: 1261-1265. |
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. |
2008 |
251 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2708-2713. |
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. |
1997 |
1897 |
Journal
EJHP 2001 ; 7, 3: 108-115. |
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
Sautou-Miranda V, Brigas F, Thibault M, Chopineau J. |
2001 |
789 |
Journal
Am J Hosp Pharm 1990 ; 47: 604-606. |
Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system.
Garner SS, Wiest DB. |
1990 |
963 |
Journal
J Clin Pharm Ther 1990 ; 15: 371-376. |
Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside.
Schaaf LJ, Tremel LC, Wulf BG, Vernon KK. |
1990 |
3708 |
Poster
ECOP 2 Krakow 2014 |
Compatibility of epirubicin-loaded DC Beads with different contrast media.
Sarakbi I, Thiesen J, Krämer I. |
2014 |
3918 |
Journal
J Oncol Pharm Practice 2016 ; 22: 749-756. |
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
Sarakbi I, Krämer I. |
2016 |
8 |
Journal
Am J Hosp Pharm 1988 ; 45: 368-371. |
Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER. |
1988 |
4598 |
Journal
Int J Pharm Compound 2021 ;78,4:336-349 |
Compatibility of Estradiol, Estriol; Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base.
Polonini H, Dijkers E, Ferreira A, Zander C, Taylor S. |
2021 |
319 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 997-999. |
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Hadzija BW, Lubarsky DA. |
1995 |
1410 |
Journal
J Am Pharm Assoc 1999 ; 39: 141-145. |
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Simmons M. |
1999 |
1722 |
Journal
EJHP 2002 ; 2: 33-40. |
Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions.
Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J. |
2002 |
1803 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 80-85. |
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. |
2003 |
1993 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1190-1192. |
Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
Lee DKT, Wang DP, Harsono R, Wong CY. |
2005 |
104 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 185-189. |
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Hall PD, Yui D, Lyons S, Bosso JA. |
1997 |
244 |
Journal
Am J Hosp Pharm 1994 ; 51: 1907-1913. |
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. |
1994 |
4458 |
Journal
Eur J Clin Microbiol Infec Dis 2017 36:2237–2242. |
Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G. |
2017 |
367 |
Journal
Am J Hosp Pharm 1985 ; 42: 116-119. |
Compatibility of furosemide with aminoglycoside admixtures.
Thompson DF, Allen LV, Desai SR, Rao PS. |
1985 |
1423 |
Journal
J Am Pharm Assoc 1999 ; 39: 514-518. |
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Gilbert DL. |
1999 |
4534 |
Journal
Int J Pharm Compound 2021 ;25,5:422-426 |
Compatibility of Gestrinone, Nimesulide, and Piroxican in Pentravan for Transdermal and Transmucosal Application.
Polonini H, De Oliveira Ferreira A, Dijkers. |
2021 |
49 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 208. |
Compatibility of granisetron hydrochloride with selected alkaline drugs.
Trissel LA, Martinez JF. |
1995 |
182 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 56-60. |
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. |
1997 |
1676 |
Journal
Int J Pharm 1997 ; 154: 95-102. |
Compatibility of granisetron towards glass and plastics and its stability under various storage conditions.
Hourcade F, Sautou-Miranda V, Normand B, Laugier M, Picq F, Chopineau J. |
1997 |
982 |
Journal
Ann Pharmacotherapy 1995 ; 29: 1168. |
Compatibility of haloperidol and diphenhydramine in a hypodermic syringes.
Ukhun IA. |
1995 |
1970 |
Journal
Support Care Cancer 2003 ; 11, 2: 107-113. |
Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Barcia E, Reyes R, Azuara M.L, S?nchez Y, Negro S. |
2003 |
617 |
Journal
Am J Hosp Pharm 1982 ; 39: 843-844. |
Compatibility of haloperidol lactate and heparin sodium.
Solomon DA, Nasinnyk KK. |
1982 |
229 |
Journal
Am J Hosp Pharm 1994 ; 51: 2962-2963. |
Compatibility of haloperidol lactate with benztropine mesylate.
Jackson CW, Cunningham K. |
1994 |
341 |
Journal
Am J Hosp Pharm 1985 ; 42: 1352-1355. |
Compatibility of heparin sodium and morphine sulfate.
Baker DE, Yost GS, Craig VL, Campbell RK. |
1985 |
767 |
Journal
Ann Pharmacotherapy 1997 ; 31: 789-790. |
Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion.
Trinkle R. |
1997 |
216 |
Journal
Am J Hosp Pharm 1994 ; 51: 2963. |
Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine.
Huang E, Anderson RP. |
1994 |
4558 |
Journal
Milit Med 2016 ; 181, 10:1305. |
Compatibility of Hydroxyethyl Starch and Tranexamic Acid for Battlefield Co-Administration.
Studer, N.M, Yassin, A.H, Keen, D.E. |
2016 |
1910 |
Manufacturer
Baxter 2002 |
Compatibility of imiglucerase (personal communication)
|
2002 |
21 |
Journal
Am J Hosp Pharm 1986 ; 43: 2803-2809. |
Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions.
Bigley FP, Forsyth RJ, Henley MW. |
1986 |
2090 |
Journal
Pharmactuel 2004 ; 37: 193-196. |
Compatibility of injectable pantoprazole in Y-site administration.
Pere H, Chasse V, Forest JM, Hildgen P. |
2004 |
4521 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2020 |
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. |
2020 |
2164 |
Journal
Perit Dial Int 2006 ; 26, 4: 498-502. |
Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials.
Voges M, Divinop-Filho JC, Faict D, Somers F, Vermeulen P. |
2006 |
4398 |
Journal
J Pharm Pract and Res 2020 |
Compatibility of intravenous busulfan with BBraun giving sets, fludarabine and Posiflush.
Smith E. K., Shergold J.A., McWhinney B.C. |
2020 |
4440 |
Journal
Ann Nutr Metab 2018 ; 73: 227-233. |
Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion.
Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M. |
2018 |
3459 |
Journal
Cancer Chemother Pharmacol 2013 ; 72: 509-513. |
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.
Sun S, Schaller J, Placek J, Duersch B. |
2013 |
4464 |
Journal
PlosOne 2018 13(1): e0190577. |
Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion.
Garcia J, Garg A, Song Y, Fotios A, Andersen C, Garg S. |
2018 |
3948 |
Journal
JPEN 2012 ;30. 416?424. |
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . |
2012 |
312 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 570-571. |
Compatibility of iron dextran with neonatal parenteral nutrient solutions.
Mayhew SL, Quick MW. |
1997 |
313 |
Journal
Am J Hosp Pharm 1992 ; 49: 2233-2235. |
Compatibility of iron dextran with total nutrient admixtures.
Tu YH, Knox NL, Biringer JM, Eichman ML, Schweinsberg PD, Howard JR. |
1992 |
3829 |
Poster
ASHP Midyear 2015 |
Compatibility of isavunazonium sulfate during simulated Y-site administration.
So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. |
2015 |
1864 |
Journal
Pain 1998 ; 75: 389-390. |
Compatibility of ketamine and morphin injections.
Lau MH, Hackman C, Morgan DJ. |
1998 |
1934 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1438-1445. |
Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes.
Ambados F, Brealey J. |
2004 |
321 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 205. |
Compatibility of ketamine hydrochloride and meperidine hydrochloride.
Ambados F. |
1997 |
469 |
Journal
Am J Hosp Pharm 1990 ; 47: 1097-1100. |
Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
Floy BJ, Royko CJ, Fleitman JS. |
1990 |
4603 |
Journal
Hosp Pharm 2021 ; 56, 4: 228-234. |
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. |
2021 |
1072 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1458-1459. |
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. |
1999 |
4176 |
Journal
Am J Health-Syst Pharm 2018 ;75:1467-1477 |
Compatibility of linezolid with commercial peritoneal dialysis solutions
Poeppl W, Rainer-Harbach E, Kussmann M, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Reznicek G. |
2018 |
2466 |
Journal
Am J Hosp Pharm 1981 ; 38: 1750-1753. |
Compatibility of lithium citrate syrup with 10 neuroleptic solutions
Theesen KA, Wilson JE, Newton DW, Ueda CT. |
1981 |
218 |
Journal
Am J Hosp Pharm 1993 ; 50: 2311. |
Compatibility of magnesium sulfate and morphine sulfate in 0.9% sodium chloride injection.
Vogt C, Ruggaber S. |
1993 |
1047 |
Journal
Am J Hosp Pharm 1984 ; 41: 323-324. |
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Souney PF, Colucci RD, Mariani G, Campbell D. |
1984 |
298 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 320-321. |
Compatibility of mannitol and sodium bicarbonate in injectable fluids.
Matuschka PR, Smith WR, Vissing RS. |
1995 |
1415 |
Journal
JPEN 1999 ; 23: 67-74. |
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M. |
1999 |
4507 |
Journal
Am J Health-Syst Pharm 2020 ;77,23:1980-1985 |
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Ross E, Salinas A, Petty K, Her C, Carpenter J. |
2020 |
4376 |
Journal
Int J Pharm Compound 2020 ;24,1:83-85 |
Compatibility of Melphalan in Iodinated Contrast Media.
Shi Z, Abruzzo T, Wanasathop A, Li S K. |
2020 |
266 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2853-2855. |
Compatibility of meropenem with commonly used injectable drugs.
Patel PR. |
1996 |
3922 |
Journal
Perit Dial Int 2016 doi:10.3747/pdi.2016.0001 |
Compatibility of meropenem with different commercial dialysis solutions.
Wiesholzer, Winter A, Kussmann M, Zeitlinger M, Pichler P, Burgmann H, Reznicek G,Poepp l W. |
2016 |
2108 |
Journal
Int J Pharm Compound 2006 ; 10: 230-232. |
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Trusley C, Kupiec TC, Trissel LA. |
2006 |
186 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2020-2022. |
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Swart EL, Mooren RAG, Van Loenen AC. |
1995 |
1842 |
Journal
Arzneimittel Forschung 1995 ; 45: 93-98. |
Compatibility of morphin, baclofen, floxuridine and fluorouracil in an implantable infusion pump.
Sadjack A, Wintersteiger R. |
1995 |
980 |
Journal
Aust J Hosp Pharm 1995 ; 25: 352. |
Compatibility of morphine and ketamine for subcutaneous infusion.
Ambados F. |
1995 |
1492 |
Journal
Can J Hosp Pharm 1995 ; 48: 155-160. |
Compatibility of morphine and midazolam or haloperidol in parenteral admixtures.
LeBelle MJ, Savard C, Gagnon A. |
1995 |
1020 |
Journal
Am J Hosp Pharm 1987 ; 44: 67. |
Compatibility of morphine sulfate injection and prochlorperazine injection.
Zuber DEL. |
1987 |
519 |
Journal
Aust J Hosp Pharm 1991 ; 21: 316. |
Compatibility of morphine tartrate admixtures in polypropylene syringes.
Poggi GL. |
1991 |
616 |
Journal
Am J Hosp Pharm 1982 ; 39: 841-843. |
Compatibility of nalbuphine hydrochloride with other preoperative medications.
Jump WG, Plaza VM, Poremba A. |
1982 |
405 |
Journal
Am J Hosp Pharm 1985 ; 42: 1108-1109. |
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Nieves-Cordero AL, Luciw HM, Souney PF. |
1985 |
2550 |
Journal
Aust J Hosp Pharm 1993 ; 23: 35-37. |
Compatibility of nebulizer solutions
Roberts GW, Rossi S.O.P. |
1993 |
316 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2611-2613. |
Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs.
Veltri M, Lee CKK. |
1996 |
1200 |
Journal
Am J Hosp Pharm 1981 ; 38: 1737-1742. |
Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives.
Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. |
1981 |
1960 |
Journal
J Pharm Biomed Anal 2005 ; 37: 259-264. |
Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers.
Kambia NK, Dine T, Dupin-Spriet T, Gressier B, Luycks M, Goudaliez F, Brunet C. |
2005 |
3865 |
Journal
Int J Pharm Compound 2016 ; 20, 3 : 236-238. |
Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration.
Vicky M, Samit S, Jaymin P, Michael C T. |
2016 |
2012 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 2001-2005. |
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M. |
2005 |
16 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1554-1556. |
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA. |
1995 |
332 |
Journal
Ann Pharmacotherapy 1995 ; 29: 1106-1109. |
Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
Xu QA, Trissel LA, Fox JL. |
1995 |
1725 |
Journal
Can J Hosp Pharm 2001 ; 54: 112-113. |
Compatibility of oxytocin, zidovudine, and penicillin G.
Oliver C, Law S. |
2001 |
1865 |
Journal
Int J Pharm 1999 ; 178: 77-82. |
Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions.
Sautou-Miranda V, Brigas F, Vanheerswinghels S, Chopineau J. |
1999 |
158 |
Journal
Am J Hosp Pharm 1994 ; 51: 2804-2810. |
Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
Trissel LA, Xu QA, Kwan J, Martinez JF. |
1994 |
2016 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1998-2000. |
Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
Xu QA, Trissel LA. |
2005 |
3210 |
Journal
Int J Pharm Compound 2011 ; 15, 3: 259-261. |
Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations.
Jasti Bhaskara R, Saraf Poonam. |
2011 |
301 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1295-1300. |
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. |
1997 |
4538 |
Journal
Archives of Disease in Childhood 2020 ; 105: 395-397. |
Compatibility of pentoxifylline and parenteral medications.
Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K. |
2020 |
81 |
Journal
Am J Hosp Pharm 1994 ; 51: 672-678. |
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF. |
1994 |
1501 |
Journal
Int J Pharm 1999 ; 185: 113-121. |
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. |
1999 |
391 |
Journal
Am J Hosp Pharm 1987 ; 44: 1620-1624. |
Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Michelini TJ, McMahon RE. |
1987 |
372 |
Journal
Am J Hosp Pharm 1988 ; 45: 609-612. |
Compatibility of premixed theophylline and verapamil intravenous admixtures.
Johnson CE, Lloyd CW, Aviles AI, Rybarz KL. |
1988 |
1860 |
Journal
Int J Pharm 1996 ; 130: 251-255. |
Compatibility of propofol diluted in 5% glucose with glass and plastics (polypropylene, molyvinylchloride) containers.
Sautou-Miranda V, Levadoux E, Groueix MT, Chopineau J. |
1996 |
300 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1287-1292. |
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. |
1997 |
1863 |
Journal
Journal of clinical anesthesia 1996 ; 8: 329-336. |
Compatibility of propofol, fentanyl,and vecuronium mixtures designed for potential use in anesthesia and patient transport.
Isert PR, Lee D, Naidoo D, Carasso ML, Kennedy RA. |
1996 |
1198 |
Journal
Am J Hosp Pharm 1982 ; 39: 1685-1687. |
Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers.
Cummings DS, Park MK, Howard B. |
1982 |
3913 |
Journal
EJHP 2018 ;25,3:150-156. |
Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.
Polonini H.C, Silva S.L, Loures S, Almy R, Balland A, Brandao M.A.F, Ferreira A.O. |
2018 |
59 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2192-2196. |
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Kim MC. |
1997 |
1665 |
Journal
J Clin Pharm Ther 2002 ; 21: 39-45. |
Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine.
Öster Svedberg K, McKenzie J, Larrivee-Elkins C. |
2002 |
295 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1048-1051. |
Compatibility of selected critical care drugs during Y-site administration.
Yamashita SK, Walker SE, Choudhury T, Iazzetta J. |
1996 |
1035 |
Journal
J Parenter Sci Technol 1983 ; 37: 129-132. |
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
Bisaillon S, Sarrazin R. |
1983 |
207 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2024-2025. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Ku YM, Min DI, Kumar V, Noormohamed SE. |
1995 |
3827 |
Poster
ASHP Midyear 2015 |
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
Ghazi I.M, Hamada Y, Nicolau D.P. |
2015 |
1165 |
Journal
Int J Pharm 1980 ; 4: 263-265. |
Compatibility of the cephalosporin, cefamandole nafate with injections.
Bowtle WJ, Heasman MJ, Prince AP, Easthope DA. |
1980 |
249 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1041-1045. |
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. |
1996 |
1420 |
Journal
J Clin Pharm Ther 1999 ; 24: 125-132. |
Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.
Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M. |
1999 |
1338 |
Journal
Am J Hosp Pharm 1985 ; 42: 777-778. |
Compatibility of total nutrient admixtures and secondary cardiovascular medications.
Baptista RJ, Dumas GJ, Bistrian BR, Condella F, Blackburn GL. |
1985 |
2002 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1299-1302. |
Compatibility of tramadol hydrochloride injection with selected drugs and solutions.
Abanmy NO, Zaghloul IY, Radwan MA. |
2005 |
4407 |
Journal
Am J Health-Syst Pharm 2020 ;77,8:649–657. |
Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration.
Bustin A, Ramsey Z, Hanna B, Kaushal G. |
2020 |
924 |
Journal
J Pharm Pharmacol 1998 ; 50: 407-411. |
Compatibility of tropisetron with glass and plastics. Stability under different storage conditions.
Brigas F, Sautou-Miranda V, Normand B, Geneve S, Chopineau J. |
1998 |
3813 |
Journal
Hosp Pharm 2015 ; 50, 8: 710-713. |
Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
Teibel H.M, Knoderer C.A, Nichols K.R. |
2015 |
1748 |
Journal
Int J Pharm Compound 1997 ; 1: 354-355. |
Compatibility of vancomycin hydrochloride and famotidine in 5% dextrose injection.
Wang DP, Wang MT, Wong CY, Lee DKT. |
1997 |
1228 |
Journal
Am J Hosp Pharm 1981 ; 38: 380-381. |
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Allen LV, Stiles ML. |
1981 |
730 |
Journal
Am J Hosp Pharm 1977 ; 34: 939-943. |
Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets.
Allen LV, Saul Levinson R, Phisutsinthop D. |
1977 |
1067 |
Journal
EJHP 1999 ; 5: 106-110. |
Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers.
Zeidler C, Dettmering D, Schrammel W, Spieteller M. |
1999 |
1057 |
Journal
Am J Hosp Pharm 1983 ; 40: 1205-1207. |
Compatibility of verapamil hydrochloride injection with commonly used additives.
Cutie MR. |
1983 |
706 |
Journal
Am J Hosp Pharm 1981 ; 38: 231. |
Compatibility of verapamil hydrochloride with other additives.
Cutie MR. |
1981 |
371 |
Journal
Am J Hosp Pharm 1988 ; 45: 142-145. |
Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection.
Thompson DF, Stiles ML, Allen LV, Tu YH. |
1988 |
552 |
Journal
Int J Pharm Compound 1997 ; 1: 356-358. |
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Martinez JF, Trissel LA, Gilbert DL. |
1997 |
4319 |
Journal
Hosp Pharm 2020 ; 55, 5: 332-337. |
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. |
2020 |
54 |
Journal
J Pharm Clin 1995 ; 14: 26-30. |
Compatibility PVC-psychotropic drugs during an infusion.
Bureau A, Lahet JJ, D?Athis P, Vailleau JL, Cosmidis V, Martin L. |
1995 |
1713 |
Journal
Int J Pharm Compound 2002 ; 6: 311-315. |
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA. |
2002 |
1721 |
Journal
Int J Pharm Compound 2001 ; 5: 69-72. |
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Trissel LA, Williams KY, Baker MB. |
2001 |
1925 |
Journal
J Am Pharm Assoc 2000 ; 40: 515-519. |
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
Trissel LA , Williams KY, Gilbert DL. |
2000 |
1662 |
Journal
J Oncol Pharm Practice 2002 ; 8: 33-37. |
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA, Ingram DS, Ogundele AB. |
2002 |
1712 |
Journal
Int J Pharm Compound 2002 ; 6: 230-233. |
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA. |
2002 |
4404 |
Poster
JFSPH 2019 2019 |
Compatibility studies of seven commonly used drugs for parenteral administration in palliative care.
Müller U, Haller F, Wiedemeier P, Steuer C. |
2019 |
162 |
Journal
Int J Pharm 1994 ; 105: 83-87. |
Compatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixtures.
Benaji B, Dine T, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Gressier B, Cazin M, Cazin JC. |
1994 |
1888 |
Journal
Ziekenhuisfarmacie 1986 ; 2: 45-48. |
Compatibility study of midazolam.
Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A. |
1986 |
1468 |
Journal
Int J Pharm 1994 ; 107: 111-119. |
Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin.
Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F. |
1994 |
4027 |
Journal
Hosp Pharm 2017 ;52,10:685-690 |
Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution.
Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M. |
2017 |
4023 |
Journal
Hosp Pharm 2017 ; 52,7 : 478-482. |
Compounded Apixaban Suspensions for Enteral Feeding Tubes.
Carabello M, Donmez S, Nathan K, Zhao F. |
2017 |
3983 |
Journal
EJHP 2016 ; 24: 157-161. |
Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder.
Zaid A.N, Assali M, Zalmout S, Basheer A. |
2016 |
2988 |
Journal
J Clin Pharm Ther 2007 ; 32: 489-496. |
Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study.
Huyghebaert N, de Beer J, Vervaet C et al. |
2007 |
1278 |
Journal
Can J Hosp Pharm 1998 ; 51: 13-19. |
Concentration and solution dependent stability of cloxacillin intravenous solutions.
Walker SE, Dufour A, Iazetta J. |
1998 |
1674 |
Journal
Hosp Pharm 1998 ; 33: 1515-1522. |
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. |
1998 |
2490 |
Journal
Am J Hosp Pharm 1989 ; 46: 304-307. |
Concentration uniformity of extemporaneously prepared ranitidine suspension
Karnes HT, Harris SR, Garnett WR, March C. |
1989 |
1637 |
Journal
Can J Hosp Pharm 2000 ; 53: 24-31. |
Concentration-dependant compatibility and stability of dexamethasone and midazolam.
Wong AH, Law S, Walker SE, Bowles SK. |
2000 |
1070 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1891. |
Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium.
Balthasar JP. |
1999 |
269 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 84-85. |
Concentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactate.
Trissel LA. |
1996 |
3262 |
Journal
J Oncol Pharm Practice 2011 ; 17, 4: 395-399. |
Conditions causing gemcitabine crystallization.
Manners S, Galettis P, de Souza P. |
2011 |
3718 |
Manufacturer
Bayer Healthcare Corporation 2012 |
Conivaptan (Vaprisol®) - Summary of Product Characteristics
|
2012 |
2446 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1299-1301. |
Content uniformity and stability of nifedipine in extemporaneously compounded oral powders
Helin MM, Kontra KM, Naaranlahti TJ, Wallenius KJ. |
1998 |
4470 |
Journal
Critical care 2005 ; 9(Suppl 1) P37 |
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. |
2005 |
2231 |
Journal
J Antimicrob Chemother 2008 ; 61, 2: 382-388. |
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. |
2008 |
501 |
Journal
Am J Hosp Pharm 1985 ; 42: 129-130. |
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Senholzi CS, Kerns MP. |
1985 |
1371 |
Journal
Am J Hosp Pharm 1985 ; 42: 2436. |
Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection.
Bornstein M, Templeton RJ. |
1985 |
1302 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 173-174. |
Cyclosporine binding to components in medication administration sets.
Parr MD, Barton SD, Haver VM, Porter WH. |
1988 |
3580 |
Manufacturer
Accord Healthcare France 2016 |
Cytarabine Accord - Résumé des caractéristiques du produit
|
2016 |
850 |
Journal
Drug Intell Clin Pharm 1982 ; 16: 765-767. |
Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes.
Munson J, Kubiak EJ, Cohon MS. |
1982 |
3605 |
Manufacturer
Lipomed 2010 |
Dacarbazine (Dacarbazine Lipomed®) - Résumé des caractéristiques du produit
|
2010 |
3267 |
Manufacturer
Lipomed 2011 |
Dacarbazine Lipomed - Summary of Product Characteristics
Lipomed Laboratories |
2011 |
3266 |
Manufacturer
Lipomed 2011 |
Dacarbazine solutions: In Use stability of dacarbazine lipomed®
Lipomed Laboratories |
2011 |
4153 |
Manufacturer
Orphan Europe (UF) Limited 2014 |
Dactinomycin (Cosmegen Lyovac®) - Summary of Product Characteristics
|
2014 |
3752 |
Manufacturer
Durata Therapeutics Holding 2014 |
Dalbavancin (Dalvance®) - Summary of Product Characteristics
|
2014 |
1509 |
Manufacturer
Norgine 2014 |
Dantrolene sodium (Dantrium®) - Summary of Product Characteristics
|
2014 |
3218 |
Journal
Perit Dial Int 2011 ; 31: 492?495. |
Daptomycin Compatibility in Peritoneal Dialysis Solutions
Peyro Saint Paul L, Albessard F, Gaillard C, Debruyn D, Ryckelynck J Ph, Antoine Coquerel, Lobbedez T |
2011 |
2271 |
Manufacturer
Novartis 2006 |
Daptomycine (Cubicin®) Résumé des caractéristiques du produits
|
2006 |
4190 |
Manufacturer
Janssen 2018 |
Daratumumab (Darzalex®) - Summary of Product Characteristics.
|
2018 |
3604 |
Manufacturer
Sanofi Aventis France 2012 |
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit
|
2012 |
3577 |
Manufacturer
Galen Limited |
Daunorubicine (Daunoxome®) - Résumé des caractéristiques du produit
|
|
4355 |
Manufacturer
Jazz Pharmaceuticals UK 2019 |
Daunorubicine/cytarabine liposomale (Vyxeos®) - Summary of Product Characteristics
|
2019 |
2217 |
Journal
Ziekenhuisfarmacie 1997 ; 13, 1: 21-23. |
De stabiliteit van clonazepaminjectievloeistof.
Guchelaar H.J, Hartog M.E. |
1997 |
2240 |
Manufacturer
Janssen Pharmaceuticals 2019 |
Décitabine (Dacogen®) - Summary of Product caracteristics
|
2019 |
1882 |
Journal
Ziekenhuisfarmacie 1993 ; 9: 97-101. |
Decrease of sufentanil citrate concentration during formulation and application of an epidural infusion solution.
Bosch EH, Van Doorne H, Brouwers JRBJ, Marskamp A, Meevis RF. |
1993 |
3671 |
Manufacturer
Teva UK Ltd 2016 |
Deferoxamine - Résumé des caractéristiques du produit
|
2016 |
3701 |
Manufacturer
Gentium SPa 2014 |
Defibrotide (Defitelio®) - Summary of Product Characteristics
|
2014 |
2291 |
Journal
Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226. |
Degradation kinetics of neostigmine in solution.
Yeh MK. |
2000 |
3390 |
Journal
Int J Pharm 1993 ; 99: 73-78. |
Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution.
Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M. |
1993 |
1157 |
Journal
Int J Pharm 1988 ; 43: 131-138. |
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM. |
1988 |
2570 |
Journal
Am J Hosp Pharm 1994 ; 51: 1205-1207. |
Degradation of captopril in solutions compounded from tablets and standard powder.
Chan DS, Sato AK, Claybaugh JR. |
1994 |
3093 |
Journal
J Pharm Sci 2010 ; 99, 3 : 1288-1298. |
Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics
Tian J, Stella VJ. |
2010 |
2243 |
Journal
Int J Pharm 1997 ; 146: 263-269. |
Degradation pathway of carboplatin in aqueous solution.
Pujol M, Girona V, Prat J, Munoz M, De Bolos J. |
1997 |
4636 |
Journal
J Oncol Pharm Practice 2022 ; |
Design and stability of pediatric oral formulation of imatinib
Hinterlang M, Gendron A, Fleury F, Rieutord A, Vrana A , Schlatter J, Annereau M. |
2022 |
2884 |
Journal
Int J Pharm 2015 ; 487 : 270-273. |
Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml
Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F. |
2015 |
3886 |
Journal
Eur J Pharm Sci 2016 ; 92 : 220-223. |
Design and stability study of an oral solution of amlodipine besylate for pediatric patients.
van der Vossen A.C, van der Velde I, Smeets O.S.N.M,. Postma D.J, Vermes A,. Koch B.C.P, Vulto A.G,.Hanff L.M. |
2016 |
3361 |
Journal
Int J Pharm 2012 ; 423: 360-364. |
Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide.
Santovena A, Hernandez-Paiz Z, Farina J.B. |
2012 |
2717 |
Journal
J Liquid Chrom 1995 ; 18: 3117-3128. |
Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation.
Barnes AR. |
1995 |
1757 |
Journal
J Clin Pharm Ther 1998 ; 23: 311-314. |
Determination of compatibility and stability of drugs used in palliative care.
Schrijvers D, Tai-Apin C, De Smet MC, Cornil P, Vermorken JB, Bruyneel P. |
1998 |
835 |
Journal
Int J Pharm 1979 ; 4: 21-26. |
Determination of the stability of mitomycin C by high performance liquid chromatography.
Edwards D, Selkirk AB, Taylor RB. |
1979 |
2239 |
Journal
Chinese J New Drugs 2005 ; 14, 2: 189-191. |
Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry.
Wang C, Zhang X, Liu HY. |
2005 |
3296 |
Journal
J Chromatographic Sci 2009 ; 47: 1-7. |
Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection.
Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F |
2009 |
3971 |
Journal
Int J Pharm Compound 2017 ; 21, 2 : 164-170. |
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
Gorman G, Sokom S, Coward L, Arnold J J. |
2017 |
4750 |
Journal
Pharmaceutics 2023 ,15, 755. |
Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation.
Lebrat M, Bouattour Y, Gaudet C, Yessaad M, Jouannet M, Wasiak M, Dhifallah I, Beyssac E, Garrait G, Chennell P, Sautou V. |
2023 |
3875 |
Journal
EJHP 2016 ; 23: 4: 213-218. |
Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus.
Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S. |
2016 |
2317 |
Journal
EJHP Science 2009 ; 15, 1: 3-5. |
Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia.
Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G. |
2009 |
4498 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2020 |
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T. |
2020 |
4628 |
Journal
Pharmaceuticals 2021 ; 14, 943. |
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B. |
2021 |
3319 |
Journal
Int J Pharm 2012 ; 433, 1-2 : 119-120. |
Development and validation of a paediatric oral formulation of clonidine hydrochloride
de Goede A.L, Boedhram R.R, Eckhardt M, Hanff L.M, Koch B.C.P, Vermaat C.H, Vermes A. |
2012 |
2165 |
Journal
J Liquid Chrom Rel Technol 2006 ; 29, 16: 2353-2365. |
Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis.
Kumar V, Madabushi R, Derendorf H, Boothby LA, Breland BD, Hatton RC, Doering PL. |
2006 |
3399 |
Poster
EAHP Congress Paris 2013 |
Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children.
Li Y.Y, Postma D.J, Wagenaar H.W.G. |
2013 |
4653 |
Journal
EJHP 2021 ; 28: 331-335. |
Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers.
Jansen MMPM, van Waas VPH, Verzijl JM, Burger D. |
2021 |
3297 |
Journal
Chromatographia 2008 ; 68, 9-10: 767-772. |
Development of an LC–DAD Method for Analysis of Dexketoprofen, Tramadol, and Haloperidol. Study of the Stability of Mixtures Used for Patient-Controlled Analgesia.
Salmeron-Garcia A, Lopez-Lopez E, Roma E, Cabeza J, Navas N, Capitan-Vallvey L.F. |
2008 |
2904 |
Journal
Ann Pharm Fr 2005 ; 63: 162-166. |
Development of an oxybutynin chloride solution: from formulation to quality control.
Fratta A, Bordenave J, Boissinot C, Le Grand J, Esquirol C, Radideau E, Benoit G. |
2005 |
650 |
Journal
Int J Pharm Compound 1997 ; 1: 274-277. |
Development of clonidine hydrochloride injections for epidural and intrathecal administration.
Trissel LA, Hassenbusch SJ. |
1997 |
3285 |
Journal
Yakugaku Zasshi 2009 129, 6: 767-771. |
Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method.
Senoo M, Tajika K, Shimizu H, Hamada M, Dobashi Y, Dan K, Katayama S. |
2009 |
3569 |
Journal
EJHP 2014 ;21:34-38 |
Development of ready-to-use cefuroxime syringes for use in ophthalmology.
Fleury-Souverain S, Sadeghipour F, Bonnabry P. |
2014 |
2287 |
Journal
EJHP Science 2008 ; 14, 1: 14-18. |
Development of ready-to-use ketamine hydrochloride syringes for safe use in post-operative pain.
Stucki MC, Leury-Souverain S, Sautter AM, Sadeghipour F, Bonnabry P. |
2008 |
4229 |
Journal
Int J Pharm Compound 2017 ;24,6:519-527 |
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure.
Ma N, Perks W, Law S, John I, Walker S. |
2017 |
2759 |
Journal
Pediatr Neurol 1999 ; 20: 195-197. |
Development of two stable oral suspensions of gabapentin.
Nahata MC. |
1999 |
2721 |
Journal
J Pad Ophtalmol Strabismus 2000 ; 37, 6: 333-337. |
Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children With Amblyopia
Nahata MC, Morosco RS, Leguire LE. |
2000 |
2949 |
Journal
Pharmazie 2007 ; 62: 519-521. |
Development validation and stability study of pediatric atenolol syrup.
Foppa T, Murakami FS, Silva MAS. |
2007 |
3700 |
Journal
Braz J Pharm Sci 2010 ; 46, 1 : 109-114. |
Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp.
Salgado A.C.G.B; Silva A.M.N.N; Machado M.C.J.C; Duarte MA.S.C; Ribeiro, Helena M.O.M. |
2010 |
4712 |
Poster
GERPAC Congrès - octobre 2022 2022 |
Développement de formulations buvables de vinorelbine à usage pédiatrique.
Macqueron L, Régnier L, Robinet P, Leroy AM, Lester MA, Boivin PN, Le Corre P. |
2022 |
3668 |
Manufacturer
Hospira 2015 |
Dexamethasone - Summary of Product Characteristics
|
2015 |
3851 |
Journal
Can J Hosp Pharm 2016 ; 69, 1: 49-51. |
Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes.
Ensom M.H.H, D?carie D. |
2016 |
28 |
Journal
PDA J Pharm Sci Technol 1996 ; 50: 261-267. |
Dexamethasone phosphate stability and contamination of solutions stored in syringes.
Lau DWC, Law S, Walker SE, Iazzetta J. |
1996 |
3581 |
Manufacturer
Clinigen Healthcare 2013 |
Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit
|
2013 |
2224 |
Journal
Bolletino SIFO 2007 ; 53: 178-180. |
Dexrazoxane: Stabilià in soluzione.
Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. |
2007 |
1388 |
Journal
Pharm J 1982 ; 228: 238-239. |
Diamorphine hydrochloride compatibility with saline.
Page J, Hudson S. |
1982 |
1385 |
Journal
Pharm J 1985 ; 235: 171. |
Diamorphine injection BP incompatibility.
Kirk B, Hain WR. |
1985 |
506 |
Journal
J Pharm Pharmacol 1989 ; 41: 275-277. |
Diamorphine stability in aqueous solution for subcutaneous infusion.
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P. |
1989 |
3885 |
Journal
Int J Pharm 2016 ; 506 : 414-419. |
Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method.
Su-Eon Jin, Siwon You, Seungho Jeon, Sung-Joo Hwang. |
2016 |
3613 |
Manufacturer
Primius Lab 2013 |
Dihydralazine (Nepressol®) - Résumé des caractéristiques du produit
|
2013 |
1809 |
Journal
EJHP 2003 ; 3: 34-42. |
Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study.
Arrault XL, Rieutord A, Hassan M, Brion F. |
2003 |
2292 |
Journal
EJHP 2016 ;23:22-27 |
Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability
Philipp E, Braitsch M, Bichsel T, Mühlebach S. |
2016 |
2074 |
Journal
Ann Intern Med 1998 ; 128: 1049. |
Dissolving phenytoin precipitate in central venous access device.
Tse T, Abdullah R. |
1998 |
4487 |
Journal
Pharmaceutics 2020 ; 12, 786. |
Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl- -Cyclodextrins Possess an Extended Physicochemical Stability?
Chennell P, Yessaad M, Abd El Kader F, Jouannet M, Wasiak M, Bouattour Y, Sautou V. |
2020 |
3606 |
Manufacturer
Wokhardt 2013 |
Dobutamine - Summary of Product Characteristics
|
2013 |
1352 |
Journal
Am J Hosp Pharm 1984 ; 41: 2588-2589. |
Dobutamine-heparin mixture inadvisable.
Hasegawa GR, Eder JF. |
1984 |
3130 |
Manufacturer
Sanofi Avantis France 2009 |
Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
|
2009 |
3911 |
Journal
EJHP 2017 ; 24: 230-234. |
Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?
Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L. |
2017 |
3638 |
Manufacturer
Hospira 2010 |
Dopamin (Dopamine 40 mg/mL sterile concentrate®) - Summary of Product Characteristics
|
2010 |
1397 |
Journal
Pharm J 1990 ; 244: 218. |
Dopamine dilutions.
Garner ST, Murdoch JM. |
1990 |
2332 |
Manufacturer
Janssen-Cilag 2009 |
Doripenem (Doribax®) - Laboratoire informations
|
2009 |
3612 |
Manufacturer
Amdipharm Mercury Company 2012 |
Doxapram (Dopram) - Summary of Product Characteristics
|
2012 |
3645 |
Manufacturer
Accord Healthcare 2014 |
Doxorubicin - Summary of Product Characteristics
|
2014 |
3142 |
Manufacturer
SP Europe 2010 |
Doxorubicin hydrochloride liposome (Caelyx®) - Summary of Product Characteristics
|
2010 |
3143 |
Manufacturer
Teva Laboratoire 2015 |
Doxorubicin hydrochloride liposome (Myocet®) - Summary of Product Characteristics
|
2015 |
3144 |
Manufacturer
Ortho Biotech 2010 |
Doxorubicin liposome (Doxil®) - Product Information
|
2010 |
681 |
Journal
Can J Hosp Pharm 1991 ; 44: 71-78. |
Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker S, Lau D, DeAngelis C, Iazetta J, Coons C. |
1991 |
3402 |
Journal
J Oncol Pharm Practice 2013 ; 19, 1: 65-74. |
Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment.
Hecq, J.-D., Lewis, A.L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., Chung, T. |
2013 |
4009 |
Manufacturer
Panpharma 2017 |
Droperidol - Résumé des Caractéristiques du Produit
|
2017 |
1187 |
Journal
Am J Hosp Pharm 1983 ; 40: 94-97. |
Droperidol stability in intravenous admixtures.
Ray JB, Newton DW, Nye MT, Leet WA. |
1983 |
2146 |
Journal
Am J Health-Syst Pharm 2006 ; 63: 2379-2382. |
Drug compatibility with new polyolefin infusion solution containers.
Trissel LA, Xu QA, Baker M. |
2006 |
763 |
Journal
Cancer Treat Rep 1985 ; 69: 1325-1326. |
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH. |
1985 |
817 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 683-685. |
Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device.
Stendal TL, Klem W, Tonnesen HH, Kjonniksen I. |
1998 |
1928 |
Journal
J Pain Symptom Manage 2004 ; 28, 3: 268-272. |
Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture.
Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P. |
2004 |
1088 |
Journal
JAMA 1984 ; 252: 2392. |
Drug trapping in intravenous infusion side arms.
Johnston A, McKenzie MA, Krasnow SH, Hood MA, Cohen MH. |
1984 |
4608 |
Manufacturer
Astra Zeneca 2021 |
Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021)
|
2021 |
2348 |
Manufacturer
Alexion Europe SAS 2007 |
Eculizumab (Soliris®) – Summary of Product Characteristics
|
2007 |
348 |
Journal
Am J Hosp Pharm 1985 ; 42: 335-339. |
Effect of a polyethylene-lined administration set on the avaibility of diazepam injection.
Hancock BG, Black CD. |
1985 |
170 |
Journal
Am J Hosp Pharm 1975 ; 62: 44-45. |
Effect of briefly heating cyclophosphamide solutions.
Brooke D, Scott JA, Bequette RJ. |
1975 |
2396 |
Journal
Am J Health-Syst Pharm 2008 ; 65: 441-447. |
Effect of buffer and antioxidant on stability of a mercaptopurine suspension
Aliabadi HM, Romanick M, Desai S, Lavasanifar A. |
2008 |
351 |
Journal
Am J Hosp Pharm 1986 ; 43: 2795-2799. |
Effect of flow rate and type of IV container on adsorption of diazepam to IV administration systems.
Yliruusi JK, Uotila JA, Kristoffersson ER. |
1986 |
2361 |
Journal
J Clin Pharm Ther 2009 ; 34, 4 : 423-428. |
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
575 |
Journal
Am J Hosp Pharm 1982 ; 39: 104-108. |
Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags.
Holmes CJ, Ausman RK, Kundsin RB, Walter CW. |
1982 |
2020 |
Journal
Can J Hosp Pharm 2005 ; 58: 65-70. |
Effect of freezing on stability of a fortified 5 mg/ml ticarcillin ophtalmic solution.
Blondeel S, Pelloquin A, Pointereau-Bellanger A, Thuillier A, Fernandez C. |
2005 |
2110 |
Journal
EJHP Science 2006 ; 12, 3: 52-56. |
Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C.
Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM. |
2006 |
2015 |
Journal
Ann Pharmacotherapy 2005 39: 1654-1658. |
Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM. |
2005 |
3076 |
Journal
Ann Pharm Fr 2009 ; 67: 427-432. |
Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags.
François JH, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
1958 |
Journal
EJHP Science 2005 ; 11: 23-25. |
Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags.
Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L. |
2005 |
2320 |
Journal
EJHP Science 2009 ; 15, 1: 15-19. |
Effect of freezing, long-term storage and microwave thawing on the stability of sodium folinate.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
1892 |
Journal
Int J Pharm Compound 2004 ; 8, 2: 156-159. |
Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags.
Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM. |
2004 |
2034 |
Journal
EJHP Science 2005 ; 11, 5: 111-113. |
Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions.
Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2005 |
1648 |
Journal
Int J Pharm Compound 2002 ; 6: 391-394. |
Effect of freezing, long-term storage, and microwave thawing on the stability of cefepime in 5% dextrose infusion polyvinyl chloride bags.
Schlesser V, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti LM. |
2002 |
1258 |
Journal
Am J Hosp Pharm 1981 ; 38: 537-540. |
Effect of gentamicin on heparin activity.
Tyler LS, Rehder TL, Davis RB. |
1981 |
510 |
Journal
Pharm World Sci 1993 ; 15: 269-275. |
Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter.
Roos PJ, Glerum JH, Schroeders MJH. |
1993 |
3439 |
Journal
Perit Dial Int 2013 ; 33:458-461 |
Effect of Glucose Concentration on the Stability of Daptomycin in Peritoneal Solutions.
Parra M.A, Campanero M.A, S?daba B, Irigoyen A, Garc?a-L?pez L,Fernandez-Reyes M.J, Ramon Azanza J. |
2013 |
729 |
Journal
Am J Hosp Pharm 1977 ; 34: 1071-1074. |
Effect of inline filtration on the potency of drugs administered intravenously.
Rusmin S, Welton S, DeLuca P, DeLuca PP. |
1977 |
703 |
Journal
Am J Hosp Pharm 1980 ; 37: 935-941. |
Effect of inline filtration on the potency of low-dose drugs.
Butler LD, Munson JM, DeLuca PP. |
1980 |
4439 |
Journal
Nutrients 2019 ; 11: 559. |
Effect of Lipid Emulsion on Stability of Ampicillin in Total Parenteral Nutrition.
Stawny M, Gostynska A, Dettlaff K, Jelinska A, Główka E, Ogrodowczyk M. |
2019 |
509 |
Journal
Pharm World Sci 1993 ; 15: 139-144. |
Effect of pH absorption of sufentanil citrate in a portable pump reservoir during storage and administration under simulated epidural conditions.
Roos PJ, Glerum JH, Meilink JW, Zwang L. |
1993 |
464 |
Journal
Am J Hosp Pharm 1986 ; 43: 2209-2213. |
Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insuline from an infusion system.
Furberg H, Kruse Jensen A, Salbu B. |
1986 |
160 |
Journal
Am J Hosp Pharm 1994 ; 51: 2701-2704. |
Effect of sodium chloride concentration and temperature on melphalan stability during storage and use.
Pinguet F, Martel P, Rouanet P, Fabbro M, Astre C. |
1994 |
2953 |
Journal
J Pharm Sci 1982 ; 71: 585-587. |
Effect of some formulation adjuncts o the stability of benzoyl peroxide.
Gupta VD. |
1982 |
587 |
Journal
Am J Hosp Pharm 1983 ; 40: 1024-1025. |
Effect of storage temperature and time stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
Smith BR. |
1983 |
347 |
Journal
Am J Hosp Pharm 1991 ; 48: 2627-2630. |
Effect of syringe filter and IV administration set on delivery of propofol emulsion.
Bailey LC, Tang KT, Rogozinski BA. |
1991 |
3284 |
Journal
Yakugaku Zasshi 2008 ; 128, 8: 1221-1226. |
Effect of the Admixture of Tetracycline and Nadifloxacin Ointments on Their Stability and Their Antibacterial Activity.
Kawamoto T, Tayama Y, Sawa A, monde T, Sashima S, Yoshioka M, Miyake K, Morita S, Kihira K. |
2008 |
2008 |
Journal
Ann Pharmacotherapy 2005 ; 39: 1244-1248. |
Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C.
Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM. |
2005 |
352 |
Journal
Am J Hosp Pharm 1986 ; 43: 2789-2794. |
Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets.
Yliruusi JK, Uotilo JA, Kristoffersson ER. |
1986 |
2115 |
Journal
J Pain Symptom Manage 2006 ; 31, 6: 563-567. |
Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
Schneider JJ, Good Ph, Ravenscroft PJ,. |
2006 |
194 |
Journal
Am J Hosp Pharm 1990 ; 47: 1559-1562. |
Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set.
Loucas SP, Maager P, Mehl B, Loucas ER. |
1990 |
1349 |
Journal
Aust J Hosp Pharm 1987 ; 17: 31-34. |
Effects of freezing, long term storage and microwave thawing on the stability of three antibiotics reconstituted in minibags.
Sanburg AL, LyndonRC, Sunderland B. |
1987 |
1946 |
Journal
Can J Hosp Pharm 2004 ; 57, 5: 276-282. |
Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion.
Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L. |
2004 |
2432 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2483-2487. |
Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids
Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC. |
1997 |
1353 |
Journal
Am J Hosp Pharm 1984 ; 41: 1835-1837. |
Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets.
Nix DE, Tharpe WN, Francisco GE. |
1984 |
592 |
Journal
J Pharm Clin 1989 ; 8: 101-106. |
Effects of storage temperature and pH on the stability of cefotaxime in PVC bags.
Barthes D, Fauconneau B, Martin JP, Courtois P. |
1989 |
1736 |
Journal
J Clin Pharm Ther 1999 ; 24: 145-150. |
Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations.
Liu J, Chan Y, Ho PC. |
1999 |
146 |
Journal
Clin Ther 1992 ; 14: 821-824. |
Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine.
Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M. |
1992 |
4314 |
Journal
J Am Pharm Assoc 2017 ; 56, 4: 457-461. |
Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection.
DenHerder J.M, Reed R.L, Sargent J.L, Bobe G, Stevens J.F, Helen E Diggs H.E. |
2017 |
4331 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 |
Emulsion Stability of Different Intravenous Propofol Formulations in Simulated Co-Administration with Remifentanil Hydrochloride.
Nilsson N, Nezvalova-Henriksen K, Tho I. |
2019 |
4717 |
Manufacturer
2022 Daiichi Sankyo Europe Gmb |
Enhertu®- Résumé des caractéristiques du produit
|
2022 |
3862 |
Journal
Hosp Pharm 2016 ; 51, 3: 246-251. |
Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions.
Cutshall B.T, Gorman G.S, Freeman M.K ,. Kyle J.A. |
2016 |
2307 |
Journal
Palliative Med 1995 ; 9, 4: 315-318. |
Epidural diamorphine and bupivacaine stability study.
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A. |
1995 |
3642 |
Manufacturer
International Medication System (UK) 2013 |
Epinephrine - Résumé des Caractéristiques du Produit
|
2013 |
659 |
Journal
Can J Hosp Pharm 1996 ; 49: 62-65. |
Epinephrine stability in plastic syringes and glass vials.
Donnely RF, Yen M. |
1996 |
683 |
Journal
Can J Hosp Pharm 1990 ; 43: 265-272. |
Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C. |
1990 |
3632 |
Manufacturer
Hospira 2017 |
Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
|
2017 |
798 |
Journal
Ann Pharmacotherapy 1996 ; 30: 1501-1502. |
Epoetin alfa loss with NaCl 0.9% dilution.
Widness JA, Schmidt R. |
1996 |
3934 |
Manufacturer
GlaxoSmithKline Laboratoire 2016 |
Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit
|
2016 |
3250 |
Manufacturer
Eisai Ltd 2011 |
Eribulin (Halaven®) - Summary of Product Characteristics.
|
2011 |
1912 |
Manufacturer
Merck Sharp Dohme 2016 |
Ertapenem (Invanz®) - Summary of Product Characteristics
|
2016 |
4480 |
Manufacturer
Jazz Pharmaceuticals UK. 2020 |
Erwinase, Lyophilisate for solution for injection.
|
2020 |
3674 |
Manufacturer
PanPharma 2016 |
Erythromycin lactobionate - Summary of Product Characteristics
|
2016 |
4700 |
Manufacturer
AS Kalceks 2022 |
Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
|
2022 |
3607 |
Manufacturer
AOP Orphan Pharmaceuticals AG 2013 |
Esmolol hydrochloride for injection - Summary of Product Characteristics
|
2013 |
2284 |
Manufacturer
Astra Zenaca 2007 |
Esomeprazole sodium (Nexium IV®) – Summary of Product Characteristics
|
2007 |
4612 |
Journal
OFIL 2014 24;2:86-90 |
Estabilidad de la solución de gentamicina y heparina para sellado de catéter.
Villaba-Moreno AM, Gil-Navarro MV, Cotrina-Luque J, Pérez-Moreno MA, Chamorro-de Vega E. |
2014 |
3489 |
Journal
Farm Hosp 1998 ; 22, 5: 249-251. |
Estabilidad de las soluciones orales de clohidrato de metadona al 0,1% y 0,5% en suero fisiologico.
Soy D, Roca M, Deulofeu R, Montes E, Codina C, Ribas J. |
1998 |
2202 |
Journal
Investig Clin Farm 2005 ; 2, 4: 195-203. |
Estabilidad de parecoxib en dilucion con ostros farmacos y administrado en perfusion continua IV para el control del dolor postoperatorio.
Acin Lazaro MP, bono Arino C, martinez Bazan R, manzanares Marin I, Faci Bouthelier A, Velamazan Blocona MJ, Facorro Gaspar E, |
2005 |
2105 |
Journal
Farm Hosp 1999 ; 23: 357-360. |
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C. |
1999 |
3198 |
Journal
Farm Hosp 2008 ; 32, 6 : 344-348. |
Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas.
Nebot Martinez J, Alos Alminana M, Diez Sales O. |
2008 |
2100 |
Journal
Farm Hosp 1995 ; 19: 38-40. |
Estabilidad fisica y quimica del sulfato magnesico combinado con heparina sodica en solucion salina al 0,9 por 100.
Gervas S, Gosalbez F. |
1995 |
2103 |
Journal
Farm Hosp 1999 ; 23: 103-108. |
Estabilidad y compatibilidad del metamizol en jeringa y en mezclas intravenosas.
Noguera Rodriguez A, Sancho Chust V, Medina Hernandez C, Medina Hernandez MJ, Jimenez Torrez NV. |
1999 |
2841 |
Journal
Atencion Pharmaceutica 2009 ; 11, 3: 161-166. |
Estudio de estabilidad de la mezcla ondansetron-dexametasona en cloruro sodico 0,9%.
Gonzalves Navaro M, Carril Aviles M, Borras Almenar C, Romero Crespo I, Jimenez Torres NV. |
2009 |
3706 |
Journal
Farm Hosp 2014 ;38, 3:154-161 |
Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia.
Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B. |
2014 |
3384 |
Journal
Farm Hosp 2013 ;37,1:10-14 |
Estudio de estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua.
Otero F.M |
2013 |
2104 |
Journal
Farm Hosp 2000 ; 24: 145-150 |
Estudio de la estabilidad de mezclas ciclofosfamida/mesna e ifosfamida/mesna en soluciones intravenosas de gran volumen.
Iriarte Izura MA, Gozalo garcia MJ, Marcotegui Ros F, Nagore Indurain C, Urdaniz Baztan AO. |
2000 |
3655 |
Manufacturer
Bristol Myers Squibb 2016 |
Etoposide phosphate (Etopophos®) - Résumé des caractéristiques du produit
|
2016 |
2181 |
Journal
Bull Cancer 1995 ; 82: 189-195. |
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Milano G, Renée N. |
1995 |
3791 |
Poster
Apifh Congress, Paris November 2014 2014 |
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P. |
2014 |
3240 |
Poster
Congrès SFPO 2011 |
Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène.
Perissutti M, Vigneron J, Zenier H, May I, Demoré B. |
2011 |
504 |
Journal
Sci Tech Pharm 1987 ; 3: 33-40. |
Etude de la stabilité dans des solutions diluées destinées à la perfusion de deux antimitotiques dérivés de la podophyllotoxine : l’étoposide (VP 16), le téniposide (VM 26).
Hamon M, Plas-Remoissenet D, Kubab-Alajati S. |
1987 |
1455 |
Journal
J Pharm Clin 1995 ; 14: 178-179. |
Etude de la stabilité de deux benzamides antiémétiques en poches PVC de chlorure de sodium 0.9% et de glucose 5% sur une période de 5 mois.
Demoré B, Raffy F, Commun N, Vigneron J, Hoffman MA, Hoffman M. |
1995 |
4007 |
Poster
Hopipharm Congress 2017-Nancy 2017 |
Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Delannoy-Rousseli?re C, Moreau F, Barthelemy C, Faure K, Decaudin B, Odou P. |
2017 |
3761 |
Book
Master en pharmacie - University of Geneva 2014 |
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Chavan E. |
2014 |
3447 |
Poster
SFPO Congress, Mandelieu, France 2013 |
Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière.
Giovanelli M, Vigneron J, May I, Nicolas A. |
2013 |
4714 |
Poster
GERPAC Congrès - octobre 2022 2022 |
Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine.
Vieillard V, Paul M |
2022 |
3848 |
Thesis
Thèse de doctorat en pharmacie 2014 |
Etude de stabilité d'un collyre à l'amphotéricine B 0,5%.
Dermu Marine. |
2014 |
4041 |
Poster
SNPHPU Congress 12th 2017 |
Etude de stabilité d'un collyre de ceftazidime à 50mg/ml conditionné en flacon de polyéthylène basse densité.
Jobard M, Brandely-Piat M-L, El Deeb G, Labat L, Cros C, Chast F, Batista R. |
2017 |
4424 |
Poster
11ème Recontres Convergences Santé Hôpital 2016 |
Etude de stabilité d'une suspension buvable de cloxacilline à usage pédiatrique.
Barbazan C, Le Daré, Lester M-A, Boivin P-N. |
2016 |
4578 |
Thesis
2011 |
Etude de stabilité de médicaments anticancéreux injectables : apports analytiques et pharmaceutiques
Respaud R. |
2011 |
3120 |
Poster
Congrès HOPIPHARM 2010 |
Etude de stabilité de solutions intravitréennes de vancomycine à 10 mg/ml.
Maillot-Pyszczek V, Bourdeaux D, Sautou V, Chopineau J. |
2010 |
1520 |
Manufacturer
B Braun 2001 |
Etude de stabilité des médicaments en Ecoflac®
|
2001 |
2760 |
Journal
Pharm Hosp et Clin 2007 ; 42, 171 : 171-176. |
Etude de stabilité d’un collyre à ,6 mg/ml de ticarciline.
Galvez O,Mullot JU, Mullot H, Simon L, Grippi R, Payen C, Bonneau D, Huart B, Gentes P. |
2007 |
4066 |
Poster
APHIF 2017 - Congress 2017 2017 |
Etude de stabilité physico-chimique et microbiologique des collyres de ciclosporine à 0.5 ; 5 et 20 mg/mL conditionnés en flacons de polyéthylène basse densité.
Mordohay A, Chanat C, Bezia C, Fresneau J, Jobard M, Brandely-Piat M.L, Batista R. |
2017 |
1289 |
Journal
Pharmakon 1998 ; 116: 145-148. |
Etude de stabilité visuelle du chlorhydrate de chlorpromazine, du chlorure de potassium, de la furosémide et de l’héparine sodique en perfusion continue.
Hecq JD, Evrard JM, Gillet P, Grosdent N. |
1998 |
3383 |
Journal
Farm Hosp 2013 ;37,1:4-9 |
Evaluación de la estabilidad de un jarabe de hidrato de cloral al 7% en envases mono y multidosis bajo condiciones ambiente y de refrigeración.
Bustos-Fierro C, Olivera M. E, Manzo P.G, Jimenez-Kairuz A.K. |
2013 |
4643 |
Journal
EJHP 2021 |
Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes.
Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L. |
2021 |
1645 |
Journal
EJHP 2010 ; 16: 42-47. |
Evaluation of a diltiazem hydrochloride gel for the treatment of anal fissure.
Pinto JF, Salgado AC, Alves ML, Alves S, Neves C, Falcao F. |
2010 |
2991 |
Journal
Drug Dev Ind Pharm 1997 ; 23: 285-291. |
Evaluation of oil/water-type cyclosporine gel ointment with commercially available oral solution.
Tamura T, Takayama K, Satoh H et al. |
1997 |
4627 |
Journal
Adv Ther 2019 36:442–450 |
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Park D, Yun J, Hwang S-J, Park SJ. |
2019 |
4637 |
Journal
Braz J Pharm Sci 2021 ;57: e18896. |
Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern.
Gobetti C, da Silva Bitencourt, A, Vinícius Ayres M, Peixoto de Freitas A.L, Loureiro Mendez A.S, Garcia C.V. |
2021 |
739 |
Journal
Am J Hosp Pharm 1978 ; 35: 402-406. |
Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate.
Cradock JC, Kleinmann LM, Rahman A. |
1978 |
3861 |
Journal
J Pharm Pract and Res 2016 ; 46: 28-33. |
Evaluation of stability of melatonin in extemporaneously compounded oral suspensions.
Friciu M , Savji T , Zaraa S, Leclair G. |
2016 |
4525 |
Journal
Adv Ther 2020 ; 37: 4308–4324. |
Evaluation of the Physico-Chemical and Biological
Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions.
Park D, Kim J, Yun J, Park S.J. |
2020 |
4003 |
Journal
EJHP 2017 ; 25, 3: 157-164. |
Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab).
Kim J, Chung J, Park S, Jung S, Kang D. |
2017 |
3825 |
Journal
J Pharm Pract and Res 2015 ; 496: 421-431. |
Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance.
Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G. |
2015 |
2730 |
Journal
J Pharm Pract and Res 2015 ; 45: 152-158. |
Evaluation of the physicochemical compatibility of cyclosporin infusion and parenteral nutrition when intravenously administered via the same central line lumen.
Coutsouvelis J, Yao-Da Dong, Witney K, Li W, Corallo C. |
2015 |
4252 |
Journal
Int J Pharm Compound 2019 ;23,2:163-166 |
Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Jamart J, Bihin B, Soumoy L, Hecq JD, Galanti LM. |
2019 |
4157 |
Journal
Pediatric Anesthesia 2018 |
Evaluation of the stability and stratification of propofol and ketamine mixtures for pediatric anesthesia.
Izgi M, Basara B, Muderrisoglu A, Yilbas A.A, Uluer M.S, Celebioglu B. |
2018 |
3345 |
Journal
Int J Pharm Compound 2012 ; 16, 5: 428-430. |
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date.
Peacock G.F, Sauvageot J. |
2012 |
3667 |
Journal
Int J Pharm Compound 2014 ; 18, 3: 253-255. |
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F,Sauvageot Jurgita |
2014 |
4117 |
Journal
Drug Design Dev Ther 2017 ;11:2087-2097 |
Evaluation of the stability of linezolid in aqueous solution and commonly used intravnous fluids.
Taylor R, Sunderland B, Luna G, Czarniak P. |
2017 |
3843 |
Journal
Int J Pharm Compound 2016 ; 20, 1: 81-85 |
Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
Peacock G.F, Sauvageot J, Hill A, Killian A. |
2016 |
2828 |
Journal
J Clin Pharm Ther 2008 ; 33, 3: 263-271. |
Evaluation of the stability of morphine sulphate in combination with Instillagel®.
Abdelmageed R, Labyad N, Watson DG, Pournamdari M, Cable CG, Stanley E. |
2008 |
4373 |
Journal
EJHP 2020 ; 27(e1):e87-e92. |
Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.
Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P. |
2020 |
4426 |
Journal
Medicine 2019 98:21(e15747) |
Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics.
Watrobska-Swietlikowska D, Pietka M, Stanislaw Klek S. |
2019 |
3408 |
Journal
Pharmactuel 2013 ; 46, 1 : 16-21. |
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Tollec S, Touzin K, Pelletier E, Forest J.M. |
2013 |
829 |
Journal
Int J Pharm 1988 ; 42: 41-46. |
Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets.
Cartwright-Shamoon JM, McElnay JC, D'Arcy PF. |
1988 |
3759 |
Journal
Yakugaku Zasshi 2014 ; 134, 2: 293-298. |
Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier.
Igarashi K, Kawahara M. |
2014 |
3169 |
Journal
Pain Clinic 1999 ; 11: 213-216. |
Experimentation about precipitation of pharmacological association: morphine and ketorolac.
Raffaeli W, Pari G, Visani L et al. |
1999 |
2932 |
Journal
J Pharm Pract and Res 2005 ; 35: 181-182. |
Extemporaneous isoniazid mixture: stability implications.
Haywood A, Mangan M, Grant G et al. |
2005 |
4729 |
Journal
Pharmaceutics 2023 ; 15, 208. |
Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with SterileWater for Ophthalmic Administration: Formulation and Stability Study.
Leanpolchareanchai J, Tangteerakoon P, Supapsophon P, Sukavatcharin S, Simaroj P, Suksiriworapong J. |
2023 |
2926 |
Journal
Am J Health-Syst Pharm 2006 ; 63: 254-257. |
Extemporaneous sildefanil citrate oral suspensions for the treatment of pulmonary hypertension in children.
Nahata MC, Morosco RS, Brady MT. |
2006 |
3682 |
Journal
EJHP 2016 ;23:33-37 |
Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study.
Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P. |
2016 |
4436 |
Journal
Anaesthesiol Intensive Ther 2018 ; 50, 3: 221-225. |
Extended compatibility of fentanyl and ketamine in dextrose 5%.
Hanifah S, Kennedy R.A; Ball P.A. |
2018 |
4755 |
Journal
J Oncol Pharm Practice 2023 |
Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C.
Vieillard V, Le Guyader G, Jallades A, Astier A. |
2023 |
110 |
Journal
Int J Pharm 1989 ; 54: 181-189. |
Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers.
Vincke BJ, Verstraeten AE, El Eini DID, Mc Carthy TM. |
1989 |
4191 |
Journal
GaBI Journal 2018 |
Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures.
Vieillard V, Astier A, Paul M. |
2018 |
1995 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1073-1074. |
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA. |
2005 |
4026 |
Journal
Hosp Pharm 2017 ; 52, 8 : 570-573 |
Extended Stability of Epinephrine Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light-Blocking Bags.
Van Matre E.T, Ho K.C., Lyda C, Fullmer B.A, Oldlan A.R, Kiser T.H. |
2017 |
88 |
Journal
J Acquired Immune Defic Syndr 1992 ; 5: 354-358. |
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.
Mole L, Oliva C, O?Hanley P. |
1992 |
3350 |
Journal
Am J Health-Syst Pharm 2012 ; 69:1999-2001 |
Extended stability of intravenous acetaminophen in syringes and opened vials.
Kwiatkowski J.L, Johnson C.E, Wagner D.S. |
2012 |
4737 |
Journal
Hosp Pharm 2023 ; 58, 2/ 183-187. |
Extended Stability of Isoproterenol Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light Blocking Bags.
Van Matre E.T, Rice P.J, Wempe M.F, Lyda C, Kiser T.H. |
2023 |
3301 |
Journal
Hosp Pharm 2012 ; 47, 4: 289-292. |
Extended Stability of Magnesium Sulfate Infusions Prepared in Polyolefin Bags.
Sayre B.E, Prettyman T, Kaushal G. |
2012 |
3866 |
Journal
Int J Pharm Compound 2016 ; 30, 3 : 247-249. |
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children.
Nahata M C. |
2016 |
2097 |
Journal
Int J Pharm Compound 2006 ; 10: 156-158. |
Extended stability of oxytocin in common infusion solutions.
Trissel LA, Zhang Y, Douglass K, Kastango E. |
2006 |
2337 |
Journal
Can J Hosp Pharm 2009 ; 62, 2: 135-141. |
Extended Stability of Pantoprazole for Injection in 0.9% Sodium Chloride or 5% Dextrose at 4°C and 23°C
Walker S.E, Iazzetta J, Law S. |
2009 |
4271 |
Journal
Adv Ther 2019 |
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Yun J, Kim J, Chung J, Hwang S-J, Park S-J. |
2019 |
3329 |
Journal
Hosp Pharm 2012 ; 47, 7: 538-543. |
Extended Stability of Sodium Bicarbonate Infusions Prepared in Polyolefin Bags.
Sayre B.E, Prettyman T, Kaushal G. |
2012 |
3945 |
Journal
Can J Hosp Pharm 2017 ; 70,1 : 7-12. |
Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags.
Perks W, Iazzetta J, Chan P.C, Brouzas A, Law S,Walker S.E. |
2017 |
4016 |
Journal
Ann Pharm Fr 2017 ; 75, 6: 420-435. |
Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag.
Vieillard V, Paul M, Ibrahim T, Astier A. |
2017 |
4649 |
Journal
GaBI Journal 2021 ; 10, 4 |
Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices.
Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J. |
2021 |
2642 |
Journal
Int J Pharm 1982 ; 11, 4: 329-336. |
Factors affecting captopril stability in aqueous solution
Timmins P, Jackson IM, Yu-chang John Wang. |
1982 |
1182 |
Journal
Am J Hosp Pharm 1981 ; 38: 1449-1454. |
Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate.
Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL. |
1981 |
122 |
Journal
Int J Pharm Pract 1993 ; 2: 39-43. |
Factors affecting the physical and chemical stability of morphine sulphate solutions stored in syringes.
Grassby PF, Hutchings L. |
1993 |
522 |
Journal
Can J Hosp Pharm 1989 ; 42: 97-103. |
Famotidine stability in total parenteral nutrient solutions.
Walker SE, Iazetta J, Lau DWC, Madorin PL. |
1989 |
3463 |
Journal
Nursing 2011 ; 29 :62-6 |
Fármacos en perfusión continua en la unidad de cuidados intensivos: estudio de compatibilidad.
Eva Perez Juan, Maria Jos? Arévalo Rubert , Silvia Monica Amoros Cerda , Palau M.M, Nicolau B.R. |
2011 |
3758 |
Journal
J Pharm Pract and Res 2014 ; 44, 89?94 |
Feasibility and stability of metaraminol in pre-filled syringes.
To T.P, Ching M.S, Booth J.C, Zeglinski P, McGrath A, Elli A.G,Garrett K. |
2014 |
3819 |
Journal
J Pharm Biomed Anal 2015 ; 118: 105-112. |
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions.
Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B. |
2015 |
3503 |
Manufacturer
Hameln Pharmaceuticals 2012 |
Fentanyl - Summary of product Characteristics
|
2012 |
3618 |
Manufacturer
Amgen 2014 |
Filgrastim (Neupogen®) - Summary of Product Characteristics
|
2014 |
1413 |
Journal
Int J Pharm Compound 1999 ; 3: 67-68. |
Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature.
Lieu CL, Chin A, Gill MA. |
1999 |
3522 |
Manufacturer
Actavis 2013 |
Flucloxacillin - Summary of Product Characteristics.
|
2013 |
3565 |
Manufacturer
Aguettant 2008 |
Flumazenil Aguettant - Résumé des caractéristiques du produit.
|
2008 |
3474 |
Manufacturer
Accord Healthcare Limited 2009 |
Fluorouracil - Summary of Product Characteristics
|
2009 |
1998 |
Journal
Am J Health-Syst Pharm 1998 55: 1315-1316. |
Fluorouracil precipitate.
Allwood MC. |
1998 |
3992 |
Journal
Int J Pharm 2016 ; 509 : 279:284. |
Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.
Bougueon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S. |
2016 |
3800 |
Journal
Iranian J Pharm Res 2003 : 157-160. |
Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop.
Rahim Bahri Najafi, Soleyman Mohammadi Samania, Nahid Pishvab, Fateme Moheimania. |
2003 |
2786 |
Journal
Am J Health-Syst Pharm 2005 ; 62, 5: 485-491. |
Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus.
Ungphaiboon S, Nittayananta W, Vuddhakul V, Maneenuan D, Kietthubthew S, Wongpoowarak W, Phadoongsombat N. |
2005 |
3321 |
Journal
Int J Pharm Compound 2012 ; 16, 4: 342-346. |
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets.
Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa. |
2012 |
3785 |
Journal
J Pain Palliat Care Pharm 2014 ;,28, 4: 367?370. |
Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl
Prohotsky D.L, . Juba K.M, Zhao F. |
2014 |
4547 |
Journal
EJHP 2021 |
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia.
Lin Y-S, Lin S-C, Hsieh Y-T,Liu L-Y,Lin C-H, Shen L-J, Huang C-F. |
2021 |
2682 |
Journal
Int J Pharm Pract 1991 ; 1: 19-22. |
Formulation and stability of cefuroxime eye-drops.
Oldham GB. |
1991 |
2476 |
Journal
Am J Hosp Pharm 1986 ; 43: 1489-1491. |
Formulation and stability of diazepam suspension compounded from tablets
Strom JG, Jr, Kalu AU. |
1986 |
2542 |
Journal
Ann Pharmacotherapy 1997 ;31:1291-1295. |
Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone.
Fawcett JP, Morgan NC, Woods DJ. |
1997 |
3669 |
Journal
Ann Pharm Fr 2015 ; 73, 1: 31-36. |
Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution
Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G. |
2015 |
4170 |
Journal
Int J Pharm Compound 2018 22,5:433-439 |
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F, Dave V.S, Mar M, Perri J. |
2018 |
4523 |
Journal
Pharm Dev Technol 2021 |
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
El Mershati S, Thouvenin A , Secretan P-H, De Lonlay P, Tuchmann-Durand C, Cisternino S, Schlatter J. |
2021 |
4360 |
Journal
Hosp Pharm 2019 |
Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients.
Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli. |
2019 |
4008 |
Poster
Hopipharm Congress 2017-Nancy 2017 |
Formulation et étude de stabilité de crèmes au sirolimus dosées à 0,1, à 0,25 ou à 0,5% m/m.
Vrignaud S, Bougueon G, Briot T, Truffaut C, Martin L, Pailhori?s H, Bastiat G, Clerc M-A, Lagarce F. |
2017 |
4104 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T. |
2018 |
3017 |
Journal
Eur Hosp Pharm 1996 ; 2: 176-180. |
Formulation of a stable calcium gluconate gel for topical treatment of hydrofluoric acid burns.
Rotheli-Simmen B, Martinelli E, Muhlebach S. |
1996 |
2720 |
Journal
J Ocular Pharm Ther 2007 ; 23, 3: 292-303. |
Formulation of sirolimus eye drops corneal permeation studies.
Buech G, Bertelmann E, Pleyer U, Siebenbrodt I, Borchert HH. |
2007 |
4517 |
Journal
EJHP 2020 |
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Cordero-Ramos J, Merino-Bohórquez V, Delgado-Valverde , Barros-Tornay R, Cameán-Fenández M, Calleja-Hernández M.A. |
2020 |
4079 |
Journal
J Pharm Anal 2017 ; 7, 4: 237-243. |
Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial.
Filali S, Bergamelli C, Tall M.L, Salmon D, Laleye D, Dhelens C, Diouf E, Pivot C, Pirot F. |
2017 |
2295 |
Manufacturer
Merck Sharp Dohme 2013 |
Fosaprepitant (Emend®) - Summary of Product Characteristics
|
2013 |
3662 |
Manufacturer
Clinigen 2014 |
Foscavir (Foscarnet®) - Summary of Product Characteristics
|
2014 |
3663 |
Manufacturer
Panpharma 2011 |
Fosfomycine (Fosfomycine Panpharma®) - Résumé des caractéristiques du produit
|
2011 |
1419 |
Journal
Int J Pharm Compound 1999 ; 3: 235-238. |
Fosphenytoin Y-site stability studies with lorazepam and midazolam hydrochloride.
Riggs RM, English BA, Webster AA, McGuire JM, Riordan JM. |
1999 |
2124 |
Journal
EJHP Science 2006 ; 12, 4: 72-75. |
Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C.
Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L. |
2006 |
1329 |
Journal
Br J Parent Ther 1986 ; march/april: 42-44. |
Freeze-thaw stability of antibiotics used in an IV additive service.
Brown AF, Harvey DA, Hoddinott DJ, Britton. |
1986 |
3639 |
Manufacturer
Wockhardt 2013 |
Furosemide - Summary of Product Characteristics
|
2013 |
1855 |
Journal
J Pharm Biomed Anal 2000 ; 23: 803-817. |
Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug.
Carla-Broch S, Esteve-Romero J, Garcia-Alvarez-Coque MC. |
2000 |
4060 |
Journal
EJHP 2018 ;25,3:144-149 |
Furosemide ethanol-free oral solutions for paediatric use : formulation, HPLC method and stability study.
Zahalka L, Klovrzova S, Matysova L, Sklubalova Z, Solich P. |
2018 |
3661 |
Manufacturer
Laboratoire L?o 2012 |
Fusidate de sodium (Fucidine®) - Résumé des caractéristiques du produit
|
2012 |
3496 |
Manufacturer
Actavis 2009 |
Gemcitabin Actavis solution - Stability Study
|
2009 |
1913 |
Manufacturer
Pfizer Europe 2020 |
Gemtuzumab ozogamicin (Mylotarg® - Summary of Product Characteristics)
|
2020 |
3643 |
Manufacturer
Sanofi 2015 |
Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
|
2015 |
1395 |
Journal
Thromb Haemost 1980 ; 43: 67. |
Glass adsorption of highly purified urokinase.
Toki N, Sumi H. |
1980 |
3599 |
Manufacturer
Amco Amdipharm Mercry 2013 |
Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
|
2013 |
1643 |
Journal
Hosp Pharm 1994 ; 29: 76. |
Haldol-benztropine incompatibility.
Raleigh F, Gibler B. |
1994 |
985 |
Journal
Ann Pharmacotherapy 1996 ; 30: 549. |
Haloperidol and diphenhydramine compatibility.
Raleigh FR, Gibler BS. |
1996 |
1022 |
Journal
Drug Intell Clin Pharm 1986 ; 20: 886. |
Heparin and aminoglycosides instability.
Hutchinson SMW. |
1986 |
3540 |
Manufacturer
Wockhardt 2010 |
Heparin sodium - Summary of Product Characteristics.
|
2010 |
3113 |
Book
Compendium Suisse des m?dicaments 2010 |
Herceptin
|
2010 |
3796 |
Journal
Br Ophtalmol 1995 ; 79: 753-755. |
High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.
Morlet N, Young S, Naidoo D et al. |
1995 |
1151 |
Journal
J Chromatogr 1981 ; 212: 339-346. |
High-performance liquid chromatographic determination of sodium nitroprusside.
Baaske DM, Smith MD, Karnatz N, Carter JE. |
1981 |
3757 |
Journal
Antimicrob Agents Chemother 2014 ; 58 : 2849-2855. |
How To Minimize Toxic Exposure to Pyridine during Continuous Infusion of Ceftazidime in Patients with Cystic Fibrosis?
Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus J.C, Jouani B.-L., Merlette C, Nov?-Josserand R, Pages J, Panzo R |
2014 |
2166 |
Journal
J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929. |
HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine.
Nassr S, Dubuc MC, Lavoie P, Brazier JL. |
2003 |
2011 |
Journal
Krankenhauspharmazie 2005 ; 26, 6: 206-210. |
HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen.
Friess D, Nguyen HC, Lipp HP. |
2005 |
1733 |
Journal
Pharmazie 1999 ; 54: 542-544. |
HPTLC-based stability assay for determination of amiodarone in intravenous admixtures.
Kopelent-Frank H, Schimper A. |
1999 |
3617 |
Manufacturer
Wockhardt 2011 |
Hyaluronidase (Hyalase®) - Summary of Product Characteristics
|
2011 |
3184 |
Manufacturer
CP Pharmaceuticals 2005 |
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
|
2005 |
2275 |
Journal
Int J Pharm 1998 ; 173: 221-232. |
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Craig Dyar S, Notari RE. |
1998 |
2215 |
Journal
Chem Pharm Bull 1984 ; 32, 3: 1113-1119. |
Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5.
Boehm J.J, Poust R.I. |
1984 |
2364 |
Poster
PharmSciFair 2009 |
Hydromorphone and dipyrone in PCA devices: Is still a therapy with hydromorphone?
M?ller S, Trittler R, Schubert R, Strehl E. |
2009 |
120 |
Journal
Can J Hosp Pharm 1988 ; 41: 177-182. |
Hydromorphone and morphine stability in portable infusion pump cassettes and minibags.
Walker SE, Coons C, Matte D, DeAngelis C, Iazzetta J, Kolos C, Birkhans B. |
1988 |
3932 |
Manufacturer
Serb Laboratoire 2015 |
Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
|
2015 |
3600 |
Manufacturer
UCB Pharma SA 2009 |
Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
|
2009 |
1380 |
Journal
Am J Hosp Pharm 1984 ; 41: 74. |
Identification of labetolol precipitate.
Alam AS. |
1984 |
1915 |
Manufacturer
Genzyme 2010 |
Imiglucerase (Cerezyme®) -Summary of product Characteristics
|
2010 |
3530 |
Manufacturer
Hospira 2013 |
Imipenem/Cilastatin – Summary of Product Characteristics
|
2013 |
1871 |
Journal
Int J Pharm 2002 ; 234: 205-212. |
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J. |
2002 |
2649 |
Journal
Int J Pharm 2002 ; 234, 1-2: 205-212. |
Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions.
Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J. |
2002 |
2733 |
Journal
J Pharm Clin 1999 ; 18: 179-182. |
Impact of deep-freezing on pefloxacin eye drops stability.
Gellis C, Sautou-Miranda V, Arvouet A. |
1999 |
4605 |
Journal
Ann Allergy 2012 ; 2:28. |
Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility.
Foinard A, Décaudin B, Barthélémy C, Debaene B, Odou P. |
2012 |
4757 |
Journal
Hosp Pharm 2023 ; 58, 3: 304-308. |
In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes.
Wojcinski J, Nathan K, Zhaohttps F. |
2023 |
966 |
Journal
JPEN 1991 ; 15: 536-539. |
In vitro assessment of vancomycin HCl compatibility after coinfusion with a specialized amino acid formulation.
Martins AM, McDougal A, Hamilton D, Igwemezie L, McErlane K. |
1991 |
4352 |
Journal
J Clin Pharm Ther 2019 ; 44: 875-882. |
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y. |
2019 |
979 |
Journal
Int Pharm J 1995 ; 9: 57. |
In vitro compatibility of granisetron with selected alkaline drugs.
D'Arcy PF. |
1995 |
3294 |
Journal
EJHP 2012 ; 19: 57-64. |
In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs
Humbert-Delaloye V, Berger M, Voirol P, Pannatier A. |
2012 |
3381 |
Journal
EJHP 2013 ; 20:110-116. |
In vitro compatibility of various cardioactive drugs during simulated Y-site administration.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Gattlen L, Pannatier A. |
2013 |
4048 |
Journal
Hosp Pharm 2017 ;52,11:752-760 |
In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes.
Reindel K, Zhao F, Hughes S, Dave V. |
2017 |
209 |
Journal
Am J Hosp Pharm 1990 ; 47: 1574-1579. |
In vitro evaluation of the stability of raniditine hydrochloride in total parenteral nutrient mixtures.
Williams MF, Hak LJ, Dukes G. |
1990 |
643 |
Journal
Cancer Treat Rep 1987 ; 71: 1189-1192. |
In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide.
Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR. |
1987 |
3205 |
Journal
AAPS Pharm Sci 2011 ; 15, 2 : 264-272. |
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. |
2011 |
3953 |
Journal
Hemodial Int 2011 ; 15, 2 : 364-272. |
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. |
2011 |
4484 |
Journal
Drugs R D 2022 ;22, 95–104 |
In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered.
Bokser A D, Holmes Adegbenle Y, Stoisavljevic V, Norton J C. |
2022 |
2793 |
Journal
Hosp Pharm 2015 ; 50, 4 : 296-303. |
In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem.
Tomasello C, Leggieri A, Cavalli R, Di Perri G, D?Avolio A. |
2015 |
2468 |
Journal
J Pharm Sci 2023 ; 112: 963-973. |
In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps.
Mohnicke M, Blecher A, Beichert K, Bidlingmaier B, Todt E-J, Dette C, Rotthaeuser B, Mukherjee B. |
2023 |
3149 |
Journal
Diabetes Tech and Ther 2006 ; 8, 3: 358-368. |
In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion.
DeFelippis MR, Bell MA, Heyob JA, Storms SM. |
2006 |
1037 |
Journal
J Pharm Sci 1984 ; 73: 838-839. |
In vitro stability of sodium nitroprusside solutions for intravenous administration.
Mahony C, Brown JE, Stargel WW, Verghese CP, Bjornsson TD. |
1984 |
1322 |
Journal
JPEN 1983 ; 7: 156-158. |
In vitro study of inline filtration of medications commonly administered to pediatric cancer patients.
Ennis CE, Merritt RJ, Neff DN. |
1983 |
4194 |
Journal
Bio Drugs 2018 32;619-625 |
In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion.
Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y. |
2018 |
3812 |
Journal
Int J Pharm Compound 2015 ; 19, 5 : 432-436. |
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
Bhattacharya S, Parekh S, Dedhiya M. |
2015 |
4518 |
Journal
EJHP 2020 |
In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion.
Mohr A, Krämer I. |
2020 |
2975 |
Poster
ESCP 2014 2014 |
In-Use stability of herceptin for subcutaneous injection with different administration materials.
Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C. |
2014 |
264 |
Journal
Pharm Hosp Fr 1997 ; 121: 124. |
Incompatibilité physico-chimique entre l’oméprazole et la vancomycine.
Leboucher G, Charpiat B. |
1997 |
1625 |
Journal
Int J Pharm Compound 2001 ; 5: 314-321. |
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Trissel LA, Saenz C, Williams YW, Ingram D. |
2001 |
4429 |
Journal
Medicine 2016 ; 95:25(e3824) |
Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration.
Fang B-X, Li P, Shi X-Y, Chen F.C, Wang L.H. |
2016 |
2630 |
Journal
Hosp Pharm 1981 ; 16: 486-487. |
Incompatibilities with orally administered liquid neuroleptic medication combinations.
Raleigh F. |
1981 |
921 |
Journal
Hosp Pharm 1998 ; 33: 284-292. |
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. |
1998 |
241 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2639. |
Incompatibility between ceftriaxone sodium and labetolol hydrochloride.
Leader WG, Jones JM. |
1996 |
1084 |
Journal
Lancet 1988 ; 1(8587): 700. |
Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies.
Raupp P, von Kriek R, Schmidt E, Pfahl HG, G?nther O. |
1988 |
3873 |
Journal
Am J Health-Syst Pharm 2016 ; 73:755. |
Incompatibility between irinotecan and fluorouracil injections
Tan X, Hu J. |
2016 |
205 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 184. |
Incompatibility of amiodarone hydrochloride and evacuated glass bottles.
Strozyk WR, Williamson R, Thompson D. |
1996 |
200 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2340. |
Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections.
Korth-Bradley JM, Ludwig S, Callaghan C. |
1995 |
3868 |
Journal
J Oncol Pharm Practice 2016 ; 22: 571-572 |
Incompatibility of busulfan with 1 ml Luer-Lock syringes.
Loboda C, Lider P, Vigneron J. |
2016 |
106 |
Journal
Am J Hosp Pharm 1990 ; 47: 519. |
Incompatibility of cefoperazone and promethazine.
Scott SM. |
1990 |
260 |
Journal
Am J Hosp Pharm 1993 ; 50: 2054, 2057. |
Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration.
Szof C, Walker PC. |
1993 |
103 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1347. |
Incompatibility of cefotetan disodium and promethazine hydrochloride.
Erickson SH, Ulici D. |
1995 |
1739 |
Journal
Am J Health-Syst Pharm 1990 ; 47: 519. |
Incompatibility of cefperazone and promethazine.
Scott SM. |
1990 |
1399 |
Journal
Pharm J 1987 ; 238: 577. |
Incompatibility of ceftazidime and vancomycin.
Cairns CJ, Robertson J. |
1987 |
1744 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 384. |
Incompatibility of ceftriaxone sodium with lactated Ringer’s injection.
Burkiewicz JS. |
1999 |
95 |
Journal
Am J Hosp Pharm 1991 ; 48: 77. |
Incompatibility of ceftriaxone with vancomycin.
Pritts D, Hancock D. |
1991 |
3475 |
Journal
Am J Health-Syst Pharm 2013 ;70:1966-1970. |
Incompatibility of ciprofloxacin and meropenem injections.
Chen L.Y, Chen J, Waters V, Boodhan S. |
2013 |
1085 |
Journal
Radiology 1989 ; 173: 91-92. |
Incompatibility of contrast agents with intravascular medications.
Irving HD, Burbridge BE. |
1989 |
3486 |
Journal
Cardiovasc Intervent Radiol 2013 ; 36: 237-238. |
Incompatibility of contrast medium and trisodium citrate.
Delcour C, Brunnix G. |
2013 |
1607 |
Journal
Hosp Pharm 2000 ; 35: 1192-1196. |
Incompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injection.
Trissel LA, Zhang Y, Xu QA. |
2000 |
3664 |
Journal
Am J Health-Syst Pharm 2014 ; 71:901-902. |
Incompatibility of esmolol hydrochloride and furosemide in a central venous access port
Zhao B, Sun W. |
2014 |
155 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 710-715. |
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Trissel LA, Martinez JF, Xu QA. |
1995 |
1326 |
Journal
Am J Roentgenol 1986 ; 146: 1300-1301. |
Incompatibility of Hexabrix and papaverine.
Pilla TJ, Beshany SE, Shields JB. |
1986 |
2349 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 1253-1254. |
Incompatibility of imipenem–cilastatin and amoxicillin
Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B. |
2009 |
1745 |
Journal
Am J Health-Syst Pharm 1992 ; 49: 836-838. |
Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate.
Thompson DF, Heflin NR. |
1992 |
494 |
Journal
Am J Hosp Pharm 1992 ; 49: 836,838. |
Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate.
Thompson DF, Heflin NR. |
1992 |
1137 |
Journal
Am J Hosp Pharm 1990 ; 47: 1745-1746. |
Incompatibility of iron dextran and a total nutrient admixture.
Vaughan LM, Small C, Plunkett V. |
1990 |
228 |
Journal
Am J Hosp Pharm 1994 ; 51: 2964. |
Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate.
Mendenhall A, Hoyt DB. |
1994 |
476 |
Journal
Am J Hosp Pharm 1992 ; 49: 2960-2962. |
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Knapp AJ, Mauro VF, Alexander KS. |
1992 |
89 |
Journal
Am J Hosp Pharm 1993 ; 50: 2521-2522. |
Incompatibility of labetalol hydrochloride and furosemide.
Zeisler J, Alagna C. |
1993 |
1079 |
Journal
Am J Hosp Pharm 1985 ; 42: 2651. |
Incompatibility of morphine sulfate and prochlorperazine edisylate in syringes.
Stevenson JG, Patriarca C. |
1985 |
3380 |
Journal
Ann Pharmacotherapy 2013 ;47:426-427. |
Incompatibility of Piritramide with Cephalosporins.
Eckle V-S, Heim E, Hahn M, Grasshoff C. |
2013 |
1646 |
Journal
Anaesthesia 2001 ; 56: 920. |
Incompatibility of prochlorperazine and ketoprofen.
Kannan S. |
2001 |
1672 |
Journal
Anesthesiology 1998 ; 89: 1609. |
Incompatibility of propofol emulsion with anesthesic drugs.
Lamontagne C, Brouillette D, Hardy JF. |
1998 |
3101 |
Journal
Perit Dial Int 2002 ; 22: 93-94. |
Incompatibility of Vancomycin and Ceftazidime for Intraperitoneal Use.
Wazny LD, Blake PG. |
2002 |
3930 |
Manufacturer
Serb laboratoire 2013 |
Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit
|
2013 |
754 |
Manufacturer
Merck Sharp & Dohme 2019 |
Infliximab (Remicade®) – Summary of Product Characteristics
|
2019 |
3137 |
Journal
Retina 2010 ; 30, 1: 81-84. |
Infliximab stability after reconstitution, dilution, and storage under refrigeration.
Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS. |
2010 |
4452 |
Poster
Congrès Hopipharm 2019 |
Influence d'un ajout de L-carnitine dans les mélanges de nutrition parentérale destinés aux patients à domicile.
Sémély D, Bello W, Daupin J, Lebland C, Carrez L, Berger M, Sadeghipour F. |
2019 |
3869 |
Journal
J Pharm Pharmacol 2016 ; 68: 433-438. |
Influence of 5% dextrose volume on amphotericin B deoxycholate preparation
Sun P, Chen J, Zhang Z, Gao X, Chen P, Li X. |
2016 |
951 |
Journal
PDA J Pharm Sci Technol 1998 ; 52: 129-133. |
Influence of DL methionine and sodium metasulphite on the photostability of vitamin K1.
Ho PC, Wong VK. |
1998 |
1147 |
Journal
J Pharm Pharmacol 1991 ; 43: 601-604. |
Influence of intravenous administration set composition on the sorption of isosorbide dinitrate.
De Muynck C, Colardyn F, Remon JP. |
1991 |
39 |
Journal
J Pharm Clin 1997 ; 16: 45-48. |
Influence of intravenous admixtures on the stability of the new solution of 5-fluorouracil.
Farhang-Asnafi S, Callaert S, Barre J, Tillement JP, Thebault A. |
1997 |
2134 |
Journal
J Pharm Sci 1998 ; 87, 12: 1572-1576. |
Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions.
Fubara JO, Notari RE. |
1998 |
2005 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 1347-1348. |
Influence of temperature and drug concentration on nafcillin precipitation.
Chan V. |
2005 |
2463 |
Journal
Am J Hosp Pharm 1979 ; 50: 486-488. |
Instability of aqueous captopril solutions
Anaizi NH, Swenson C. |
1979 |
1167 |
Journal
Antimicrob Agents Chemother 1987 ; 31: 610-611. |
Instability of vancomycin in infusaid drug pump model 100.
Grennberg RN, Saeed AM, Kennedy DJ, McMillian R. |
1987 |
1091 |
Journal
Anesthesiology 1974 ; 40: 400-404. |
Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing.
Petty C, Cunningham NL. |
1974 |
1175 |
Journal
Am J Hosp Pharm 1981 ; 38: 995-997. |
Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets.
Hirsch JI, Wood JH, Thomas RB. |
1981 |
1245 |
Journal
JPEN 1989 ; 13: 539-543. |
Insulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusion.
Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F, Sofo L, Migliore A, Manna R, Crucitti F. |
1989 |
3935 |
Manufacturer
Sanofi Laboratoire 2016 |
Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit
|
2016 |
1359 |
Journal
Am J Hosp Pharm 1985 ; 42: 2420-2421. |
Interaction between vancomycin and ticarcillin.
Perest M, Allison J. |
1985 |
433 |
Journal
Am J Hosp Pharm 1986 ; 43: 2221-2224. |
Interaction of aztreonam with nafcillin in intravenous admixtures.
Riley CM, Lipford LC. |
1986 |
377 |
Journal
Am J Hosp Pharm 1988 ; 45: 1350-1352. |
Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry.
Pereira-Rosario R, Utamura T, Perrin JH. |
1988 |
1120 |
Journal
Am J Hosp Pharm 1974 ; 31: 72-78. |
Interactions between drugs and plastic intravenous fluid bags. Part I: Sorption studies on 17 drugs.
Moorhatch P, Chiou WL. |
1974 |
1173 |
Journal
Am J Hosp Pharm 1981 ; 38: 1308-1314. |
Interactions between drugs and polyvinyl chloride infusion bags.
Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. |
1981 |
499 |
Journal
Hosp Pharm 1991 ; 26: 634-635. |
Intramuscular antibiotic preparation and administration using a 1% lidocaine diluent: policies for the pediatric patient.
Rockwell K, Burch K. |
1991 |
4548 |
Journal
Clin Ther 2020 ; 42, 8: 1580-1586. |
Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration.
O'Donnell J.N, Xu A, Lodise T.P. |
2020 |
1109 |
Journal
Crit Care Med 1990 ; 18: 858-861. |
Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible.
Horrow JC, Digregorio J, Barbieri EJ, Rupp E. |
1990 |
4666 |
Journal
J Anal Sci Tech 2020 ; 11: 32. |
Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron.
Lee C.H, Kim A.R, Lee M.K, Oh J.S, Lee D.K, Choi S.S. |
2020 |
4724 |
Journal
Int J Pharm Compound 2022 ;26,6:522-526 |
Intravenous Physical Compatibility of Heparin Sodium and Furosemide.
Maktabi B, Howard MS, Baki G, Churchwell MD |
2022 |
732 |
Journal
Am J Hosp Pharm 1975 ; 32: 575-578. |
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: Stability with common intravenous fluids.
Gardella LA, Zaroslinski JF, Possley LH. |
1975 |
738 |
Journal
Am J Hosp Pharm 1978 ; 35: 581-584. |
Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives.
Gardella LA, Kesler H, Amann A, Carter JE. |
1978 |
2324 |
Journal
Int J Pharm 2009 ; 369, 1-2 : 30-37 |
Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application
Treleano A, Wolz G, Brandsch R, Welle F. |
2009 |
3666 |
Journal
Int J Pharm Compound 2014 ; 18, 3: 248-252. |
Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A,Khokhlova Kateryna O,Georgiyants Victoriya A,Vyshnevska Liliia I. |
2014 |
4644 |
Journal
Adv Ther 2021 ; 38 : 5609–5622 |
Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17.
Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A. |
2021 |
1961 |
Journal
Int J Pharm 2005 ; 293: 303-310. |
Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles.
Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC. |
2005 |
4012 |
Journal
EJHP 2018 ; 25, e2 |
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.
Khaleel I, Tabish R Zaidi S, Shastri M, Suji Eapen M, Chiau Ming L, Wanandy T, P Patel R. |
2018 |
4570 |
Journal
Pharmaceuticals 2019 |
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Greenhill K, Hornsby E, Gorman G. |
2019 |
2655 |
Journal
Int J Pharm 2008 ; 353, 1-2: 1-7. |
Invitro release and stability of an artesunate rectal gel suitable for pediatric use.
Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AML, Dubost JP, Millet P, Fawaz F. |
2008 |
4377 |
Journal
Radiology 1992 ; 184: 385-387. |
Ionic lodinated Contrast Medium and Amobarbital Sodium Mixtures: Potential for Precipitation.
Monsein L.H, Miller T.J, Kuwahara S.K, Sostre S, Debrun G.M. |
1992 |
3352 |
Manufacturer
Bristol Myers Squibb 2011 |
Ipilimumab (Yervoy®) - Summary of Product Characteristics
|
2011 |
3129 |
Manufacturer
Pfizer 2008 |
Irinotécan (Campto®) – Résumé des caractéristiques du produits
|
2008 |
1391 |
Journal
Can J Hosp Pharm 1998 ; 51: 271-272. |
Is heparin always compatible with TPN and fat emulsion admixtures?
Vanstone GL. |
1998 |
4617 |
Manufacturer
Sanofi Genzyme 2021 |
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021
|
2021 |
2864 |
Manufacturer
Astellas Pharma 2015 |
Isavuconazonium (Cresemba®) - Summary of Product Characteristics
|
2015 |
3660 |
Manufacturer
Hospira 2016 |
Isoprenaline (Isuprel®) - Résumé des caractéristiques du produit
|
2016 |
3341 |
Journal
Krankenhauspharmazie 2001 ; 7: 331-333. |
Ist teurer immer auch besser? Analytiklabor der Apotheke unterstütz Einkauf sentcheidungen bei Carboplatin-Präparaten.
Trittler R, Jung B, Strehl E. |
2001 |
1270 |
Journal
J Pharm Belg 1980 ; 35: 389-393. |
IV infusion of glyceryl trinitrate. Study of the sorption on various plastic containers.
Mathot F, Bonnard J, Han P, Bosly J. |
1980 |
3084 |
Manufacturer
Bristol Myers Squibb 2009 |
Ixabepilone (Ixempra®) – Summary of Product Characteristics
|
2009 |
3488 |
Journal
Farm Hosp 1995 ; 19, 1: 41-44. |
Jarabe de midazolam: Estudio de estabilidad de una solucion oral para uso hospitaliaro.
Caldes R, Ciges S.M, Borras E, Calvelo R, Lisart F. |
1995 |
3501 |
Manufacturer
Pfizer 2011 |
Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
|
2011 |
3593 |
Manufacturer
Beacon Pharmaceuticals 2011 |
Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics
|
2011 |
1703 |
Journal
Krankenhauspharmazie 1995 ; 16: 101-103. |
Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln.
Schuster F, Bernard R. |
1995 |
1481 |
Journal
Krankenhauspharmazie 1994 ; 9: 337-340. |
Kompatibilität von ofloxacin mit ampicillin.
Messerschmidt W. |
1994 |
3686 |
Manufacturer
Eusapharma 2013 |
L asparaginase (Kidrolase®) - Résumé des caractéristiques du produit
|
2013 |
3609 |
Manufacturer
Aspen Pharma 2013 |
Labetalol (Trandate®) - Summary of Product Characteristics
|
2013 |
1014 |
Journal
Clin Pharmacol Ther 1988 ; 43: 183. |
Lack of photodegradation but significant adsorption of nifedipine in administration systems.
Larsen JS, Uden DL, Zaske DE. |
1988 |
1819 |
Journal
J Clin Pharm Ther 2002 ; 27: 139-142. |
Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution.
Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M. |
2002 |
1984 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 182-188. |
Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions.
Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J. |
2005 |
455 |
Journal
Am J Hosp Pharm 1986 ; 43: 2800-2802. |
Leaching of diethylhexyl phtalate from polyvinyl chloride bags into intravenous cyclosporine solution.
Venkataramanan R, Burckart GJ, Ptachcinski RJ, Blaha R, Logue LW, Bahnson A, Giam CS, Brady JE. |
1986 |
140 |
Journal
Am J Hosp Pharm 1993 ; 50: 1405-1409. |
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Pearson SD, Trissel LA. |
1993 |
165 |
Journal
Int J Pharm 1994 ; 105: 89-93. |
Leaching of diethylhexyl phthlate from PVC bags into intravenous teniposide solution.
Faouzi MA, Dine T, Luyckx M, Gressier B, Goudaliez F, Mallevais ML, Brunet C, Cazin M, Cazin JC. |
1994 |
4665 |
Manufacturer
Sanofi Aventis 2021 |
LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021
|
2021 |
3920 |
Manufacturer
Fresenius Kabi 2018 |
Levofloxacine - Résumé Caractéristique du Produit
|
2018 |
3369 |
Manufacturer
MEDAC France 2011 |
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
|
2011 |
4571 |
Manufacturer
Orion Pharma 2010 |
Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics
|
2010 |
1126 |
Journal
Am J Hosp Pharm 1983 ; 40: 97-101. |
Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags.
Lackner TE, Baldus D, Butler CD, Amyx C, Kessler G. |
1983 |
3286 |
Journal
Yakugaku Zasshi 2010 ; 130, 10: 1369-1374. |
Light-induced Deterioration Test of Carboplatin under Clinical Settings.
Okamoto Y, Tazumi K, Sanada Y, Tsugane M, Uejima E. |
2010 |
3560 |
Manufacturer
Pharmacia 2013 |
Linezolid (Zyvox®) - Summary of Product Characteristics
|
2013 |
2163 |
Journal
Perit Dial Int 2002 ; 22: 419-422. |
Linezolid stability in peritoneal dialysis solutions.
Manley HJ, McClaran ML, Bedenbaugh A, Peloquin CA. |
2002 |
2654 |
Journal
Int J Pharm 2007 ; 344, 1-2: 150-153. |
Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability.
Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F. |
2007 |
4479 |
Journal
J Oncol Pharm Practice 2020 ;27,6:1328-1332 |
Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5 +/- 3°C.
Closset M, Goderniaux N, Colsoul M-L, Soumoy L, Bihin B, Jamart J, Odou P, Hecq J-D, galanti L. |
2020 |
1291 |
Journal
Int J Pharm Pract 1995 ; 3: 253-255. |
Long term stability of heparin in dextrose-saline intravenous fluids.
Wright A, Hecker J. |
1995 |
35 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2128-2130. |
Long term stability of interferon alfa-2b diluted to 2 million units/mL.
Schepart BS, Burns BA, Evans S, Poleon G. |
1995 |
1962 |
Journal
Pharmakon 2004 ; 36, 1: 8-14. |
Long term stability of sufentanyl citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion P.V.C bags at 4°C.
Hecq JD, Boitquin L, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. |
2004 |
3115 |
Journal
Ann Pharm Fr 2010 ; 68: 157-162. |
Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2010 |
2174 |
Journal
EJHP Science 2006 ; 12, 6: 129-134. |
Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions.
Kattige A. |
2006 |
4568 |
Journal
Journal of Chemotherapy 2021 |
Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump.
Closset M,Onorati S, Colsoul M.L,Goderniaux N,Bihin B, Jamart J, Soumoy L, Hecq J.D, Odou P, Galanti L. |
2021 |
3386 |
Journal
Int J Pharm 2013 ; 448: 101-104. |
Long-term physico-chemical stability of diluted trastuzumab.
Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A. |
2013 |
4735 |
Journal
J Oncol Pharm Practice 2023 |
Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags.
Closset M, Onorati S, Colsoul M-L, Goderniaux N, Bihin B, Jamart J, Soumoy L, Hecq J-D, Odou P, Galanti L. |
2023 |
4573 |
Journal
Am J Health-Syst Pharm 2021 ;78, 9:806–812, |
Long-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparation.
Legeron R, Bougueon G, Berroneau A, De-Germay S, Bernadou JM, Djabarouti S, Crauste-Manciet S, Xuereb F. |
2021 |
4374 |
Journal
Int J Pharm Compound 2020 ;24,1:64-68 |
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit.
Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M. |
2020 |
4342 |
Journal
Int J Pharm Compound 2019 ;23,5:434-437 |
Long-term Physicochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics.
Lardinois B, Baltzis A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq JD, Galanti L. |
2019 |
4148 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Long-Term Stability Comparison between an Original and a Generic Version of Piperacillin/Tazobactam in Dextrose 5% Infusion Polyolefin Bags at 5+/-3°C after Microwave Freeze-Thaw Treatment.
Huvelle S, Godet M, Galanti L, Closset M, Bihin B, Jamart J, Hecq J.D. |
2018 |
4199 |
Journal
EJHP 2018 |
Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.
Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M. |
2018 |
4584 |
Journal
EJHP 2021 |
Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials.
Gilliot S, Henry H, Carta N, Genay S, Barthélémy C, Décaudin B, Odou P. |
2021 |
2323 |
Journal
Can J Hosp Pharm 2009 ; 62, 1 |
Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and Refrigeration
Galanti L, Lebitasy M.P, Hecq J.D, Cadrobbi J, Vanbeckbergen D, Jamart J. |
2009 |
1475 |
Journal
J Pharm Biomed Anal 1996 ; 14: 395-399. |
Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs.
Martel P, Petit I, Pinguet F, Poujol S, Astre C, Fabbro M. |
1996 |
2771 |
Journal
Skin Pharm Appl Skin Physiol 1999 ; 12: 266-270. |
Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy (Cream PUVA).
Martens-Lobenhoffer J, Rinke M, Losche D. |
1999 |
2789 |
Journal
Bone Marrow Transplantation 2006 ; 37, 8: 781-784. |
Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels.
Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL. |
2006 |
3001 |
Journal
Ann Pharm Fr 2015 ; 73: 108-113. |
Long-term stability of aciclovir in 0.9% NaCl infusion polyolefin bags at 2-8°C after freeze-thaw treatment: A generic product versus the brand name.
Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq JD. |
2015 |
3312 |
Journal
Ann Pharm Fr 2012 ; 70, 3: 139-154. |
Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration.
Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A. |
2012 |
656 |
Journal
J Clin Pharm Ther 1996 ; 21: 185-189. |
Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. |
1996 |
2808 |
Journal
Int J Pharm Compound 2015 ; 19, 3: 268-270. |
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles.
Dewulf J, Hecq J.D, Huvelle S, Godet M, Gillet P, Jamart J, Galanti L.M. |
2015 |
3925 |
Journal
Ann Pharm Fr 2016 ; 75, 1 : 30-39. |
Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C.
Simar J, Godet M, Hecq J.-D, Closset M, Gillet P, Langhendries C, Bihin B, Jamart J, Galanti L. |
2016 |
3323 |
Journal
Int J Pharm 2012 ; 436, 1-2: 282-290. |
Long-term stability of diluted solutions of the monoclonal antibody rituximab.
Paul M, Vieillard V, Jaccoulet E, Astier A. |
2012 |
2827 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 1722-1725. |
Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles
Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S. |
2009 |
394 |
Journal
Am J Hosp Pharm 1989 ; 46: 2333-2335. |
Long-term stability of famotidine 20 mg/L in a total parenteral nutrient solution.
DiStefano JE, Mitrano FP, Baptista RJ, Der MM, Silvestri Ap, Palombo JD, Bistrian BR. |
1989 |
4021 |
Journal
J Oncol Pharm Practice 2017 ;25,2: 303-308 |
Long-term stability of ganciclovir in polypropylene containers at room temperature.
Guichard N, Bonnabry P, Rudaz S, Fleury S. |
2017 |
3874 |
Journal
Ann Pharm Fr 2016 ; 74: 283-287. |
Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes
Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L. |
2016 |
4248 |
Journal
Hosp Pharm 2019 ; 55, 3: 199-193. |
Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers.
Colsoul M.L, Breuer A, Goderniaux N, Hecq J.D, Soumoy L, Bihin B, Jamart J, Galanti L. |
2019 |
1885 |
Journal
Pharm World Sci 1999 ; 21: 144-146. |
Long-term stability of morphine and bupivacaine mixture for spinal use.
Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA. |
1999 |
3572 |
Journal
Int J Pharm Compound 2014 ; 18, 1 : 78-82. |
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C.
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L. |
2014 |
4201 |
Journal
Am J Health-Syst Pharm 2020 ; 77, 9: 681-689. |
Long-term stability of ready-to-use 1-mg/mL midazolam solution.
Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P. |
2020 |
2204 |
Journal
J Oncol Pharm Practice 2007 ; 13: 99-103. |
Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C.
Cadrobbi J, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2007 |
1908 |
Journal
J Pain Symptom Manage 2004 ; 28, 1: 4-6. |
Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C.
Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. |
2004 |
3255 |
Journal
Ann Pharm Fr 2011 ; 69, 6 : 296-301. |
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment
Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L. |
2011 |
3154 |
Journal
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046. |
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
Carryn S, Couwenbergh N, Tulkens PM |
2010 |
365 |
Journal
Med Sci Monit 2015 ; 21:2528-2534. |
Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery.
Junfeng Gu, Wengang Qin, Fuchao Chen, Zhongyuan Xia. |
2015 |
3082 |
Journal
J Oncol Pharm Practice 2009 ; 15: 195-200. |
Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C.
Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
2814 |
Journal
Ann Pharm Fr 2009 ; 67: 272-277. |
Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C.
Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
1899 |
Journal
Int J Pharm Compound 2004 ; 8, 3: 231-235. |
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Trissel LA, Zhang Y. |
2004 |
931 |
Journal
J Clin Pharm Ther 1997 ; 22: 353-356. |
Long-term stability of vancomycin hydrochloride in intravenous infusions.
Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. |
1997 |
2111 |
Journal
EJHP Science 2006 ; 12, 3: 57-59. |
Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C.
Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L. |
2006 |
3856 |
Journal
Int J Pharm Compound 2016 ; 20, 2:164-166. |
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata M.C. |
2016 |
3313 |
Journal
J Oncol Pharm Practice 2012 ; 18, 2: 218-221. |
Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Kaiser J, Krämer I. |
2012 |
2495 |
Journal
Am J Hosp Pharm 1986 ; 43: 380-383. |
Long-term stability study of histamine in sterile bronchoprovocation solutions
Marwaha RK, Johnson BF. |
1986 |
532 |
Journal
Ann Pharmacotherapy 1996 ; 30: 343-346. |
Lorazepam stability in parenteral solutions for continuous intravenous administration.
Hoey LL, Vance-Bryan K, Clarens DM, Wright DH, Konstantinides FN, Guay DRP. |
1996 |
1980 |
Journal
Act Pharm Nord 1991 ; 3, 3: 131-136. |
Loss of nitroglycerin during passage through two different infusion sets.
Hansen HC, Spillum A. |
1991 |
1108 |
Journal
Crit Care Med 1983 ; 11: 50-52. |
Loss of nitroglycerin to cardiopulmonay bypass apparatus.
Dasta JF, Jacobi J, Wu LS, Sokoloski T, Beckley P, Reilley TE, Howie MB. |
1983 |
239 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 655-658. |
Loss of quinidine gluconate injection in a polyvinyl chloride infusion system.
Darbar D, Dell'Orto S, Wilkinson GR, Roden DM. |
1996 |
4739 |
Journal
PlosOne 2023 18(2): e0282164. |
Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules.
Thevin P, Curti C, Benech A, Jean C, Lamy E, Castera Ducros C, Primas N, Bertault-Perez P, Vanelle P. |
2023 |
4740 |
Manufacturer
Roche Products Limited 2021 |
MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021
|
2021 |
1522 |
Manufacturer
Maco Pharma 2001 |
Macoflex N®
|
2001 |
3838 |
Manufacturer
Martindale Pharmaceuticals Ltd 2007 |
Magnesium Sulphate - Summary of Product Characteristics
|
2007 |
4457 |
Journal
J Obstet Gynaecol Can 2016 ;38,10:936e944. |
Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes.
Houlihan, S, Decarie, D, Benes, C, Cleve, R, Vidler M, Magee L.A, Ensom M.H.H, vonDadelszen P. |
2016 |
4344 |
Journal
EJHP 2018 |
Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments.
Yay? HS, Faucheron A, Dupont L, El Kouari F, Fekkar A, Bellanger A, Tilleul P. |
2018 |
3307 |
Journal
Hosp Pharm 2012 ; 47, 1: 27-30. |
Managing the intravenous calcium shortage: Evaluation of calcium chloride stability in 0.9% sodium chloride and dextrose 5% water polyvinyl chloride bags.
Kiser T.H, Barber G.R, Robinson A. |
2012 |
1861 |
Journal
Int J Pharm 1996 ; 127: 255-259. |
Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture.
Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J. |
1996 |
4490 |
Journal
Sci Pharm 2020 ; 88, 25 |
Medication Safety in Intravenous Therapy: A Compatibility Study and Analysis of Reaction Products of Dihydralazine and Metamizole.
Koller A.K, Fischer O, Krebs S. |
2020 |
3584 |
Manufacturer
Aspen Pharma 2013 |
Melphalan (Alkéran®) - Résumé des caractéristiques du produit
|
2013 |
3602 |
Manufacturer
Baxter SAS 2013 |
Mesna (Uromitexan®)- Summary of Product Characteristics
|
2013 |
3637 |
Manufacturer
Hameln Pharmaceuticals 2014 |
Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics
|
2014 |
978 |
Journal
Can J Hosp Pharm 1994 ; 47: 147. |
Methotrexate and cytarabine for intrathecal administration.
Dick DM, Woloschuk DMM. |
1994 |
1021 |
Journal
J Clin Hosp Pharm 1986 ; 11: 343-348. |
Methotrexate in solutions - A stability test for the hospital pharmacy.
Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J. |
1986 |
3594 |
Manufacturer
Zentiva 2013 |
Metronidazole (Flagyl®) - Summary of Product Characteristics
|
2013 |
3573 |
Manufacturer
Astellas 2013 |
Micafungin (Mycamine®) – Summary of Product Characteristics
|
2013 |
823 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1584-1587. |
Microbial inhibitory properties and stability of topotecan hydrochloride injection.
Patel K, Craig SB, McBride MG, Palepu NR. |
1998 |
3859 |
Journal
RRJHCP 2016 ; 1, 3: 31-37. |
Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems.
Foy G, Poinsignon V, Mercier L, Laurent S, Paci A. |
2016 |
2118 |
Journal
J Pain Symptom Manage 2006 ; 32, 1: 90-97. |
Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems.
Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph. |
2006 |
3126 |
Journal
J Pain Symptom Manage 2010 ; 40, 1: 87-94. |
Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems.
Amri A, Achour AB, Chachaty E, Mercier L, Bourget P, Paci A. |
2010 |
4366 |
Journal
Braz J Pharm Sci 2019 ;55:e17351 |
Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures.
Estan-Cerezo G, Rodriguez-Lucena F.J, Matoses Chirivella C, Jiminez-Pulido I, Garcia-Monsalve A, Navarro-Ruiz A. |
2019 |
2007 |
Journal
J Pharm Biomed Anal 2005 ; 38: 709-713. |
Migration of diethylhexyl phtalate from PVC into intravenous cyclosporine solutions.
Gotardo MA, Monteiro M. |
2005 |
1699 |
Journal
Krankenhauspharmazie 2000 ; 21: 107-109. |
Mischbarkeit von serotonin-antagonisten mit dexamethason und heparin.
Plaas S, Heck C, Kubrich M. |
2000 |
3315 |
Poster
Communication orale Hopipharm 2012 |
Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon.
Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E. |
2012 |
3128 |
Manufacturer
Prostrakan 2013 |
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
|
2013 |
3575 |
Manufacturer
Prostrakan 2013 |
Mitomycine (Ametycine®) - Résumé des caractéristiques du produit
|
2013 |
3640 |
Manufacturer
Hospira 2013 |
Mitoxantrone - Summary of Product Characteristics
|
2013 |
465 |
Journal
Am J Hosp Pharm 1990 ; 47: 297-298. |
More information on the visual compatibility of hetastarch with injectable critical-care drugs.
Wohlford JG, Wright JC, Wilson MR. |
1990 |
322 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2639. |
More on compatibility of mannitol and sodium bicarbonate in injectable fluids.
Matuschka PR, Hill LJ. |
1996 |
2362 |
Poster
ADKA Congress 2009 2009 |
Morphin-Haloperidol mischungen in PCA Pumpen : Kompatibel?
Trittler R, M?ller S, Esteban M. |
2009 |
2363 |
Poster
ADKA Congress 2006 |
Morphin-Metamizol mischungen zur kontinuierlichen parenteralen applikation : Sind sie immer inkompatibel?
M?ller S, Trittler R, Schubert R, von Hornstein W.F, Strehl E. |
2006 |
3531 |
Manufacturer
Wockhardt 2014 |
Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
|
2014 |
2055 |
Journal
Int J Pharm 2006 ; 307: 278-284. |
Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients.
Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E. |
2006 |
626 |
Journal
Am J Hosp Pharm 1982 ; 39: 1495-1498. |
Moxalactam disodium compatibility with intramuscular and intravenous diluents.
Bornstein M, Lo AY, Thomas PN, Wilham WL. |
1982 |
3162 |
Manufacturer
Bayer HealthCare 2010 |
Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits
|
2010 |
3109 |
Manufacturer
Bayer Schering Pharma 2010 |
Moxifloxacine (Izilox®) -Notice information
|
2010 |
1366 |
Journal
Am J Hosp Pharm 1981 ; 38: 462,464. |
Nafcillin sodium incompatibility with acidic solutions.
Jeglum EL, Winter E, Kotos M. |
1981 |
3672 |
Manufacturer
Mylan SAS 2016 |
Nalbuphine Mylan - Résumé des caractéristiques du produit
|
2016 |
3264 |
Poster
AAPS Congress - Washington, October 2011 2011 |
Nalbuphine stability at 1 mg/mL concentration.
Hammer C, Perello L, Dory A, Lev?que D, Ubeaud-S?quier G. |
2011 |
2678 |
Journal
Int J Pharm Compound 2000 ; 4: 69-71. |
Naratriptan hydrochloride in extemporaneously compounded oral suspensions.
Zhang YP, Trissel LA, Fox JL. |
2000 |
4068 |
Manufacturer
2018 Biogen Idec Ltd |
Natalizumab (Tysabri®) - Summary of Product Characteristics
|
2018 |
3938 |
Manufacturer
Lilly S.A 2016 |
Necitumumab (Portrazza®) – Résumé des caractéristiques du produits
|
2016 |
2311 |
Journal
J Clin Pharm Ther 2009 ; 34: 25-31. |
Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. |
2009 |
2265 |
Journal
J Pharm Sci 1990 ; 79, 1: 48-52. |
Nefopam hydrochloride degradation kinetics in solution.
Tu YH, Wang DP, Allen LV. |
1990 |
958 |
Journal
Ann Pharmacotherapy 1990 ; 24: 440-442. |
Netilmicin sulfate stability in combinaison with metronidazole or ranitidine hydrochloride in NaCl 0.9% infusion.
Vervloet E, Lammers J, Tan LSL, Van Mourik CH, Rots M. |
1990 |
4561 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20200013. |
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study.
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S. |
2021 |
3306 |
Journal
EJOP 2012 ; 6, 1: 1-2. |
New stability studies for fludarabine according to the European Pharmacopoeia 7.0
Trittler R. |
2012 |
3941 |
Manufacturer
Concordia International 2017 |
Nicardipine - Summary of Product Characteristics
|
2017 |
3614 |
Manufacturer
American Regent Inc 2013 |
Nicardipine Injection - Summary of Product Characteristics
|
2013 |
3206 |
Journal
Int J Pharm Compound 2011 ; 15, 2: 166-169. |
Nifedpine in Compounded Oral and Topical Preparations.
McCluskey Susan V, Brunn Gregory J. |
2011 |
708 |
Journal
Am J Hosp Pharm 1980 ; 37: 201-205. |
Nitroglycerin compatibility with intravenous fluid filters containers, and administration sets.
Baaske DM, Amann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG. |
1980 |
1113 |
Journal
Am J Hosp Pharm 1989 ; 46: 2031-2035. |
Nitroglycerin delivery through a polyethylene-lined intravenous administration set.
Tracy TS, Bowman L, Black CD. |
1989 |
4652 |
Manufacturer
Bristol Myers Squibb Pharmaceuticals 2022 |
Nivolumab (Opdivo®) - Summary of Product Characteristics
|
2022 |
642 |
Journal
Hosp Pharm 1988 ; 23: 44,49, 59. |
Norepinephrine stability in saline solutions.
Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA. |
1988 |
3455 |
Journal
J Drug Deliv Sci Tecnol 2012 ; 22, 4: 347-352. |
Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo.
Tous S.S, El Sayed A.M, Abd El Mohsen M.G, Yoissef E.M.K, Agban M.N, Boushra M.F. |
2012 |
4720 |
Manufacturer
Paratek Pharmaceuticals 2021 |
Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
|
2021 |
3768 |
Manufacturer
Roche Products Limited 2014 |
Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics
|
2014 |
4086 |
Manufacturer
Novartis Pharma 2017 |
Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit
|
2017 |
3138 |
Manufacturer
GlaxoSmithKline 2009 |
Ofatumumab (Arzerra®) - Summary of Product Characteristics
|
2009 |
3562 |
Manufacturer
Sanofi 2014 |
Ofloxacin (Tarivid®) - Summary of Product Characteristics
|
2014 |
889 |
Journal
Pharm Weekbl [Sci] 1991 ; 13: 207-209. |
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. |
1991 |
3776 |
Manufacturer
Teva Pharmaceuticals 2014 |
Omecetaxine (Synribo®) - Summary of Product Characteristics
|
2014 |
3658 |
Manufacturer
Sandoz 2014 |
Omeprazole - Summary of Product Characteristics.
|
2014 |
3574 |
Manufacturer
Accord Healthcare France SAS 2013 |
Ondansetron - Résumé des caractéristiques du produit
|
2013 |
1396 |
Journal
J Clin Oncol 1993 ; 11: 197. |
Ondansetron compatible with sodium acetate.
Hauser AR, Trissel LA, Martinez JF. |
1993 |
3924 |
Journal
Ann Pharm Fr 2016 ; 75, 1 : 17-29. |
One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C.
Vieillard V, Astier A, Sauzay C, Paul M. |
2016 |
3949 |
Poster
JFSPH Congress, Bern, Switzerland. 2016 |
Optimisation du processus de préparation des solutions de melphalan destinées à l’administration intra-vitréenne dans le traitement du rétinoblastome et étude de leur stabilité
Brönnimann C, Berger-Gryllaki M, Podilsky G, Sadeghipour F. |
2016 |
3787 |
Manufacturer
The Medicines Company 2016 |
Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics
|
2016 |
4211 |
Journal
PlosOne 2019 |
Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A. |
2019 |
3589 |
Manufacturer
PanPharma 2013 |
Oxacilline PanPharma – Résumé des caractéristiques du produits
|
2013 |
3413 |
Journal
Pharm Res 2004 ; 21, 5: 891-894. |
Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex.
Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. |
2004 |
3634 |
Manufacturer
Accord Healthcare 2011 |
Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit
|
2011 |
2366 |
Poster
ADKA Congress 2009 |
Oxycodon-Metamizol in PCA pumpen : Kompatibel?
M?ller S, Trittler R, Schubert R. |
2009 |
1903 |
Journal
Am J Obstet Gynecol 2002 ; 186: 496-498. |
Oxytocin preparation stability in several common obstetric intravenous solutions.
Gard JW, Alexander JM, Bawdon RE, Albrecht JT. |
2002 |
1956 |
Manufacturer
Hospira UK Limited 2015 |
Paclitaxel - Summary of Product Characteristics
|
2015 |
3157 |
Manufacturer
Celgene Europe Limited 2015 |
Paclitaxel albumin (Abraxane®) - Summary of Product Characteristics
|
2015 |
669 |
Journal
Ann Pharmacotherapy 1994 ; 28: 35-36. |
Paclitaxel stability and compatibility in polyolefin containers.
Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS. |
1994 |
4101 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins.
Ey C, Hosselet C, Villon B, Mar?on F. |
2018 |
1955 |
Journal
Ann Pharmacotherapy 2005 ; 39: 280-283. |
Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Trissel LA, Zhang Y. |
2005 |
2214 |
Journal
Int J Pharm Compound 2007 ; 11, 6: 520-524. |
Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration.
Ben M, Trusley C,Kupiec T.C, Trissel L.A. |
2007 |
3619 |
Manufacturer
Wockhardt 2016 |
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
|
2016 |
755 |
Manufacturer
MSD France 2016 |
Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
|
2016 |
3769 |
Manufacturer
B Braun laboratoire 2014 |
Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit
|
2014 |
3504 |
Manufacturer
Pfizer 2012 |
Parecoxib (Dynastat®) - Summary of Product Characteristics
|
2012 |
4173 |
Manufacturer
Baxalta Innovations GmbH 2018 |
Pegaspargase (Oncaspar®) - Résumé des Caractéristiques du Produit
|
2018 |
3771 |
Manufacturer
Merck Sharp Dohme 2017 |
Pembrolizumab (Keytruda®) - Summary of Product Characteristics
|
2017 |
1914 |
Manufacturer
Eli Lilly 2016 |
Pemetrexed (Alimta®) - Summary of Product Characteristics
|
2016 |
4589 |
Manufacturer
Mylan 2021 |
Pemetrexed Mylan - Résumé des caractéristiques du produit
|
2021 |
4629 |
Manufacturer
2021 Sandoz |
Pemetrexed Sandoz - Summary of Product Characteristics (SmPc)
|
2021 |
3559 |
Manufacturer
Sanofi Aventis France 2013 |
Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit
|
2013 |
1235 |
Journal
Br J Pharm Pract 1988 ; 10: 22-23. |
Pentamidine infusion stability.
Leigh PH, Buddle GC. |
1988 |
4024 |
Poster
SFPO Congress 2017 - Nantes 2017 |
Pénurie mondiale d'Etopophos et conséquences pratiques : Intérêt des études de stabilité dans le choix d'un générique.
Sadou Yaye H, Rieber Z, HassaniI L, Hoffmann-Martinot C, Babiard M, Aouti H, Bellanger A, Tilleul P. |
2017 |
4686 |
Manufacturer
Roche Products Ltd. 2022 |
Pertuzumab (Perjeta®) - Summary of Product Characteristics.
|
2022 |
3525 |
Manufacturer
AMCO Amdipharm Mercury 2012 |
Pethidine hydrochloride - Summary of product Characteristics
|
2012 |
3871 |
Poster
Synprefh Congress Clermont Ferrand, France 2016 |
Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ?
Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. |
2016 |
2175 |
Journal
J Pharm Clin 2006 ; 25, 3: 147-152. |
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J. |
2006 |
1317 |
Journal
Pharm J 1987 ; 238: 476-478. |
Pharmaceutical aspects of home infusion therapy for cancer patients.
Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG. |
1987 |
4747 |
Journal
Pharmaceutics 2023 ,15, 957. |
Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease.
Querin B, Schweitzer-Chaput A, Cisternino S, Auvity S, Fauqueur A-S, Negbane A, Hadchouel A, Schlatter J, Cotteret C. |
2023 |
4283 |
Journal
Eur J Pharm Sci 2019 |
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate.
Lopalco A, Curci A, Lopedota A, Cutrignelli A, Laquintana V, Franco M, Denora N. |
2019 |
1274 |
Journal
TAP Pharmazeutische Zeitung 1997 ; 31: 30-33. |
Pharmazeutische aspekte von topotecan-infusionen.
Krämer I, Thiesen J. |
1997 |
1482 |
Journal
Krankenhauspharmazie 1992 ; 3: 98-100. |
Pharmazeutische kompatibilität der kombination cefotiam und ampicillin.
Messerschmidt W. |
1992 |
1692 |
Journal
Krankenhauspharmazie 1998 ; 19: 226-228. |
Pharmazeutische kompatibilität von piperacillin mit metronidazol.
Messerschmidt W. |
1998 |
1949 |
Journal
Clinical Cancer Research 2001 ; 7: 1569-1576. |
Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. |
2001 |
3620 |
Manufacturer
Beacon Pharmaceuticals 2012 |
Phenylephrine - Summary of Product Characteristics
|
2012 |
3770 |
Manufacturer
Eclat Pharmaceuticals 2014 |
Phenylephrine hydrochloride (Vazculep®) - Summary of Product Characteristics
|
2014 |
1169 |
Journal
Am J Hosp Pharm 1981 ; 38: 358-362. |
Phenytoin sodium solubility in three intravenous solutions.
Pfeifle CE, Adler DS, Gannaway WL. |
1981 |
3621 |
Manufacturer
Renaudin 2008 |
Phosphate dipotassique - Résumé des caractéristiques du produit
|
2008 |
1887 |
Journal
Int J Pharm 1995 ; 123: 229-235. |
Photochemical decomposition of midazolam. IV . Study of pH dependant stability by high-performance liquid chromatography.
Andersin R, Tammilehto S. |
1995 |
1265 |
Journal
J Clin Pharm Ther 1990 ; 15: 291-300. |
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
Wood MJ, Irwin WJ, Scott DK. |
1990 |
2816 |
Journal
J Pharm Biomed Anal 1999 ; 25: 269-275. |
Photodegradation of folic acid in aqueous solution
Aktar J, Khan A, Ahmad I. |
1999 |
796 |
Journal
PDA J Pharm Sci Technol 1996 ; 50: 158-162. |
Photodegradation of furosemide solutions.
Asker AF, Ferdous AJ. |
1996 |
1918 |
Journal
J Pharm Sci 1997 ; 86, 12: 1410-1416. |
Photodegradation of irinotecan (CPT-11) in aqueous solutions : identification of fluorescent products and influence of solution composition.
Dodds HM, Craik DJ, Rivory LP. |
1997 |
1383 |
Journal
J Pharm Pharmacol 1978 ; 30: 47P. |
Photodegradation of solutions of the antitumour drug DTIC.
Stevens MFG, Peatey L. |
1978 |
948 |
Journal
J Pharm Sci 1994 ; 83: 463-467. |
Photodegradation of some quinolones used as antimicrobial therapeutics.
Tiefenbacher EM, Haen E, Przybilla B, Kurz H. |
1994 |
1920 |
Journal
Drug Stability 1996 ; 1: 118-122. |
Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution.
Akimoto K, Kaway A, Ohya K et al. |
1996 |
1921 |
Journal
Drug Stability 1996 ; 1; 141-146. |
Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution.
Akimoto K, Kawai A, Ohya K. |
1996 |
1696 |
Journal
J Pharm Biomed Anal 1999 ; 21: 851-857. |
Photodegradation studies on Atenolol by liquid chromatography.
Andrisano V, Gotti R, Leoni A, Cavrini V. |
1999 |
1284 |
Journal
Photochem Photobiol 1981 ; 34: 131-134. |
Photoinactivation of anthracyclines.
Williams BA, Tritton TR. |
1981 |
847 |
Journal
J Pharm Pharmacol 1980 ; 32: 860-862. |
Photolytic degradation of adriamycin.
Tavoloni N, Guarino AM, Berck PD. |
1980 |
145 |
Journal
J Pharm Clin 1992 ; 11: 285-295. |
Photosensibility of 5-fluorouracile and methotrexate in translucent or opaque perfusers.
Lorillon P, Corbel JC, Mordelet MF, Basle B, Guesnier LR. |
1992 |
1851 |
Journal
J Pharm Biomed Anal 2001 ; 25, 3-4: 589-597. |
Photostability and phototoxicity studies on diltiazem.
Andrisano V, Hrelia P, Gotti R, Leoni A, Cavrini V. |
2001 |
2089 |
Journal
Pharmazie 2004 ; 59: 457-463. |
Photostability of epinephrine - the influence of bisulfite and degradation products.
Brustugun J, Kristensen S, Tonnesen HH. |
2004 |
1965 |
Journal
PDA J Pharm Sci Technol 2004 ; 58, 6: 296-308. |
Photostability of sympatomimetic agents in commonly used infusion media in the absence and presence of bisulfite.
Brustugun J, Kristensen S, Tonnesen HH. |
2004 |
3571 |
Journal
Hosp Pharm 2014 ; 49, 1: 42-47. |
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M. |
2014 |
289 |
Journal
Ann Pharmacotherapy 1993 ; 27: 704-707. |
Physical and chemical compatibility of intravenous ciprofloxacin with other drugs.
Jim LK. |
1993 |
4369 |
Journal
J Pharm Biomed Anal 2020 ;178:112896 |
Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate
Sadou Yayé H, Hassani L, Secrétan PH, Babiard M, Aouati H, Bellanger A, Tilleul P, Yagoubi N, Do B, Rietveld I. |
2020 |
4001 |
Journal
Int J Pharm Compound 2017 ; 21:4 :322-329 |
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox).
Ip K,Carvalho M,Shan A,Banov D. |
2017 |
4059 |
Journal
EJHP 2017 ; 25, e2 |
Physical and chemical stability of ceftaroline in an elastomeric infusion device.
Madfai F, Zaidi S, Ming L, Wanandy T, Patel R. |
2017 |
3183 |
Journal
EJOP 2010 ; 4, 3: 11-13. |
Physical and chemical stability of cisplatin infusions in PVC containers.
Sewell G |
2010 |
4455 |
Journal
J Oncol Pharm Practice 2020 online first |
Physical and chemical stability of cytarabine in polypropylene syringes.
Ben Ayed W, Drira C, Ali Soussi M, Ouesleti H, Hamdene B, Khrouf M, Safta F, Fradi I. |
2020 |
1937 |
Journal
Ann Pharmacotherapy 2004 ; 38: 1612-1616. |
Physical and chemical stability of daptomycin with nine medications.
Lai JJ, Brodeur SK. |
2004 |
4602 |
Journal
Hosp Pharm 2021 ; 56, 4: 215-220. |
Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting.
Buga I, Uzoma J.I, Reindel K, Rashid K, Diep T, McCartan P, Zhao F. |
2021 |
3195 |
Journal
EJHP 2011 ; 17, 2: 39-43. |
Physical and chemical stability of docetaxel infusions.
MacLeod S, Sewell G. |
2011 |
2270 |
Journal
Ann Pharmacotherapy 2008 ; 42, 9: 1247-1251. |
Physical and chemical stability of esomeprazole sodium solutions.
Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J. |
2008 |
4174 |
Journal
Int J Pharm Compound 2018 ;22,6:504-511 |
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase).
Ip K, Shan A, Yan W, Banov D. |
2018 |
1411 |
Journal
J Am Pharm Assoc 1999 ; 39: 146-150. |
Physical and chemical stability of etoposide phosphate solutions.
Zhang Y, Trissel LA. |
1999 |
1422 |
Journal
J Am Pharm Assoc 1999 ; 39: 509-513. |
Physical and chemical stability of gemcitabine hydrochloride solutions.
Xu QA, Zhang Y, Trissel LA. |
1999 |
3610 |
Journal
J Oncol Pharm Practice 2014 ; 20, 1: 51-57. |
Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
Zhang, Y., Kawedia, J.D., Myers, A.L., McIntyre, C.M., Anderson, P.M., Kramer, M.A., Culotta, K. |
2014 |
1706 |
Journal
Int J Pharm Compound 2002 ; 6: 74-76. |
Physical and chemical stability of hydromorphone hydrochloride 1.5 and 80 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA. |
2002 |
1707 |
Journal
Int J Pharm Compound 2002 ; 6: 70-73. |
Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes.
Trissel LA, Xu QA, Pham L. |
2002 |
1708 |
Journal
Int J Pharm Compound 2002 ; 6: 66-69. |
Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes.
Xu QA, Trissel LA, Pham L. |
2002 |
31 |
Journal
Hosp Pharm 1996 ; 31: 965-970. |
Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solution.
Zhang Y, Xu QA, Trissel LA, Gilbert DL. |
1996 |
1661 |
Journal
J Oncol Pharm Practice 2002 ; 8: 27-32. |
Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott’s B Solution for intrathecal use.
Trissel LA, King KM, Zhang Y, Wood AM. |
2002 |
1709 |
Journal
Int J Pharm Compound 2002 ; 6: 62-65. |
Physical and chemical stability of morphine sulfate 5 mg/ml and 50 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA. |
2002 |
2172 |
Journal
J Oncol Pharm Practice 2006 ; 12, 4: 211-222. |
Physical and chemical stability of paclitaxel infusions in different container types.
Donyai P, Sewell GJ. |
2006 |
1936 |
Journal
Ann Pharmacotherapy 2004 ; 38: 1608-1611. |
Physical and chemical stability of palonosetron HCl in 4 infusion solusions.
Trissel LA, Xu QA. |
2004 |
1950 |
Journal
J Oncol Pharm Practice 2004 ; 10: 191-195. |
Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration.
Trissel LA, Yanping Z. |
2004 |
2107 |
Journal
Int J Pharm Compound 2006 ; 10: 234-236. |
Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration.
Trissel LA, Zhang Y, Xu QA. |
2006 |
2279 |
Journal
Am J Health-Syst Pharm 2008 ; 65, 18: 1735-1759. |
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupiec T, Trusley C, Ben M, Trissel LA. |
2008 |
2196 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 11: 1209-1213. |
Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration.
Trissel LA, Trusley C, Ben M, Kupiec TC. |
2007 |
2009 |
Journal
Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322. |
Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration.
Trissel LA, Zhang Y. |
2005 |
2286 |
Journal
Int J Pharm Compound 2008 ; 12, 4: 368-371. |
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Ben M, Trusley C, Kupiec TC, Trissel LA. |
2008 |
1975 |
Journal
Int J Pharm Compound 2005 ; 9, 3: 235-237. |
Physical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA. |
2005 |
1976 |
Journal
Int J Pharm Compound 2005 ; 9, 3: 238-241. |
Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA. |
2005 |
2179 |
Journal
Int J Pharm Compound 2007 ; 11, 1: 82-85. |
Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA. |
2007 |
2114 |
Journal
Ann Pharmacotherapy 2006 ; 40, 6: 1082-1085. |
Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y, Trissel LA. |
2006 |
2036 |
Journal
Ann Pharmacotherapy 2005 ; 39, 12: 2026-2028. |
Physical and chemical stability of pemetrexed solutions in plastic syringes.
Zhang Y, Trissel LA. |
2005 |
4691 |
Journal
Int J Pharm Compound 2022 ;26,3:248-254 |
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine.
Catry E, Colsoul ML, Closset Me, Hubert J, Soumoy L, Bihin B, Thiry E, Jamart J, Hecq JD, Galanti L. |
2022 |
3691 |
Journal
J Oncol Pharm Practice 2016 ; 22: 21-25 |
Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer
Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S. |
2016 |
3611 |
Journal
J Oncol Pharm Practice 2014 ; 20, 1: 58-64. |
Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. |
2014 |
3163 |
Journal
EJHP 2010 ; 16, 5: 26-28. |
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
Acott SR, Hart M. |
2010 |
1898 |
Journal
Int J Pharm Compound 2004 ; 8, 3: 228-230. |
Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirs.
Xu QA, Trissel LA, Pham L. |
2004 |
3881 |
Journal
Int J Pharm Compound 2016 ; 20, 4 : 343-346 |
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump.
Tomasello C, Leggieri A, Rabbia F, Veglio F, Baietto L,Fulcheri C, De Nicol? A, De Perri G, D'Avolio A. |
2016 |
3849 |
Journal
Curr Pharm Biotech 2013 ; 14, 2: 220-225. |
Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions.
Pabari R.M, Ryan B, Ahmad W, Ramtoola Z. |
2013 |
4559 |
Journal
Drug Design Dev Ther 2020 ;14, 4179-4187. |
Physical Compatibility and Chemical Stability of
Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.
Chen P, Chen F, Lei J, Zhou B. |
2020 |
2297 |
Journal
Int J Pharm Compound 2008 ; 11, 6: 550-552 |
Physical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/ml) for use as an antidote in nerve agent casualties.
Donnelly R.F, Corman C. |
2008 |
561 |
Journal
Current Ther Res 1976 ; 20: 359-368. |
Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions. Part II.
Nunning BC, Granatek AP. |
1976 |
682 |
Journal
Ann Pharmacotherapy 1991 ; 25: 123-126. |
Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection.
Raymond GG, Davis RL. |
1991 |
865 |
Journal
Int J Pharm Compound 1998 ; 2: 79-81. |
Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion.
Bhatt-Mehta V, Hirata S. |
1998 |
1931 |
Journal
Can J Hosp Pharm 2004 ; 4: 230-235. |
Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes.
Donnely RF. |
2004 |
4131 |
Journal
Hosp Pharm 2019 ;54,1:32-36. |
Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine.
Fleming K, Donnelly R. |
2019 |
2322 |
Journal
Can J Hosp Pharm 2009 ; 62, 1 |
Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes.
Donnelly R.F. |
2009 |
2192 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414. |
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Cochran BG, Sowinski KM, Fausel C, Overholser BR. |
2007 |
1971 |
Journal
Support Care Cancer 2001 |
Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care.
Azuara ML, Sanchez Y, Reyes R, Barcia E. |
2001 |
4245 |
Poster
2019 |
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE. |
2019 |
3186 |
Journal
Am J Health-Syst Pharm 2011 ; 68:377-378. |
Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin.
Bryan Dotson B, Churchwell MD. |
2011 |
3122 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 1195-1198. |
Physical compatibility of 4% sodium citrate with selected antimicrobial agents.
Dotson B, Lynn S, Savakis K, Churchwell MD. |
2010 |
3201 |
Journal
J Pediatr Pharmacol Ther 2006 ; 11:233?6. |
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
Dice JE. |
2006 |
4491 |
Journal
Eur J Pedia 2020 |
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. |
2020 |
4651 |
Journal
Eur J Pedia 2021 ;180,1169–1176. |
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. |
2021 |
1822 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 1650-1652. |
Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate.
Trissel LA, Seanz C. |
2003 |
3470 |
Journal
Support Care Cancer 2012 ; 20: 2501-2509. |
Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
Destro M, Ottolini L, Vicentini L, Boschetti S. |
2012 |
3268 |
Journal
Am J Health-Syst Pharm 2012 ;69: 98. |
Physical compatibility of calcium gluconate and magnesium sulfate injections.
Beauregard N, Bertrand N, Dufour A, Blaizel O, Leclair G |
2012 |
4528 |
Journal
Int J Pharm Compound 2021 ;25,1:52-61 |
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. |
2021 |
3429 |
Journal
Am J Health-Syst Pharm 2015 ; 72:483-486 |
Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration
Foushee J.A, Fox L.M, Gormley L.R, Lineberger M.S. |
2015 |
4055 |
Journal
Am J Health-Syst Pharm 2018 , 75, 1:36-44 |
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. |
2018 |
3131 |
Journal
Can J Hosp Pharm 2010 ; 63, 2: 154-155. |
Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl.
Donnely RF, Wong K, Spencer J. |
2010 |
4419 |
Journal
J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161. |
Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.
Holt R.J, Siegert S.W.K, Krishna A. |
2008 |
4254 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40 |
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
D'Huart E, Vigneron J, Demoré B. |
2019 |
4108 |
Journal
Am J Health-Syst Pharm 2018 ;75;8:510-512 |
Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine.
Cruz K, Chrchwell M, Mauro V, Boddu. |
2018 |
4411 |
Journal
Int J Pharm Compound 2020 ;24,3:238-241. |
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions.
Wilder A.G, Foushee J.A, Fox L.M, Navalle J, Wright A.M, Greer M.A. |
2020 |
169 |
Journal
Am J Hosp Pharm 1993 ; 50: 2359-2363. |
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. |
1993 |
2346 |
Journal
Am J Health-Syst Pharm 2009 ; 66: 986-987. |
Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents
Newland A.M, Mauro V.F, Alexander K.S. |
2009 |
4057 |
Journal
Hosp Pharm 2018 ; 53, 2: 125-127. |
Physical Compatibility of Micafungin With Sodium Bicarbonate Hydratation Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.
Joiner L, Ynes C, Arnold J, Miller R, Gorman G. |
2018 |
4506 |
Journal
Am J Health-Syst Pharm 2020 ;77,23:1938-1940. |
Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
Griffith S, Stapleton E, Padilla S, Mruk A, Thomas C. |
2020 |
4144 |
Journal
EJHP 2018 ;75,14:1010-1012 |
Physical compatibility of milrinone with levofloxacin and ceftriaxone injection.
Ross A, Boddu S, Mauro V, Churchwell M. |
2018 |
4545 |
Journal
Journal of Nippon Medical school 2021 |
Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H. |
2021 |
4655 |
Journal
Am J Health-Syst Pharm 2022 ;79,1:27-33 |
Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
Holyk A, Lindner A, Lindner S, Shippert B |
2022 |
1902 |
Journal
Can J Hosp Pharm 2004 ; 57, 2: 90-96. |
Physical compatibility of pantoprazole with selected medications during simulated Y-site administration.
Walker SE, Wyllie A, Law S. |
2004 |
1953 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 2289-2293. |
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Trissel LA, Saenz CA, Ogundele AB, Ingram DS. |
2004 |
4543 |
Journal
Archives of Disease in Childhood 2018 ;104:292–295. |
Physical compatibility of pentoxifylline and intravenous medications.
Senarathna G, Strunk T, Petrovski M, Batty K. |
2018 |
4145 |
Journal
Am J Health-Syst Pharm 2018 ;75,14:1048-1056 |
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. |
2018 |
4080 |
Journal
Anaesthesia 2017 ;124,3:776-781 |
Physical Compatibility of Propofol-Sufentanil Mixtures.
Zbytovska J, Gallusova J, Vidlarova L, Prochazkova K, Simek J, Stepanek F. |
2017 |
3558 |
Journal
Can J Hosp Pharm 2013 ; 66, 5: 332. |
Physical Compatibility of Ranitidine and Metoclopramide in 50-mL Minibags of Normal Saline.
Rowe H, Riley J, Newby B. |
2013 |
58 |
Journal
Can J Hosp Pharm 1985 ; 38: 160-161. |
Physical compatibility of ranitidine HCl with preoperative injectable medications.
Parker WA. |
1985 |
4723 |
Journal
Am J Health-Syst Pharm 2022 https://doi.org/10.1093/a |
Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.
Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H |
2022 |
3416 |
Journal
Am J Health-Syst Pharm 2013 ; 70: 932-937 |
Physical compatibility of sodium citrate with alcohol and cefepime.
Csaba M, Boddu,S.H.S , Churchwell M.D. |
2013 |
3254 |
Journal
Am J Health-Syst Pharm 2011 ; 68: 2265-2270. |
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L. |
2011 |
4524 |
Poster
ESCP Symposium, Geneva, Switzerland 2009 |
Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology.
Stucki C, Sautter A-M, Bonnabry P. |
2009 |
3967 |
Journal
J Pharm Pharmacol 2017 ;69,7:448-462 |
Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
Staven V, Herra I, Wang S, Grönlie I,Tho I. |
2017 |
3942 |
Journal
Am J Health-Syst Pharm 2017 ; 74, 5: 280-281. |
Physical compatibility of valproate sodium injection with dobutamine and dopamine.
Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D. |
2017 |
3421 |
Journal
Am J Health-Syst Pharm 2013 ;70:1163-1166. |
Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions.
Leung E, Venkatesan N, Ly S.C, Scheetz M.H. |
2013 |
3379 |
Journal
Am J Health-Syst Pharm 2013 ;70:520-524. |
Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
Fox L.M, Wilder A.G, Foushee J.A. |
2013 |
1801 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 1271-1272. |
Physical compatibility of vasopressin with medications commonly used in cardiac arrest.
Feddema S, Rusho WJ, Tyler LS, Barker B. |
2003 |
1647 |
Journal
Anaesthesia 2001 ; 56: 294. |
Physical incompatibility between atracurium and intravenous diclofenac.
Ackland G. |
2001 |
3557 |
Journal
Can J Hosp Pharm 2013 ; 66, 5: 310-312 |
Physical Incompatibility between Parenteral Cloxacillin and Vancomycin.
Chan A, Tawfik G, Cheng W. |
2013 |
2117 |
Journal
Ann Pharmacotherapy 2006 ; 40, 7: 1289-1292. |
Physical instability of frozen pemetrexed solutions in PVC bags.
Zhang Y, Trissel LA. |
2006 |
4370 |
Journal
EJHP 2018 2018;0:1-7 |
Physical stability of an all-in one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs
Staven V, Wang S, Gronlie I, Tho I. |
2018 |
4368 |
Journal
J Pharm Health Care Sci 2019 ; 5: 25. |
Physical, chemical, and microbiological stability study of diluted atropine eye drops.
Saito J, Imaizumi H, Yamatani A. |
2019 |
1660 |
Journal
Pharm World Sci 1999 ; 21: 137-141. |
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Thiesen J, Krämer I. |
1999 |
3707 |
Journal
J Oncol Pharm Practice 2014 ; 20: 183-189 |
Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions.
Spindeldreier K, Thiesen J, Lipp H.P, Krämer I. |
2014 |
1723 |
Journal
Pharmazie 1998 ; 53: 386-391. |
Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine.
Sattler A, Jage J, Krämer I. |
1998 |
2825 |
Journal
Int J Pharm Compound 2015 ; 19, 3: 261-267. |
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials.
Mueller C, Dietel E, Heynen S, Nalenz H, Goldbach P, Mahler H, Schmidt J, Grauschopf U, Schoenhammer K. |
2015 |
3225 |
Journal
EJHP Science 2011 ; 17, 1: 7-12. |
Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags.
Kaiser J, Krämer I. |
2011 |
4126 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,3:135-142 |
Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours.
D'Huart E, Vigneron J, Ranchon F, Vantard N, Rioufol C, Demor2 B |
2018 |
3041 |
Journal
Acta Pol Pharm 2006 ; 63: 293-299. |
Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A, Zawiswa T, Taberska J , Kukula H. |
2006 |
3755 |
Journal
Int J Pharm Compound 2014 ; 18, 5: 427-431. |
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R. |
2014 |
4052 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 |
Physicochemical and microbiological stability of a new paediatric oral solution of clonidine.
Verhlac C, Bourdon F, Titecat M, Frealle E, Dhorne C, Berneron C, Odou P. |
2017 |
4695 |
Journal
Int J Pharm Compound 2022 ;24,6:342-351 |
Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T Graves R. |
2022 |
3789 |
Journal
Int J Pharm Compound 2015 ; 19, 1: 73-77. |
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions.
Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Do Nascimento Afonso V. |
2015 |
4575 |
Journal
Int J Pharm Compound 2021 ;25,2:169-175 |
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Richard A. |
2021 |
4530 |
Journal
Int J Pharm Compound 2021 ;25,5:431-439 |
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R. |
2021 |
4741 |
Journal
Int J Pharm Compound 2023 ;27,2:160-168 |
Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base,
SuspendIt.
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R |
2023 |
4272 |
Journal
Pharm Dev Technol 2019 |
Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients.
Merino-Bohorquez, Delgado-Valverde M, Garcia-Palomo M, Dàvila- Pousa MC, Canete C, Villaronga M, Rodriguez-Marrodan B, Lopez-Ro |
2019 |
2530 |
Journal
Int J Pharm Compound 2022 ;26,4:330-335 |
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes.
Bartoll A, Bellés Medall M, Peñarrocha J, Escrig L, Clemente R, Azuara J. |
2022 |
761 |
Journal
EJHP 2015 ;22:89-93 |
Physicochemical and microbiological stability studies of a melatonin oral suspension in a commercially available vehicle for paediatric use.
Zerbit J, Bordenave J, Benoit G. |
2015 |
4011 |
Journal
EJHP 2016 2016;0:1-11 |
Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.
Gersonde F, Eisend S, Haake N, Kunze T. |
2016 |
4461 |
Journal
Molecules 2019 24, 1242. |
Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition.
Tomczak S, Stawny M, Dettlaff K, Kieliszek, M, Słominska D, Jelinska A. |
2019 |
1847 |
Journal
J Pharm Biomed Anal 2003 ; 32, 6: 1235-1241. |
Physicochemical compatibility between ketoprofen kysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration.
Anacardo R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G. |
2003 |
1859 |
Journal
Il Farmaco 2002 ; 57: 925-930. |
Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy.
Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G. |
2002 |
4371 |
Journal
Journal of Parenteral and Enteral Nutrition 2018 |
Physicochemical Compatibility of Amiodarone with Parenteral Nutrition.
Mediavilla MM, Molina A, Navarro L, Grau L, Pujol MD, Cardenete J, Cardona D, Riera P. |
2018 |
3705 |
Journal
EJHP 2014 ;21:161-166 |
Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine.
Knudsen L, Eisend S, Haake N, Kunze T. |
2014 |
4357 |
Journal
Nutrition in clinical Practice 2020 ; 35: 967-972. |
Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
Campos-Baeta, Saavedra-Mitjans M, Garin N, Cardenete J, Cardona D, Riera P. |
2020 |
2790 |
Journal
Int J COPD 2007 ; 1, 4: 599-607. |
Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
Kamin W, Schwabe A, Krämer I. |
2007 |
1506 |
Journal
EJHP 2015 ;22:107-112. |
Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units.
Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D. |
2015 |
150 |
Journal
J Pharm Clin 1993 ; 12: 31-35. |
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
Aujoulat P, Coze C, Braguer D, Raybaud C. |
1993 |
3334 |
Journal
EJHP 2013 ;20:36-41 |
Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate.
Krämer I, Walz-Jung H, Stanko C, Kamin W. |
2013 |
3440 |
Journal
Pharmazie 2013 ; 68: 744-748. |
Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin.
Wollstadt A, Krämer I, Kamin W. |
2013 |
2770 |
Journal
Pharmazie 2007 ; 62, 10: 760-766. |
Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol.
Krämer I, Schwabe A, Lichtinghagen R, Kamin W. |
2007 |
126 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2606-2610. |
Physicochemical compatibility of propofol with thiopental sodium.
Prankerd RJ, Jones RD. |
1996 |
2053 |
Journal
Anesth Analg 2003 ; 97: 1646-1651. |
Physicochemical compatibility of propofol-lidocaine mixture.
Masaki Y, Tanaka M, Nishikawa T. |
2003 |
3919 |
Journal
Eur J Pharm Sci 2017 ; 96: 449-455. |
Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice.
Aeberhard C, Steuer C, Saxer C, Huber A, Stanga Z, Mühlebach S. |
2017 |
4633 |
Journal
Pharmaceutics 2021 ; 13, 1447. |
Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures.
Reber E, Neyer P, Schönenberger K.A, Saxer C, Bernasconi L, Stanga Z, Huber A, Hammerer-Lercher A, Mühlebach S. |
2021 |
4696 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220005 |
Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)
Adoum A, Le P., Faisant S, Legendre P, Lester MA, Boivin PN. |
2022 |
4077 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspensions in Syrspend® SF PH4.
Bonnaure Anne-Claire, Bellay R, Rault P, Lester M.A, Boivin P.N. |
2018 |
3124 |
Journal
EJHP Science 2010 ; 16, 1: 17-22. |
Physicochemical stability of a 1mg/ml dexamethasone acetate oral suspension.
Tiphine T, Armand A, Navas D, Dailly E, Menanteau M, Thomare P. |
2010 |
4096 |
Journal
Pharm Dev Technol 2014 |
Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma.
Merino-Bohorquez V, Casas M, Caracuel F, Camean M, Fernandez-Anguita M.J, Ramirez*Soto G, Lucero M.J. |
2014 |
4673 |
Journal
Pharmaceutics 2022 ;14,1:118 |
Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases.
Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V. |
2022 |
4350 |
Journal
EJHP 2019 ;0:1-5 |
Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia.
Beiler B, Barraud D, Vigneron J, Demor? B. |
2019 |
4030 |
Journal
Int J Pharm Compound 2017 ; 21, 5 : 430-435 |
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt.
Graves R, Phan K, Bostanian L, Mandal T, Pramar Y. |
2017 |
4697 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003 |
Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage.
Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B. |
2022 |
4362 |
Journal
EJHP 2018 Eur J Hosp Pharm 2018;0:1 |
Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use.
Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M. |
2018 |
3804 |
Journal
EJHP 2014 ;22:150-155. |
Physicochemical stability of cabazitaxel and docetaxel solutions.
Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A. |
2014 |
4761 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ; 8(1): 20220009 |
Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags.
D'Huart E, Sacrez M, Vigneron J, Demoré B. |
2023 |
4097 |
Journal
Pharm Dev Technol 2013 |
Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
Casas M, Alvarez J, Lucero M. |
2013 |
4047 |
Journal
J Oncol Pharm Practice 2017 ;25,2: 339-350 |
Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period.
Kim S.H, Krämer I. |
2017 |
4762 |
Journal
EJHP 2021 Knoll L, et al. Eur J Hos |
Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature
Knoll L, Kraemer I, Thiesen J. |
2021 |
4268 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2019 |
Physicochemical Stability of Cefotaxime Sodium in Polypropylene Syringes at High Concentrations for Intensive Care Units.
D'Huart E, Vigneron J, Blaise F, Charmillon A, Demoré B. |
2019 |
4478 |
Journal
Int J Pharm Compound 2020 ;24,5:413-419 |
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt.
Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Graves R. |
2020 |
4520 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2020 |
Physicochemical stability of compounded midazolam capsules over a one-year storage period.
Boivin P-N, Legendre P, Bonnaure A-C, M-A. |
2020 |
4251 |
Journal
Int J Pharm Compound 2019 ;23,2:157-162 |
Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base, SuspendIt.
Pramar YV, Mandal TK, Bostanian LA, Nguyen ATQ, Morris TC, Graves RA. |
2019 |
4677 |
Poster
EAHP Congress Vienna 2022 |
Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
Linxweiler H, Thiesen J, Krämer I. |
2022 |
3258 |
Journal
Int J Pharm Compound 2011 ; 15, 6 : 515-520. |
Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags.
Kaiser J, Krämer I. |
2011 |
3343 |
Poster
ECOP Congress, Budapest, Hungary 2012 |
Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C.
Vieillard V, da Silva R, Astier A, Paul M. |
2012 |
4767 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1 |
Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening.
Almasi K, Thiesen J, Krämer I. |
2023 |
4125 |
Journal
EJHP 2020 ; 27, 1: 43-48. |
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags.
D'Huart E, Vigneron J, Lider P, Demoré B. |
2020 |
4353 |
Journal
J Clin Pharm Ther 2019 |
Physicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndrome.
Lu D, Harmanjeet H, Wanandy T, Paine M, . PetersonG.M, Patel R. |
2019 |
4107 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Physicochemical Stability of Extemporaneously Prepared Oral Suspension of Fluconazole 50 mg/mL in SuspendIt.
Ip K, Shan A, Carvalho M, Baker S, Banov D. |
2018 |
4748 |
Journal
Pharmaceutics 2023 ,15, 309. |
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment.
Linxweiler H, Thiesen J, Krämer I. |
2023 |
4635 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20210005. |
Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes.
Mohr A, Erdnüß F, Krämer I. |
2021 |
2241 |
Journal
J Oncol Pharm Practice 2000 ; 6, 3: 115-121. |
Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags.
Thiesen J, Krämer I. |
2000 |
4600 |
Journal
EJOP 2021 ; 4: 3. |
Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose.
Loeuille G, Vigneron J, D’Huart E, Demoré B. |
2021 |
3896 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:73-81 |
Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period
Kim S.H, Thiesen J, Krämer I. |
2016 |
4267 |
Journal
EJHP 2019 |
Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demoré B. |
2019 |
4250 |
Journal
Ann Pharm Fr 2019 ;77,3:212-221. |
Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units.
D'Huart E, Vigneron J, Clarot I, Demoré B. |
2019 |
2883 |
Journal
Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933. |
Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags.
Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F. |
2009 |
4143 |
Journal
EJHP 2016 ; 25, 4 |
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use.
Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R. |
2016 |
4334 |
Journal
J Oncol Pharm Practice 2020 ; 26, 3: 641-646. |
Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag.
Sundaramurthi P, Sean Chadwick S, Narasimhan C. |
2020 |
4702 |
Journal
EJOP 2022 ; 5: 2. |
Physicochemical stability of pemetrexed diarginine at 25 mg/mL in partially-used vials and at 3 and 12 mg/mL diluted in dextrose 5% or in sodium chloride 0.9% in polyolefin bags.
Nisse Y-E, Sobalak N, Vigneron J, Demoré B. |
2022 |
4754 |
Journal
J Oncol Pharm Practice 2023 ;29,3: |
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E |
2023 |
4756 |
Journal
J Oncol Pharm Practice 2022 ;29, 5: 1032-1043 |
Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E. |
2022 |
3397 |
Poster
EAHP Congress Paris 2013 |
Physicochemical stability of ready-to-administer epinephrine injection solutions 20 µg/mL, 50 mL.
Heeb R.M, Krämer I. |
2013 |
4043 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4: 145-157. |
Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen.
Kim S, Heeb R, Krämer I. |
2017 |
4711 |
Poster
GERPAC Congrès - octobre 2022 2022 |
Physicochemical stability of subcutaneous daratumumab (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature.
Knoll L, Thiesen J, Klassen M, Reinders L, Türk J, Krämer I. |
2022 |
4115 |
Journal
Drug Design Dev Ther 2016 ;10:3873-3878 |
Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use.
Fang B, Wang L, Gu J, Chen F, Shi X. |
2016 |
4516 |
Journal
GaBI Journal 2020 ; 9, 4 |
Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags.
Seckute J, Castellanos I, Bane S. |
2020 |
4763 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1 |
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Almasi J, Erdnuss F, Thiesen J, Krämer I. |
2023 |
4348 |
Journal
Can J Hosp Pharm 2019 ;72(5):360-8 |
Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes.
D'Huart E, Vigneron J, Charmillon A, Clarot I, Demoré B. |
2019 |
4035 |
Journal
EJHP 2017 ;0:1-5 |
Physicochemical stability of voriconazole in elastomeric devices.
Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P. |
2017 |
4745 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2023 |
Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags.
Vieillard V, Paul M |
2023 |
3448 |
Journal
Ann Pharm Fr 2013 ; 71, 5: 358-363. |
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. |
2013 |
4493 |
Journal
J Oncol Pharm Practice 2020 |
Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion.
Le Guyader G, Vieillard V, Paul M. |
2020 |
4692 |
Journal
The Scientific World Journal 2022 |
Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease.
Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J. |
2022 |
3895 |
Journal
Ann Pharmacotherapy 2016 ; 50: 790-792. |
Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients
Lim Tze-Peng, Kim-Hor Hee D, Lee W, Qi-Min Teo J, Cai Y,Yu-Hng Chia S, Yee-Kiat Leaw J, Jing-Yi Lee S, Soon-U Lee L, Kwa A.L. |
2016 |
4669 |
Journal
Neuromodulation 2021 : 1-16. |
Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration.
Robert J, Sorrieul J, Dupoiron D, Jubier-Hamon S, Bienfait F, Visbecq A, Devys C. |
2021 |
3472 |
Journal
Krankenhauspharmazie 2007 ; 28, 5: 170-178. |
Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten.
Krämer I, Schwabe A, Kamin W. |
2007 |
3538 |
Journal
Krankenhauspharmazie 2013 ; 11: 524-525. |
Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml.
Gilcher Th, Heeb R M, Krämer I. |
2013 |
3986 |
Journal
Krankenhauspharmazie 2017 ;38:377-82. |
Physikalisch-chemische Stabilität von Carfilzomib (Kyprolis®) im Originalbehältnis nach Erstanbruch und in applikationsfertigen Zubereitungen.
Kim S, Krämer I. |
2017 |
3110 |
Poster
Poster ADKA Congress May 2010 2010 |
Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen.
Kaiser J, Krämer I. |
2010 |
4004 |
Journal
Krankenhauspharmazie 2017 ;38,7:334?340. |
Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln.
Krämer I, Sarakbi I, Thiesen J, Mainz. |
2017 |
4018 |
Journal
Krankenhauspharmazie 2017 ;38:423-429 |
Physikalisch-chemische Stabilität von rekonstituierten Trabectedin-haltigen Lösungen.
Lipp H-P, Gfrörer W |
2017 |
999 |
Journal
JPEN 1985 ; 9: 220-224. |
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
Watson D. |
1985 |
3586 |
Manufacturer
Actavis France 2010 |
Piperacilline tazobactam Actavis® - Résumé des caractéristiques du produit
|
2010 |
3590 |
Manufacturer
Dakota Pharm 2011 |
Piperacilline - Résumé des caractéristiques du produit
|
2011 |
3320 |
Manufacturer
CTI Life Sciences Limited 2012 |
Pixantrone (Pixuvri®) - Summary of Product Characteristics
|
2012 |
1223 |
Journal
Am J Hosp Pharm 1980 ; 37: 618. |
Plastic IV container for nitroglycerin.
Amann AH, Baaske DM, Wagenknecht DM. |
1980 |
2078 |
Journal
J Ped Surg 2000 ; 35: 1775-1781. |
Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers.
Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL. |
2000 |
4380 |
Manufacturer
Merck Sharp & Dohme Limited 2019 |
Posaconazole (Noxafil®) - Summary of Product Characteristics
|
2019 |
3839 |
Journal
Current Ther Res 2015 ; 77: 105-110. |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions.
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
2015 |
1941 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 1586-1589. |
Potency and stability of frozen urokinase solutions in syringes.
Dedrick SC, Ramirez-Rico J. |
2004 |
892 |
Journal
Am J Hosp Pharm 1992 ; 49: 1156-1164. |
Practical guidelines for preparing and administering amphotericin B.
Kintzel PE, Smith GH. |
1992 |
4716 |
Journal
J Pediatr Pharmacol Ther 2022 ;27,7:625-631 |
Pre-formulation and Stability Study of 20 mcg Clonidine Hydrochloride Pediatric Capsules.
Wasilewski M, Curti C, Panuccio C, Bouguergour C, Primas N, Lamy E, Castera-Ducros C, Jean C, Pirre Bertault-Peres P, Vanelle P |
2022 |
1959 |
Journal
Hosp Pharm 2005 ; 40, 2: 154-155. |
Precipitate formation after subconjonctival administration of ceftazidime and vancomycin.
Mac Lellan C, Papadopoulos A. |
2005 |
2073 |
Journal
Can J Anesth 1998 ; 45: 347-351. |
Precipitate formed by thiopentone and vecuronium causes pulmonary embolism.
Taniguchi T, Yamamoto K, Kobayashi T. |
1998 |
3377 |
Journal
Anaesthesia 1983 ; 38: 601-602. |
Precipitation betwen meptazinol and thiopentone.
Huddy NC, Durcan JJ. |
1983 |
3372 |
Journal
Rev Bras Anestesiol 2013 ; 63, 1: 163-166. |
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. |
2013 |
3374 |
Journal
Anaesthesia 2001 ; 56: 494-495. |
Precipitation in Manchester: ketorolac/cyclizine
Smith R.P.R, Jones M. |
2001 |
270 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1449. |
Precipitation of amphotericin B from IV fat emulsion.
Heide PE. |
1997 |
138 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1845-1848. |
Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint.
Corbrion V, Crauste-Manciet S, Allain P, Brossard D. |
1997 |
233 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1850. |
Precipitation of lorazepam during infusion by volumetric pump.
Grillo JA, Barie PS. |
1996 |
780 |
Journal
Ann Pharmacotherapy 1996 ; 30: 1037-1038. |
Precipitation of lorazepam infusion.
Boullata J, Gelone SP, Mancano MA, Borenstein MR, Zitterman R. |
1996 |
969 |
Journal
N Engl J Med 1991 ; 325: 1315-1316. |
Precipitation of ondansetron in alkaline solutions.
Jarosinski PF, Hirschfeld S. |
1991 |
1741 |
Journal
Am J Hosp Pharm 1993 ; 50: 2518-2521. |
Precipitation of paclitaxel during infusion by pump.
Pfeifer RW, Hale KN, Cronquist SE, Daniels M. |
1993 |
173 |
Journal
J Infus Chemother 1994 ; 4: 140-142. |
Precipitation of paclitaxel from continuous infusion fluids.
Williams DA, Naik A. |
1994 |
2071 |
Journal
Anesth Analg 2002 ; 95: 785. |
Precipitation of protamine by cefazolin.
Ng HP, Koh KF. |
2002 |
3373 |
Journal
J R Soc Med Sh Rep 2011 ; 2: 58. |
Precipitation of thiopental with muscle relaxants: a potential hazard.
Khan S, Stannard N, Greijn J. |
2011 |
1099 |
Journal
Ann Intern Med 1984 ; 101: 880. |
Precipitation of verapamil in an intravenous line.
Tucker R, Gentile JF. |
1984 |
1351 |
Journal
Am J Hosp Pharm 1984 ; 41: 2588. |
Precipitation of verapamil with nafcillin.
Tucker R, Gentle JF. |
1984 |
1100 |
Journal
Ann Intern Med 1982 ; 97: 619. |
Precipitation of verapamil.
Bar-Or D, Kulig K, Marx JA, Rosen P. |
1982 |
2557 |
Journal
Aust J Hosp Pharm 1991 ; 21: 239-241. |
Prednisolone stability in a hydroalcoholic prednisolone mixture.
Sullivan JA. |
1991 |
1424 |
Journal
Am J Emerg Med 1999 ; 17: 333-337. |
Prehospital stability of diazepam and lorazepam.
Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK. |
1999 |
2051 |
Journal
Br J Anaesth 2003 ; 90: 179-182. |
Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability.
Sanchez del Aguila MJ, Jones MF, Vohra A. |
2003 |
4050 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:193-201 |
Preparation and physico-chemical stability of dexamethasone oral suspension.
Binson G, Venisse N, Bacle A, Beuzit K, Dupuis A. |
2017 |
4492 |
Journal
Int J Antimicrob Agents 2020 |
Preparation and physicochemical stability of 50 mg/ml hydroxychloroquine oral suspension in Syrspend pH4 dry.
Binson G, Venisse N , Sauvaget A , Bacle A , Lazaro P , Dupuis A. |
2020 |
4256 |
Journal
Pharmaceutics 2019 ;11,190: |
Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A. |
2019 |
3624 |
Journal
Int J Pharm Compound 2014 ; 18, 2 : 169-174. |
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets.
Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu. |
2014 |
2998 |
Journal
J Pharm Technol 1989 ; 5: 202-205. |
Preparation and stability of an oral suspension of dipyridamole.
Ameer B, Callahan RJ, Dragotakes SC et al. |
1989 |
2692 |
Journal
J Am Pharm Assoc 2007 ; 47, 6; 747-755. |
Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. |
2007 |
2810 |
Journal
Antimicrob Agents Chemother 2009 ; 53, 2: 798-799. |
Preparation and stability of voriconazole eye drop solution.
Dupuis A, Tournier N, Le Moal G, Venisse N. |
2009 |
2567 |
Journal
Pakistan J Biol Sci 2000 ; 3, 10: 1755-1757. |
Preparation and stability study of diclofenac sodium suppositories.
Ahmed M, Jalil R, Islam MA, Shaheen SM. |
2000 |
4719 |
Journal
SAGE Open Medicine 2022 ; 10: 20503121221135568. |
Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump.
Bower J, Wright K, Burdette J. |
2022 |
4751 |
Journal
Pharmaceutics 2023 https://doi.org/10.3390/ |
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects.
Polak Y, Jacobs B.A.W, Bouwhuis N, Hollak C.E.M, Kroon M.A.G.M, Kemper E.M. |
2023 |
4583 |
Journal
Int J Pharm Compound 2021 ;25,3:246-257 |
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. |
2021 |
4163 |
Journal
Int J Pharm Compound 2018 22;5:417-423 |
Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags.
Nalenz H, K?pf E, Dietel E. |
2018 |
3956 |
Journal
ASAIO Journal 2005 ; 51,6:761-763. |
Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique.
Bastani B; Amin K; Herr A. |
2005 |
3659 |
Manufacturer
AstraZeneca 2016 |
Propofol (Diprivan®) - Résumé des caractéristiques du produit
|
2016 |
3502 |
Manufacturer
Astra Zeneca 2012 |
Propofol (Diprivan®) - Summary of Products Characteristics
|
2012 |
919 |
Journal
Anesth Analg 1998 ; 86: 422-426. |
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS. |
1998 |
660 |
Journal
Ann Pharmacotherapy 1996 ; 30: 228-232. |
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Michaels MR, Stauffer GL, Haas DP. |
1996 |
3091 |
Journal
Wien Med Wochenschr 2005 ; 155, 13-14: 337-343. |
Prüfung von Stabilität und Kompatibilität von Flucloxacillin (Floxapen®) und Ceftazidim (Fortum®) in zwei Infusionslösungen:Relevanz für die klinische Praxis.
Thalhammer F, Maier-Salamon A, Jäger W. |
2005 |
4044 |
Journal
Pharm Sci Communications 2017 ;9:5:28-35 |
Quality assessment and stability study of compounded furosemide syrup.
Alfred-Ugbendo D, Zdoryk O.A, Georgiyants V.A. |
2017 |
4192 |
Journal
Pediatric Anesthesia 2018 |
Quality control and stability of ketamine, remifentanil and sufentanil syringes in a pediatric operating theater.
Bourdon F, Simon N, Lannoy D, Berneron C, D?caudin B, Reumaux L, Duhamel A, Richart P, Odou P. |
2018 |
2000 |
Journal
J Pharm Biomed Anal 2005 ; 38: 180-185. |
Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal J, Bourget Ph, Paci A. |
2005 |
653 |
Journal
Int J Pharm Compound 1997 ; 1: 125-127. |
Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture.
Das Gupta V. |
1997 |
1357 |
Journal
Ann Pharmacotherapy 1989 ; 23: 91-92. |
Quinolones and penicillins incompatibility.
Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. |
1989 |
1513 |
Manufacturer
Monarch Pharmaceuticals Ireland 2006 |
Quinupristine / dalfopristine (Synercid®) - Résumé des caractéristiques du produit
|
2006 |
1518 |
Manufacturer
Hospira UK Ltd 2013 |
Raltitrexed (Tomudex®) - Summary of Product Characteristics
|
2013 |
3773 |
Manufacturer
Eli Lilly 2014 |
Ramicirumab (Cyramza®) - Summary of Product Characteristics
|
2014 |
1166 |
Journal
Int J Pharm 1980 ; 6: 63-76. |
Rapid adsorptive loss of nitroglycerin from aqueous solution to plastic.
Sokoloski TD, Wu CC, Burkman AM. |
1980 |
514 |
Journal
Ann Pharmacotherapy 1997 ; 31: 297-302. |
Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers.
Xu QA, Trissel LA, Martinez JF. |
1997 |
4255 |
Journal
J Pharm Anal 2013 ;3,6:408-414 |
Rapid, simple and stability-indicating determination of polyhexamethylene biguanide in liquid and gel-like dosage forms by liquid chromatography with diode-array detection.
Kusters M, Beyer S, Kutschera S, Schlesingera H, Gerhartzb M. |
2013 |
1517 |
Manufacturer
Sanofi-Aventis 2015 |
Rasburicase (Fasturtec®) - Summary of Product Characteristics
|
2015 |
4 |
Journal
Act Pharm Biol Clin 1995 ; 8: 525-528. |
Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité.
Zazempa V, Morgenszejn J, Paul M, Astier A. |
1995 |
353 |
Journal
Am J Hosp Pharm 1987 ; 44: 2519-2524. |
Reductive destruction of dacarbazine, procarbazine hydrochloride, isoniazid, and iproniazid.
Lunn G, Sansone EB. |
1987 |
2341 |
Poster
Poster ESCP Stockholm May 2005 |
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Bourlon S, Sautou-Miranda V, Dalle M. |
|
1271 |
Journal
J Pharm Belg 1982 ; 37: 153-156. |
Reliable continuous IV perfusion system for diazepam.
Mathot F, Bonnard J, Paris P, Bosly J. |
1982 |
3519 |
Manufacturer
Glaxo Smith Kline 2011 |
Remifentanil hydrochloride(Ultiva®) - Summary of Product Characteristics
|
2011 |
2212 |
Manufacturer
Actavis UK Ltd 2015 |
Reteplase (Rapilysin®) - Summary of Product Characteristics
|
2015 |
3541 |
Manufacturer
Sanofi 2011 |
Rifampicin (Rifadin®) – Summary of Product Characteristics
|
2011 |
3968 |
Manufacturer
Fresenius Kabi 2015 |
Ringer lactate - Résumé des Caractéristiques du Produit
|
2015 |
3564 |
Manufacturer
B Braun 2012 |
Rocuronium B Braun - Résumé des caractéristiques du produit.
|
2012 |
3432 |
Manufacturer
Celgene Corporation 2020 |
Romidepsin (Istodax®) - Summary of Product Characteristics
|
2020 |
2360 |
Journal
Int J Pharm Compound 2008 ; 12, 1: 83-85. |
Room temperature stability of injectable succinylcholine dichloride.
Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P. |
2008 |
1516 |
Manufacturer
Mercury Pharmaceuticals Limited 2012 |
Ropivacaine (Naropeine®) - Summary of Product Characteristics
|
2012 |
4438 |
Journal
Pharmaceutics 2020 ; 12: 292 |
Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition
Stawny M, Gostyńska A, Nadolna M, Jelińska A. |
2020 |
4103 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 |
Safe use of Dexamethasone in pediatrics: design and evaluation of a novel stable oral suspension.
Santovena--Estevez A, Dorta-Vera D, Gonzelez-Garcia I, Suarez-Gonzalez J, Teigell-Perez N, Farina J. |
2018 |
1496 |
Journal
Hosp Pharm 1996 ; 31: 1425-1428. |
Screening cladribine for Y-site physical compatibility with selected drugs.
Trissel LA, Martinez JF, Gilbert DL. |
1996 |
3781 |
Journal
EJHP 2015 ;22:1 56-58 |
Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide.
Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Testa B, Pannatier A |
2015 |
905 |
Journal
Hosp Pharm 1994 ; 29: 1010-1017. |
Screening teniposide for Y-site physical incompatibilities.
Trissel LA, Martinez JF. |
1994 |
2014 |
Journal
J Clin Pharm Ther 2005 ; 30: 455-458. |
Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non PVC bags.
Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D. |
2005 |
2683 |
Journal
Int J Pharm Pract 1993 ; 23: 163-167. |
Shelf life of cefuroxime eye-drops when dispensed in artificial tear preparations.
Hebron B, Scott H. |
1993 |
1050 |
Journal
Am J Hosp Pharm 1984 ; 41: 300-302. |
Shelf life of unrefrigerated succinylcholine chloride injection.
Boehm JJ, Dutton DM, Poust RI. |
1984 |
2001 |
Journal
J Pharm Biomed Anal 2005 ; 38: 332-336. |
Shelf lives of aseptically prepared medicines - stability of hydrocortisone sodium succinate in PVC and non-PVC bags and in polypropylene syringes.
Rigge DC, Jones MF. |
2005 |
1929 |
Journal
J Pharm Biomed Anal 2004 ; 35: 1251-1256. |
Shelf lives of aseptically prepared medicines - stability of netilmicin injection in polypropylene syringes.
Rigge DC, Jones MF. |
2004 |
2026 |
Journal
J Pharm Biomed Anal 2005 ; 39: 339-343. |
Shelf lives of aseptically prepared medicines - stability of piperacillin/tazobactam in PVC and non-PVC bags.
Rigge D, Jones MF. |
2005 |
119 |
Journal
J Clin Pharm Ther 1994 ; 19: 361-369. |
Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices.
Strong ML, Schaaf LJ, Pankaskie MC, Robinson DH. |
1994 |
4137 |
Journal
Newsletter Stabilis 2018 41;2-6 |
Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare).
Patel T, Sewell G. |
2018 |
3456 |
Journal
Curr Med Res Opin 2011 ; 27, 12: 2241-2243. |
Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D. |
2011 |
3772 |
Manufacturer
Janssen Biotech 2017 |
Siltuximab (Sylvant®) - Summary of Product Characteristics
|
2017 |
4675 |
Journal
Pharmaceuticals 2021 ;14, 1242. |
Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations.
Secretan P-H, Thirion O, Sadou Yayé H, Damy T, Astier A, Paul M, Do B. |
2021 |
2475 |
Journal
Hosp Pharm 2015 ; 50: 376-379. |
Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam
Wade J, Cooper M, Ragan R. |
2015 |
2340 |
Journal
Can J Hosp Pharm 2005 ; 58, 4: 212-222. |
Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers
Walker S.E, Law S, Puodziunas A. |
2005 |
2027 |
Journal
Can J Hosp Pharm 2005 ; 58: 212-222. |
Simulation of Y-site compatibility of irinotecan and leucovorin at room temperature in 5% dextrose in water in 3 different containers.
Walker SE, Shirley L, Puodziunas A. |
2005 |
4522 |
Journal
J Pharm Biomed Anal 2020 |
Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV.
Lin Q, Van Schepdael A, Adams E. |
2020 |
3745 |
Journal
Am J Hosp Pharm 1979 ; 36: 881. |
Sodium chloride residue provides potential for drug incompatibiities.
Kuenhle C, Moore |
1979 |
2028 |
Journal
EJHP Science 2005 ; 11, 4: 88-90. |
Sodium nitroprusside stability at 1 µg/ml in aqueous solutions.
Kaisserlian CE, Razzouq N, Astier A, Paul M. |
2005 |
1316 |
Journal
Pharm J 1987 ; 239: 599-601. |
Sodium nitroprusside stability in light-protective administration sets.
Davidson SW, Lyall D. |
1987 |
3969 |
Journal
Neuromodulation 2017 |
Solubility and stability of Baclofen 3 mg/mL intrathecal formulation and its compatibility with implantable programmable intrathecal infusion systems.
Yue B, Brendel R, Lukitsch A, Prentice T, Doty B. |
2017 |
707 |
Journal
Am J Hosp Pharm 1980 ; 37: 95-98. |
Solubility and stability of phenytoin sodium when mixed with intravenous solutions.
Carmichael RR, Mahoney CD, Jeffrey LP. |
1980 |
4282 |
Journal
Drugs R D 2017 |
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M. |
2017 |
4701 |
Journal
Pharm Dev Technol 2018 ; 23, 10: 1024-1029. |
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.
Singh R, Chen J, Miller T, Bergren M, Mallik R. |
2018 |
2868 |
Journal
Int J Pharm Compound 2000 ; 4, 2: 146-149. |
Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution.
Kommanaboyina B, Lindauer RF, Rhodes CT, Grady LT. |
2000 |
379 |
Journal
Am J Hosp Pharm 1985 ; 42: 2679-2683. |
Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets.
Weir SJ, Szucs Myers VA, Bengtson KD, Ueda CT. |
1985 |
190 |
Journal
Am J Hosp Pharm 1986 ; 43: 1945-1950. |
Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets.
Lee MG. |
1986 |
1161 |
Journal
Int J Pharm 1987 ; 39: 183-188. |
Sorption of parenteral nitrates during administration with a syringe pump and extension set.
Allwood MC. |
1987 |
350 |
Journal
Am J Hosp Pharm 1990 ; 47: 369-373. |
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Martens HJ, De Goede PN, Van Loenen AC. |
1990 |
896 |
Journal
J Clin Pharm Ther 1992 ; 17: 223-227. |
Sorption studies of dipotassium clorazepate salt (Tranxene®) and midazolam hydrochloride (Hypnovel®) in polyvinyl chloride and glass infusion containers.
Bianchi C, Airaudo CB, Gayte-Sorbier A. |
1992 |
621 |
Journal
Am J Hosp Pharm 1982 ; 39: 1018-1021. |
Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers.
Yliruusi JK, Sothmann AG, Laine RH, Rajasilta RA, Kristoffersson ER. |
1982 |
1472 |
Journal
Int J Pharm 1994 ; 110: 197-201. |
Sorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags).
Salomies HEM, Heinonen RM, Toppila MAI. |
1994 |
2168 |
Journal
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534. |
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Ozdemir FA, Anilanmert B, Pekin M. |
2005 |
3563 |
Manufacturer
Sanofi Aventis France 2013 |
Spiramycine adipate (Rovamycine®) - Résumé des caractéristiques du produit
|
2013 |
1700 |
Journal
Krankenhauspharmazie 1996 ; 17: 398-399. |
Stabilität hochkonzentrierter dobutaminlösungen.
Ritter C. |
1996 |
1691 |
Journal
Krankenhauspharmazie 1999 ; 20: 121-125 |
Stabilität und kompatibilität von zytostatika-zubereitungen mit infusionlösungsbehältern aus polyethylen.
Beitz C, Einberger C, Wehling M. |
1999 |
3235 |
Poster
ADKA Congress 2011 2011 |
Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen.
Klemmer A, Krämer I. |
2011 |
2289 |
Journal
Pharmazie 1994 ; 49, 10: 775-777. |
Stabilität von bendamustinhydrochloride in infusion lösungen.
Maas B, Huber C, Krämer I. |
1994 |
1698 |
Journal
Krankenhauspharmazie 1997 ; 18: 474-478. |
Stabilität von dopaminhydrochlorid (Dopamine Solvay°) in mischungen mit infusionlösungen.
Körner A, Bonnacker I. |
1997 |
1687 |
Journal
Krankenhauspharmazie 2000 ; 21: 435-438. |
Stabilität von gemcitabin.
Müller H-J, Frank C. |
2000 |
3346 |
Journal
Krankenhauspharmazie 2012 ; 33: 427-431. |
Stabilität, Qualität und Analytik individueller Noradrenalin-Zubereitungen.
H?llein L, Bennack E, Holzgrabe U. |
2012 |
4323 |
Poster
ADKA Kongress 2019 |
Stabilitätsprüfung von applikationsfertigen Adrenalin- und Noradrenalinverdünningen.
Wethmar U, Hochbrügge H, Strobel HG. |
2019 |
1688 |
Journal
Krankenhauspharmazie 1999 ; 20: 55-58. |
Stabilitätsstudie zu alizaprid im PVC-infusionbeutel.
M?ller H-J, Frank C. |
1999 |
1689 |
Journal
Krankenhauspharmazie 1997 ; 18: 468-473. |
Stabilitätsstudie zu apomorphin-hydrochlorid im PVC-infusionbeutel.
Müller H-J, Berg J. |
1997 |
1694 |
Journal
Krankenhauspharmazie 1998 ; 19: 553-557. |
Stabilitätsstudie zu fosfomycin-dinatrium (Fosfocin° p.i. 5.0) in applikationsfertigen perfusorspritzen.
Stahlmann SA, Frey OR, Kovar K-A. |
1998 |
1685 |
Journal
Krankenhauspharmazie 1998 ; 19: 229-234. |
Stabilitätsstudie zu metamizol-natrium im PVC-infusionbeutel.
Müller H-J, Berg J. |
1998 |
1684 |
Journal
Krankenhauspharmazie 1998 ; 19: 469-472. |
Stabilitätsstudie zu pentoxifyllin im PVC-infusionbeutel.
Müller H-J, Frank C. |
1998 |
1690 |
Journal
Krankenhauspharmazie 1997 ; 18: 75-79. |
Stabilitätsstudie zu tramadolhydrochlorid im PVC-infusionbeutel.
Müller H-J, Berg J. |
1997 |
1697 |
Journal
Krankenhauspharmazie 2000 ; 21: 615-617. |
Stabilitätsuntersuchung von Dipidolor°-zubereitungen.
Witt C, Wolkewitz B, Lorenz C. |
2000 |
3244 |
Poster
SFPO Congress Mandelieu, France 2011 |
Stabilité chimique et microbiologique d'une suspension de mercaptopurine à 5 mg/mL.
Sutra C, Guillemot C, Monnier S, Puiset F, Canonge JM. |
2011 |
2881 |
Poster
SFPO Congress 2009 |
Stabilité d'un anticorps monoclonal d'intérêt thérapeutique après reconstitution: le rituximab.
Jaccoulet E, Guirao S, Morand K, Astier A, Paul M. |
2009 |
3317 |
Poster
APHIF Congress 2009 |
Stabilité de l'infliximab en solutions diluées.
Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. |
2009 |
4128 |
Poster
GRITA Symposium Perfusion 2017, Lille, France. 2017 |
Stabilité de la vancomycine à des doses méningées dans les seringues au cours d'une perfusion de 24 heures.
Masse M, Genay S, Carta N, Moreau F, Delannoy-Rousselière C, Barthélémy C, Décaudin B, Faure K, Odou P. |
2017 |
3119 |
Poster
Congrès HOPIPHARM 2010 |
Stabilité de la vincristine sans conservateurs.
Henriet Th, El Kateb N, Jourdan N, Faure P, Bellenger P. |
2010 |
2882 |
Poster
SFPO Congress 2009 |
Stabilité de solutions diluées de bévacizumab en fonction de la température.
Morand K, Paul M, Lahlou A, Blanchet B, Astier A. |
2009 |
604 |
Manufacturer
Baxter 1998 |
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
|
1998 |
3816 |
Poster
SFPO Congress, Nantes, France 2015 |
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F. |
2015 |
3723 |
Journal
Archives de Pédiatrie 1998 ; 5, 10: 1170-1171. |
Stabilité des préparations extemporanées de doxapram (Doprams®) à usage néonatal.
Barb? F, Legagneur H, Boisseau D, Badonnel Y, Boutroy M.J. |
1998 |
2130 |
Journal
Bull Cancer 1999 ; 86, 11: 946-954. |
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. |
1999 |
3516 |
Poster
SFPO Congress, Mandelieu, France. 2013 |
Stabilité du melphalan à 2 mg/ml dans le chlorure de sodium 0,9% dans des conditions pratiques d'utilisation.
Vigneron J, Zenier H, May I, Nicolas A. |
2013 |
2261 |
Journal
Can J Hosp Pharm 2008 ; 61, 3: 191-195. |
Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution.
Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R. |
2008 |
4119 |
Poster
Hôpitaux Universitaire de Genève 2004 |
Stabilité et compatibilité de solutions injectables d'amiodarone (Cordarone®)
Marcoz N, Ing H, Sautter AM, Saadi JF, Roulin JF, Bonnabry P. |
2004 |
1868 |
Journal
Nutr Clin Metab 2003 ; 17: 8-14. |
Stabilité galénique de mélanges commercialisés de nutrition parentérale en présence de médicaments: médicaments dans le mélange.
Husson E, Crauste-Manciet S, Hadj-Salah E, ,Segier JC, Broissard D. |
2003 |
2344 |
Manufacturer
Ebewe Pharma 2009 |
Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
|
2009 |
3246 |
Poster
SFPO Congress Mandelieu, France 2011 |
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M. |
2011 |
4025 |
Poster
SFPO Congress 2017 - Nantes 2017 |
Stabilité physico-chimique de solutions de Nivolumab à 1 mois.
Vieillard V, Bardo P, Akrout W, Le Guyader G, Astier A, Paul M. |
2017 |
4358 |
Journal
Ann Fr Anesth Réanim 2014 ; 33, 5: 304-309. |
Stabilité physico-chimique des solutions injectables de bésilate de cisatracurium dans les conditions cliniques d'utilisation
Pignard J, Bourdeaux D, Kauffmann S, Constantin J.M, Sautou V. |
2014 |
3265 |
Poster
SFPO Congress, France 2011 |
Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène.
Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M. |
2011 |
3446 |
Poster
SFPO Congress, Mandelieu, France 2013 |
Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois.
Bardo P, Vieillard V, Astier A, Paul M. |
2013 |
3344 |
Poster
ECOP Congress, Budapest, Hungary 2012 |
Stabilité physicochimique du bevacizumab 5 mg/mL dilué dans le chlorure de benzalkonium 0.1 mg/mL.
Moine M, Vieillard V, Astier A, Paul M. |
2012 |
196 |
Journal
J Clin Pharm Ther 1991 ; 16: 203-207. |
Stabilities of dobutamine, dopamine, nitroglycerin and sodium nitroprusside in disposable plastic syringes.
Pramar Y, Das Gupta V, Neal Gardner S, Yau B. |
1991 |
1239 |
Journal
Pharm Weekbl [Sci] 1986 ; 8: 286-288. |
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Stolk LML, Fruijtier A, Umans. |
1986 |
240 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1904-1909. |
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. |
1995 |
1318 |
Journal
Pharm J 1987 ; 238: 116-118. |
Stability and administration of intravenous Augmentin.
Ashwin J, Lynn B, Taskis CB. |
1987 |
2046 |
Journal
Antimicrob Agents Chemother 2003 ; 47: 1991-1994. |
Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA. |
2003 |
4264 |
Journal
Acta Ophtalmol 2008 |
Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V. |
2008 |
454 |
Journal
Am J Hosp Pharm 1986 ; 43: 94-97. |
Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
Ptachcinski RJ, Logue LW, Burckart GJ, Venkataramanan R. |
1986 |
453 |
Journal
Am J Hosp Pharm 1986 ; 43: 692-694. |
Stability and availability of cyclosporine stored in plastic syringes.
Ptachcinski RJ, Walker S, Burckart GJ, Venkataramanan R. |
1986 |
1469 |
Journal
Int J Pharm 1996 ; 128: 283-286. |
Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days.
Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F. |
1996 |
1817 |
Journal
J Oncol Pharm Practice 2003 ; 9: 109-112. |
Stability and compatibility of 5-fluorouracil infusions in the Braun Easypump®.
Roberts S, Sewell GJ. |
2003 |
2184 |
Journal
J Pain Symptom Manage 2006 ; 32, 4: 297-299. |
Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes.
Vranken JH, van Kan HJM, ven der Vegt MH. |
2006 |
152 |
Journal
Pharm Acta Helv 1995 ; 70: 141-148. |
Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J. |
1995 |
285 |
Journal
Clin Ther 1996 ; 18: 246-255. |
Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs.
Elmore RL, Contois ME, Kelly J, Noe A, Poirier A. |
1996 |
2086 |
Journal
J Pharm Pract and Res 2003 ; 33: 279-281. |
Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes.
Sharley NA, Burgess NG. |
2003 |
2648 |
Journal
Int J Pharm 1999 ; 190, 1: 103-107. |
Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone
Rieutord A, Arnaud P, Dauphin JF, Brion F. |
1999 |
1178 |
Journal
Am J Hosp Pharm 1981 ; 38: 1914-1918. |
Stability and compatibility of antitumor agents in glass and plastic containers.
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL. |
1981 |
1467 |
Journal
Int J Pharm 1995 ; 118: 181-189. |
Stability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pump.
Sitaram BR, Tsui M, Rawicki HB, Lam S, Courage P, Sitaram M, Chapman CB. |
1995 |
1966 |
Journal
Support Care Cancer 2005 ; 13, 4: 239-245. |
Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.
Barcia E, Reyes R, Azuara L, Sànchez Y, Negro S. |
2005 |
4746 |
Poster
2023 |
Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C.
Shead K, Derrick H, Lyons D, Law S, Ma N.H. |
2023 |
1759 |
Journal
Antimicrob Agents Chemother 2001 ; 45: 2643-2647. |
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Servais H, Tulkens PM. |
2001 |
539 |
Journal
Drug Intell Clin Pharm 1988 ; 22: 592-593. |
Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection.
Baptista RJ, Mitrano FP. |
1988 |
164 |
Journal
J Clin Pharm Ther 1994 ; 19: 95-100. |
Stability and compatibility of cisplatin and carboplatin with PVC infusion bags.
Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Gressier B, Cazin JC. |
1994 |
226 |
Journal
Can J Hosp Pharm 1991 ; 44: 289-295. |
Stability and compatibility of combinations of hydromorphone and a second drug.
Walker SE, DeAngelis C, Iazzetta J. |
1991 |
1497 |
Journal
Can J Hosp Pharm 1993 ; 46: 61-65. |
Stability and compatibility of combinations of hydromorphone and dimenhydrinate lorazepam or prochlorperazine.
Walker SE, Iazetta J, DeAngelis C, Lau DWC. |
1993 |
4185 |
Journal
Hosp Pharm 2019 ; 54, 5: 330-334. |
Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures : A New Look at an Old Drug.
Sabins D, Diep T, McCartan P, Patel S, Zhao F |
2019 |
3172 |
Journal
J Clin Pharm Ther 2011 ; 36, 1: 99-102. |
Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion.
Xu F, Xu G, LSu L, Feng E. |
2011 |
2305 |
Journal
Anaesthesia 2008 63, 9: 972-978. |
Stability and compatibility of drug mixtures in an implantable infusion system.
Bianchi F, Ginggen A, Tardy Y. |
2008 |
161 |
Journal
Am J Hosp Pharm 1994 ; 51: 2706-2709. |
Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers.
Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY. |
1994 |
1613 |
Journal
Can J Hosp Pharm 2000 ; 53: 338-345. |
Stability and compatibility of etoposide in normal saline.
Lepage R, Walker SE, Godin J. |
2000 |
262 |
Journal
Am J Hosp Pharm 1993 ; 50: 703-706. |
Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
Johnson CE, Jacobson PA, Pillen HA, Woycik CL. |
1993 |
411 |
Journal
Am J Hosp Pharm 1991 ; 48: 2158-2160. |
Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
Woloschuk DMM, Wermeling JR, Pruemer JM. |
1991 |
513 |
Journal
Ann Pharmacotherapy 1996 ; 30: 756-761. |
Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride.
Xu QA, Trissel LA, Martinez JF. |
1996 |
148 |
Journal
Pharm Weekbl [Sci] 1992 ; 14: 365-369. |
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I. |
1992 |
70 |
Journal
Am J Hosp Pharm 1991 ; 48: 2641-2643. |
Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days.
Silvestri AP, Mitrano FP, Baptista RJ, Williams DA. |
1991 |
1633 |
Journal
Can J Hosp Pharm 2002 ; 55: 27-38. |
Stability and compatibility of granisetron alone and in combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions.
Walker SE, Law S. |
2002 |
57 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 294-304. |
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs.
Mayron D, Gennaro AR. |
1996 |
1867 |
Journal
J Pain Symptom Manage 2001 ; 22, 6: 1042-1047. |
Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system.
Hildebrand KR, Elsberry DE, Anderson VC. |
2001 |
1678 |
Journal
Int J Pharm 1997 ; 153: 13-24. |
Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine.
Sitaram BR, Tsui M, Rawicki HB, Lam S, Sitaram M. |
1997 |
1988 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 88-92. |
Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.
Sprandel KA, Styrszula DE, Deyo K, Sibley C, Rodvold KA. |
2005 |
619 |
Journal
Am J Hosp Pharm 1982 ; 39: 1013-1015. |
Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drugs additives.
Kirschenbaum HL, Aronoff W, Perentesis GP, Plitz GW, Cutie AJ. |
1982 |
1620 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 1753-1756. |
Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration.
Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM. |
2001 |
211 |
Journal
Am J Hosp Pharm 1991 ; 48: 1237-1241. |
Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection.
Strom JG, Miller SW. |
1991 |
263 |
Journal
Am J Hosp Pharm 1993 ; 50: 698-702. |
Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures.
Pearson SD, Trissel LA. |
1993 |
1276 |
Journal
Can J Hosp Pharm 1998 ; 51: 110-116. |
Stability and compatibility of morphine with bupivacaine.
Shiffman E, Walker SE, Yoon T, Yeung M. |
1998 |
2083 |
Journal
J Pharm Pract and Res 2002 ; 32: 65-68. |
Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion.
La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. |
2002 |
1869 |
Journal
J Pain Symptom Manage 2003 ; 25, 5: 464-471. |
Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
Hildebrand KR, Elsberry DD, Hassenbusch SJ. |
2003 |
4036 |
Journal
EJHP 2017 ;25,4: 200-203. |
Stability and compatibility of ondansetron with haloperidol in parenteral admixtures.
Estan-Cerezo G, Matoses-Chirivella C, Soriano-Iriga L, Murcia-Lopez A.C, Rodrguez-Lucena F.J, Navarro-Ruiz A. |
2017 |
2122 |
Journal
EJHP Science 2006 ; 12, 4: 81-84. |
Stability and compatibility of paracetamol injection admixed with ketoprofen.
Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C. |
2006 |
1069 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1835-1838. |
Stability and compatibility of promethazine hydrochloride and dihydroergotamine mesylate in combination.
Peek BT, Webster KD, Da Camara CC. |
1999 |
3140 |
Journal
Int J Pharm Compound 2010 ; 14, 5 : 436-439. |
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device.
Tsiouris M, Ulmer M, Yurcho J F, Hooper K L, Gui M. |
2010 |
1906 |
Journal
Am J Health-Syst Pharm 2004 ; 61: 38-45. |
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ. |
2004 |
66 |
Journal
Can J Hosp Pharm 1996 ; 49: 140-145. |
Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin.
Avelar MA, Walker SE. |
1996 |
345 |
Journal
Can J Hosp Pharm 1996 ; 49: 290-298. |
Stability and compatibility of reconstituted sterile hydromorphone with midazolam.
Walker SE, Meinders A, Tailor H. |
1996 |
1421 |
Journal
J Am Pharm Assoc 1999 ; 39: 505-509. |
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
Johnson CE, Truong NM. |
1999 |
4444 |
Journal
Clinical Nutrition 1999 ; 19, 3: 159-165. |
Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics.
Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P. |
1999 |
2140 |
Journal
EJHP Science 2006 ; 12, 5: 91-95. |
Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion.
Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. |
2006 |
2890 |
Journal
Acta Pharm 2000 ; 50: 219-228. |
Stability and compatibility of thiamine hydrochloride in liquid dosage forms et various temperatures.
El-Khawas M, Boraie NA. |
2000 |
1603 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 1218-1223. |
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
Bergquist PA, Manas D, Hunke WA, Reed RA. |
2001 |
1075 |
Journal
J Pharm Biomed Anal 1997 ; 16: 199-205. |
Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
Craig SB, Bhatt UH, Patel K. |
1997 |
1026 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 875-881. |
Stability and compatibility of topotecan hydrochloride with selected drugs.
Mayron D, Gennaro AR. |
1999 |
3385 |
Journal
J Antimicrob Chemother 2013 ; 68: 1179-1182. |
Stability and compatibility of vancomycin for administration by continuous infusion.
Raverdi V, Ampe E, Hecq JD, Tulkens PM. |
2013 |
1656 |
Journal
Pharmazie 1994 ; 49: 425-427. |
Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags.
Faouzi A, Dine T, Luyckx M, Gressier B, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Cazin JC. |
1994 |
40 |
Journal
Pharm Sci Communications 1994 ; 4: 97-101. |
Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
Dine T, Lebegue S, Benaji B, Gressier B, Segard V, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Kablan J, Cazin M, Cazin JC. |
1994 |
144 |
Journal
Int J Pharm 1991 ; 77: 279-285. |
Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags.
Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML. |
1991 |
1667 |
Journal
Int J Pharm 1996 ; 138: 125-128. |
Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion.
Vali?re C, Arnaud P, Caroff E, Dauphin JF, Cl?ment G, Brion F. |
1996 |
166 |
Journal
Int J Pharm 1994 ; 101: 257-262. |
Stability and compatibility study of carboplatin with three portable infusion pump reservoirs.
Rochard E, Barthes D, Courtois P. |
1994 |
2141 |
Journal
J Antimicrob Chemother 2003 ; 51: 651-658. |
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM. |
2003 |
423 |
Journal
Am J Hosp Pharm 1985 ; 42: 332-335. |
Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.
Mansur JM, Abramowitz PW, Lerner SA, Smith RB, Townsend RJ. |
1985 |
2120 |
Journal
J Pharm Biomed Anal 2006 ; 41: 1363-1366. |
Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
Mendez A.S.L, Dalomo J, Steppe M; Schapoval E.E.S. |
2006 |
4289 |
Journal
Photochemical & Photobiological Sciences 2018 |
Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood.
Mindt S, Karampinis I, John M, Neumaier M, Nowak K. |
2018 |
4298 |
Journal
Biomed Chromatogr 2019 ; 33, 4:e4471 |
Stability and degradation products of imipenem applying High-Resolution Mass Spectrometry: an analytical study focused on solutions for infusion.
Fabio de Souza Barbosa F, Capra Pezzi L, Tsao M, Franco de Oliveira T, Dias Macedo S.M, Schapoval E.E.S, Mendez A.S.L. |
2019 |
4670 |
Journal
Molecules 2022 ; 27(3): 1070. |
Stability and Formulation of Erlotinib in Skin Creams.
Nguyen D, Secrétan P-H, Cotteret , Jacques-Gustave E, Greco C, Bodemer C, Schlatter J, Cisternino S. |
2022 |
2057 |
Journal
J Antimicrob Chemother 2003 ; 51: 849-855. |
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis.
Droste JC, Jeraj HA, MacDonald A, Farrington K. |
2003 |
3754 |
Journal
Int J Pharm Compound 2014 ;18, 5: 418-426. |
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation.
Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H. |
2014 |
1379 |
Journal
Aust J Hosp Pharm 1986 ; 16: 55-56. |
Stability and light sensitivity of sodium nitroprusside infusions.
Saunders A. |
1986 |
2076 |
Journal
Ann Emerg Med 2003 ; 42: 9-13. |
Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning.
Dribben WH, Porto SM, Jeffords BK. |
2003 |
3844 |
Journal
Ann Pharmacotherapy 2016 ; 50: 243-244. |
Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates.
Sauberan J.B, Phuong P, Ilog N.D, Rossi S.S. |
2016 |
1904 |
Journal
Am J Health-Syst Pharm 2003 ; 60: 916-922. |
Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents.
Phares KR, Weiser WE, Miller SP, Myers MA, Wade M. |
2003 |
305 |
Journal
Am J Hosp Pharm 1992 ; 49: 1463-1466. |
Stability and sorption of calcitriol in plastic tuberculin syringes.
Pecosky DA, Parasrampuria J, Li LC, Stelmach A. |
1992 |
475 |
Journal
Am J Hosp Pharm 1992 ; 49: 119-122. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE. |
1992 |
468 |
Journal
Am J Hosp Pharm 1991 ; 48: 2631-2634. |
Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days.
Tarr BD, Campbell RK, Workman TM. |
1991 |
1346 |
Journal
Am J Hosp Pharm 1981 ; 38: 881-883. |
Stability and sterility of cimetidine admixtures frozen in minibags.
Walker SE, Paton TW, Fabian TM, Liu CC, Coates PE. |
1981 |
1986 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 896-899. |
Stability and sterility of dolasetron mesylate in syringes stored at room temperature.
Steiner ME, Lensmeyer G, Vermeulen LC. |
2005 |
4413 |
Journal
J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326. |
Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J. |
2016 |
1679 |
Journal
Int J Pharm 2001 ; 212: 93-99. |
Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes.
Micard S, Rieutord A, Prognon P, Hassan M, Brion F. |
2001 |
2402 |
Journal
Am J Health-Syst Pharm 2006 ; 63: 2240-2247. |
Stability and viscosity of a flavored omeprazole oral suspension for pediatric use
Burnett JE, Balkin ER. |
2006 |
1193 |
Journal
Am J Hosp Pharm 1983 ; 40: 1010-1012. |
Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
Perentesis GP, Plitz GW, Kirschenbaum HL, Navalakha P, Aronoff W, Cutie AJ. |
1983 |
3810 |
Journal
Int J Pharm Compound 2015 ; 19, 5 : 420-427. |
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Geiger C M, Sorenson B, Whaley P. |
2015 |
4449 |
Journal
J Pharm Pract and Res 2020 |
Stability assessment of levofloxacin in three different suspension vehicles.
Tardif V.,Lepage O.,Friciu M., St-Jean I., Forest J.M. |
2020 |
4215 |
Journal
Int J Pharm Compound 2019 ;23,1:82-87 |
Stability Assessment of Topical Amitriptyline HCl Extemporaneously Compounded with Lipoderm Base and PLO Gel Mediflo 30.
Shakshuki A, Agu R.U. |
2019 |
4560 |
Journal
J Pediatr Pharmacol Ther 2021 ; 26, 3: 265-270. |
Stability Determination of an Extemporaneously Compounded Ambrisentan Suspension by High Performance Liquid Chromatography Analysis.
Cramer J, Bevry M, Handler S, Tillman K, Abourashed E.A. |
2021 |
4499 |
Journal
J Pharm Pract and Res 2020 |
Stability evaluation of an extemporaneously compounded carbimazole oral suspension.
Song Y, Lwin E, Ellis D, Turner S, Williams D, Garg S. |
2020 |
4648 |
Journal
PlosOne 2021 16(11): e0260279. |
Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method.
Coache D, Friciu M, Roullin G, Boule M, Forest J-M, Leclair G. |
2021 |
4694 |
Journal
PlosOne 2022 |
Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization.
Coache D, Friciu M, Bernine Marcellin R, Bonnemain L, Viau A, Gaëlle Roullin V, Forest J.M, Leclair G. |
2022 |
4544 |
Journal
Int J Pharm Compound 2021 ;25,3:236-240 |
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design.
Lupatini , Sidhu R, Patel H, Bichar K. |
2021 |
4664 |
Journal
Biomed Chromatogr 2022 ;e5340. |
Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care.
Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M. |
2022 |
4183 |
Poster
Professional Practice Conference - the Canadian So 2018 |
Stability if 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C).
Hook R, Riss V, Scharrer E, Law S, Walker S.E. |
2018 |
4403 |
Journal
J Pharm Biomed Anal 2020 ; 179: 112973. |
Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products.
De Souza Barbosa F, Capra Pezzi L, Tsao M, Manoela Dias Macedo S, Franco de Oliveira T, Schapoval EES, Mendez ASL. |
2020 |
3188 |
Journal
J Clin Pharm Ther 2011 ; 36, 2: 161-165. |
Stability indicating HPLC assay for the determination of piritramide and droperidol in PCA solutions.
Selbach S, Diederich WE, Fett, Fründ SD, Koch T, Eberhart LHJ. |
2011 |
3798 |
Journal
Analytical Letter 1994 . 27: 1159-1164. |
Stability indicating HPLC assay of zidovudine in extemporaneously syrup.
Radwan M.A. |
1994 |
2865 |
Journal
Int J Pharm 2001 ; 223: 49-54. |
Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel
Gebauer MG, McClure AF, Vlahakis TL. |
2001 |
4230 |
Poster
Prof Practice Conference - Canadian Society of PH 2017 |
Stability of 0.2 and 10 mg/mL Hydromorphone Solutions In CADD reservoirs, PVC and Ethylene/Propylene Co-Polymer (PAB) Bags at Room Temperature (23°C°).
Perls W, Law S, Iazetta J, Walker S. |
2017 |
2494 |
Journal
Am J Hosp Pharm 1986 , 43: 2225-2228. |
Stability of 1% rifampin suspensions prepared in five syrups
Krukenberg CC, Mischler PG, Massad EN, Moore LA, Chandler AD. |
1986 |
4216 |
Poster
Sunnybrook 2019 |
Stability of 1.0, 0.2 and 0.025 mg/mL Milrinone Solutions Stored in Syringes at 4ºC and at Room Temperature (25ºC).
Hook R, Riss V, Scharrer E, Robillard J, Law S, Walker SE. |
2019 |
4228 |
Poster
Prof Practice Conference - Canadian Society of PH 2017 |
Stability of 10 and 50 microg/mL Fentanyl Solutions in CADD Reservoirs, PVC containers and Ethylene/Propylene Co-Polymer (PAB) Bags at Refrigerated (4°C) and Room Temperature (23°C).
Law S, Perks W, Iazetta J, Walker S. |
2017 |
1972 |
Journal
Drug Dev Ind Pharm 2016 ; 42, 1: 166-174. |
Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC–UV stability-indicating method.
Feutry, F., Simon, N., Genay, S., Lannoy, D., Barthelemy, C., Decaudin, B., Labalette, P., Odou, P. |
2016 |
4574 |
Journal
Am J Hosp Pharm 2021 ;78,9:825–831 |
Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions.
Ancedy D, Sebti M, Postaire M, Vidal F, Cisternino S. |
2021 |
4070 |
Journal
Hosp Pharm 2018 ;53, 2: 73-74. |
Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags.
DeAngelis M, Ferrara A, Gregory K, Zammit K, Zhao F. |
2018 |
4246 |
Poster
2019 |
Stability of 2.5mg/mL Indocyanine Green (ICG) Solutions Stored in Syringes at 25ºC, 4ºC, -20ºC and -67ºC.
Perks W, Law S, Marchesano R, Walker SE. |
2019 |
4223 |
Poster
Prof Practice Conference - Canadian Society of PH 2019 |
Stability of 20,40 and 50 microg/mL Fentanyl Solutions Stored in Syringes at Room Temperature (23°C).
Riss V, Hook R, Neault A, Scharrer E, Law s, Walker S.E. |
2019 |
3818 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16. |
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F. |
2017 |
4231 |
Poster
Professional Practice Conference - Canadian Societ 2018 |
Stability of 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C)
Roxanne Hook, Vera Riss, Erica Scharrer, Shirley Law and Scott E. Walker |
2018 |
1675 |
Journal
Int J Pharm Compound 2002 ; 6, 2: 155-157. |
Stability of 4-Aminopyridine and 3,4-Diaminopyridine oral capsules
Trissel LA, Zhang Y, Xu QA. |
2002 |
4087 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:31-37 |
Stability of 5 mg/mL Nitrendipine Oral Suspension in SyrSpend® SF PH4.
Bellay R, Bonnaure A.C, Rault P, Pertuisel S, Lester M.A, Boivin P.N. |
2018 |
4596 |
Journal
Am J Health-Syst Pharm 2021 ;78,15:444–1447 |
Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days.
Roura-Turet J, Rodriguez-Reyes M, Guerrero-Molina L, Soy-Muner D, López-Cabezas C. |
2021 |
2496 |
Journal
Am J Hosp Pharm 1986 ; 43: 118-120. |
Stability of 5-aminosalicylic acid suspension
Montgomery HA, Smith FM, Scott BE, White SJ, Gerald KB. |
1986 |
840 |
Journal
Can J Hosp Pharm 1986 ; 39: 60-66. |
Stability of 5-fluorouracil and flucytosine in parenteral solutions.
Biondi L, Nairn JG. |
1986 |
2331 |
Journal
Hospital Pharmacy Europe 2009 ; 42 : 30-31. |
Stability of 5-fluorouracil and sodium folinate admixture.
Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L. |
2009 |
4759 |
Poster
Sunnybrook Healt Science Centre 2023 |
Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers.
Ma NH, Charbonneau LF, Law S, Walker S. |
2023 |
1812 |
Journal
Int J Pharm Compound 2000 ; 4, 4: 320-323. |
Stability of 5-fluorouracil in an extemporaneously compounded ophtalmic solution.
Fuhrman LC, Godwin DA, Davis RA. |
2000 |
842 |
Journal
J Pharm Clin 1990 ; 9: 155-158. |
Stability of 5-fluorouracil to heat and light.
Pinguet F, Favre G, Canal P, Pujol A, Soula G. |
1990 |
3975 |
Poster
EAHP congress - Cannes 2017 |
Stability of 50 and 100 µg/0,1mL intraocular solutions of voriconazole at 2-8°C.
Roche M, Simon N, Bourdon F, Dhorne C, Berneron C, Lannoy D, Odou P. |
2017 |
2221 |
Journal
Am J Health-Syst Pharm 2007 ; 64, 23: 2480-2482. |
Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy.
Cober M.P, Johnson C.E. |
2007 |
4284 |
Journal
Journal of Chemotherapy 2018 ; 30, 6-8: 371-374. |
Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion.
Vercheval C, Streel S, Servais A-C, Fillet M, Van Hees T. |
2018 |
4197 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:219-226 |
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation.
Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T. |
2018 |
1601 |
Journal
Hosp Pharm 2001 ; 36: 950-954. |
Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration.
Godwin DA, Kim NH, Zuniga R. |
2001 |
442 |
Journal
Am J Hosp Pharm 1989 ; 46: 732-737. |
Stability of a concentrated trimethoprim-sulfamethoxazole admixtures.
Jarosinski PF, Kennedy PE, Gallelli JF. |
1989 |
2395 |
Journal
Am J Health-Syst Pharm 2008 ; 65: 558-561. |
Stability of a flavored formulation of acetylcysteine for oral administration
Siden R, Johnson CE. |
2008 |
2191 |
Journal
J Oncol Pharm Practice 2007 ; 13: 33-37 |
Stability of a heparin-free 50% ethanol lock solution for central venous catheters.
Pomplum M, Johnson JJ, Johnston S, Kolesar JM. |
2007 |
4661 |
Journal
J Pharm Biomed Anal 2022 |
Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization
Bourcier B, Lagarce R, Lebreton V. |
2022 |
3473 |
Journal
Int J Pharm 2015 ; 495, 2: 956-962. |
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B. |
2015 |
4053 |
Journal
Am J Health-Syst Pharm 2017 ;74,24:2060-2064 |
Stability of a pyrimethamine suspension compounded from bulk powder.
Lewis P, Cluck D, Huffman J, Ogle A, Brown S. |
2017 |
2591 |
Journal
Can J Hosp Pharm 1988 ; 41: 121-123. |
Stability of a sotalol hydrochloride oral liquid formulation.
Dupuis LL, James G, Bacola G. |
1988 |
2138 |
Journal
Eur J Anaesthesiol 2002 ; 19: 295-297. |
Stability of a sufentanil-ropivacaine mixture in a glass and a PVC reservoir.
Brodner G, Ermert T, Van Aken H et al. |
2002 |
460 |
Journal
Am J Hosp Pharm 1987 ; 44: 358-360. |
Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection.
Parasrampuria J, Das Gupta V, Stewart KR. |
1987 |
2434 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1944-1949. |
Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1996 |
3999 |
Journal
Int J Pharm Compound 2017 ; 21:4 :339-346 |
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A. |
2017 |
2426 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 549-553. |
Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution
Anaizi NH, Swenson CF, Dentinger PJ. |
1997 |
2400 |
Journal
Am J Health-Syst Pharm 2007 ; 64: 762-766. |
Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings
Kiser TH, Oldland AR, Fish DN. |
2007 |
822 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 574-577. |
Stability of acyclovir sodium 1, 7, and 10 mg/ml in 5% dextrose injection and in 0.9% sodium chloride injection.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL. |
1998 |
1717 |
Journal
Int J Pharm Compound 2001 ; 5: 75-77. |
Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V. |
2001 |
68 |
Journal
J Clin Pharm Ther 1989 ; 14: 451-456. |
Stability of acyclovir sodium in dextrose and sodium chloride injections.
Das Gupta V, Pramar Y, Bethea C. |
1989 |
2216 |
Journal
J Pharm Biomed Anal 1998 ; 17: 415-418. |
Stability of adenosin infusion.
Proot P, Schepdael A.V, Raymakers A.A, Hoogmartens J. |
1998 |
820 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1161-1164. |
Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution.
Naud C, Marti B, Fernandez C, Astier A, Paul M. |
1998 |
1948 |
Journal
J Pain Symptom Manage 2004 ; 28, 6: 603-611. |
Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system.
Classen AM, Wimbish GH, Kupiec TC. |
2004 |
930 |
Journal
J Clin Pharm Ther 1997 ; 22: 339-345. |
Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chloride.
Hor MMS, Chan SY, Yow KL, Lim LY, Chan E. |
1997 |
824 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1602-1605. |
Stability of albumin-free interferon alfa-2b for 42 days.
Appenheimer MM, Schepart BS, Poleon GP, Evans SS. |
1998 |
2960 |
Journal
Respiratory Care 1991 ; 36: 1387-1390. |
Stability of albuterol and tobramycin when mixed for aerosol administration.
Gooch MD. |
1991 |
2670 |
Journal
Int J Pharm Compound 1998 ; 2: 394-396. |
Stability of albuterol in continuous nebulization.
Hunter DA, Yoo SD, Fox JL. |
1998 |
2255 |
Manufacturer
Ebewe Pharma 2007 |
Stability of Alexan "Ebewe" infusion solutions.
|
2007 |
3902 |
Journal
Int J Pharm Compound 2016 ; 20, 5 : 426-434. |
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O. |
2016 |
3994 |
Journal
Int J Pharm Compound 2017 ; 3: 255-263 |
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A. |
2017 |
2422 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1915-1920. |
Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1998 |
3961 |
Journal
Int J Pharm Compound 2017 ; 21, 2: 150-153. |
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
McCluskey S.V,Kirkham K,Munson J.M. |
2017 |
1816 |
Journal
Int J Pharm Compound 2003 ; 7, 3: 230-232. |
Stability of amikacin sulfate in autodose infusion system bags.
Zhang Y, Trissel LA. |
2003 |
550 |
Journal
Int J Pharm Compound 1997 ; 1: 132-134. |
Stability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Zhang YP, Trissel LA. |
1997 |
478 |
Journal
Am J Hosp Pharm 1992 ; 49: 2962-2963. |
Stability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1992 |
1188 |
Journal
Am J Hosp Pharm 1983 ; 40: 428-432. |
Stability of aminophylline injection in three parenteral nutrient solutions.
Niemiec PW, Venderveen TW, Hohenwarter MW, Gadsden RH. |
1983 |
242 |
Journal
Am J Hosp Pharm 1986 ; 43: 917-921. |
Stability of amiodarone hydrochloride in admixtures with other injectable drugs.
Campbell S, Nolan PE, Bliss M, Wood R, Mayersohn M. |
1986 |
2541 |
Journal
Ann Pharmacotherapy 1997 ;31:851-852. |
Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature.
Nahata MC. |
1997 |
3792 |
Journal
J Ped Pharm Pract 1999 ; 4: 186-189. |
Stability of amiodarone in extemporaneous oral suspension prepared from commercially available vehicles.
Nahata M.C, Morosco R.S, Hipple T.F. |
1999 |
2689 |
Journal
J Am Pharm Assoc 1999 ; 39: 375-377. |
Stability of amlodipine mesylate in two liquid dosage form.
Nahata MC, Morosco RS, Hipple TF. |
1999 |
2951 |
Journal
J Clin Pharm Ther 1994 ; 19: 313-315. |
Stability of amoxicillin and potassium clavulanate in co-amoxiclav oral suspension.
Mehta AC, Hart-Davies S, Payne J, Lacey RW.. |
1994 |
2508 |
Journal
Am J Hosp Pharm 1988 ; 45: 1092-1099. |
Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes
Tu YH, Stiles ML, Allen LV, Jr, Olsen KM, Barton CI, Greenwood RB. |
1988 |
12 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 683-686. |
Stability of amphotericin B 0.05 and 0.5 mg/ml in 20% fat emulsion.
Owens LC, Fleming RA, Restino MS, Cruz JM, Hurd DD. |
1997 |
2820 |
Journal
J Pharm Biomed Anal 2006 ; 42: 362-366. |
Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate
Groeschke J, Solassol I, Bressolle F, Pinguet F. |
2006 |
1407 |
Journal
Hosp Pharm 1998 ; 33: 1203-1207. |
Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Xu QA, Trissel LA, Gilbert DL. |
1998 |
497 |
Journal
Am J Hosp Pharm 1991 ; 48: 1681. |
Stability of amphotericin B in 5% dextrose injection at 25°C.
Kintzel PE, Kennedy PE. |
1991 |
439 |
Journal
Am J Hosp Pharm 1991 ; 48: 283-285. |
Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line.
Kintzel PE, Kennedy PE. |
1991 |
283 |
Journal
Am J Hosp Pharm 1994 ; 51: 394-396. |
Stability of amphotericin B in 5% dextrose injection stored at 4 or 25°C for 120 hours.
Lee MD, Hess MM, Boucher BA, Apple AM. |
1994 |
2867 |
Journal
Int J Pharm Compound 1999 ; 3, 4: 316-320. |
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution.
Peyron F, Elias R, Ibrahim E, Amirat-Combralier V, Bu?s-Charbit M, Balansard G. |
1999 |
2940 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 1021-1024. |
Stability of amphotericin B in an extemporaneously compounded oral suspension.
Dentinger PJ, Swenson CF, Anaizi NH. |
2001 |
435 |
Journal
Am J Hosp Pharm 1991 ; 48: 2430-2433. |
Stability of amphotericin B in four concentrations of dextrose injection.
Wiest DB, Maish WA, Garner SS, El-Chaar GM. |
1991 |
3069 |
Journal
Eur Hosp Pharm 1997 ; 3: 59-60. |
Stability of amphotericin B in water solution for inhalation.
Juarez JC, ,Lopez RM, Hucto M et al. |
1997 |
3777 |
Journal
Am J Health-Syst Pharm 2015 ; 72:13-14 |
Stability of ampicillin and amoxicillin in peritoneal dialysis solutions
Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D. |
2015 |
3880 |
Journal
Int J Pharm Compound 2016 ; 20, 4 : 338-342 |
Stability of Ampicillin in Normal Saline and Buffered Normal Saline.
Maher M, Jensen Kara J,Lee David, Nix David E |
2016 |
4640 |
Journal
Hosp Pharm 2021 ; 56, 5: 507–512. |
Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation.
Huskey M, Lewis P, Brown S.D. |
2021 |
1705 |
Journal
Int J Pharm Compound 2002 ; 6: 226-229. |
Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags.
Zhang Y, Trissel LA. |
2002 |
4063 |
Journal
Int J Pharm Compound 2018 ;22,1:66-75 |
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Manchanda A, Laracy M, Savji T, Bogner R. |
2018 |
342 |
Journal
Am J Hosp Pharm 1985 ; 42: 339-342. |
Stability of an analgesic-sedative combination in glass and plastic single-dose syringes.
Conklin CA, Kerege JF, Christensen JM. |
1985 |
3780 |
Journal
EJHP 2015 ;22:7-11 |
Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride
Chen F, Peng L, Zhou B, Fang B, Yang Y. |
2015 |
2306 |
Journal
Anaesthesia 2004 ; 59, 10: 979-983. |
Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine.
Priston M.J, Hughes J.M, Santillo M, Christie I.W. |
2004 |
3401 |
Journal
J Clin Pharm Ther 2013 ;38, 2: 104-108 |
Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine.
Helin-Tanninen, M., Lehtonen, M., Naaranlahti, T., Ven?l?inen, T., Pentik?inen, J., Laatikainen, A., Kokki, H. |
2013 |
1875 |
Journal
Acta Anaesthesiol Scand 2000 ; 44: 864-867. |
Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl.
Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W. |
2000 |
3187 |
Journal
Am J Health-Syst Pharm 2011 ; 68:420-423. |
Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE, Cober MP, Thome T, Rouse E. |
2011 |
2773 |
Journal
Support Care Cancer 2009 ; 17, 6: 701-706. |
Stability of an extemporaneous oral liquid aprepitant formulation.
Dupuis LL, Lingertat-Walsh K, Walker SE. |
2009 |
2478 |
Journal
Am J Hosp Pharm 1993 ; 50: 2353-2355. |
Stability of an extemporaneously compounded baclofen oral liquid
Johnson CE, Hart SM. |
1993 |
2502 |
Journal
Am J Hosp Pharm 1992 ; 49: 122-125. |
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid
Levinson ML, Johnson CE. |
1992 |
4075 |
Journal
Am J Health-Syst Pharm 2018 ;75,5: 309-315 |
Stability of an extemporaneously compounded minoxidil oral suspension.
Song Y, Whey Chin Z, Ellis D, Mon Phyo Lwin E, Turner S, Williams D, Garg S. |
2018 |
3872 |
Journal
Hosp Pharm 2016 ; 51: 389-395. |
Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.
Malik A, Gorman G, Coward L ,. Arnold J.J. |
2016 |
2851 |
Journal
Int J Pharm Compound 2005 ; 9, 1: 82-86. |
Stability of An Extemporaneously Compounded Propylthiouracil Suspension
Alexander KS, Mitra P. |
2005 |
2503 |
Journal
Am J Hosp Pharm 1991 ; 48: 293-295. |
Stability of an extemporaneously compounded terbutaline sulfate oral liquid
Horner RK, Johnson CE. |
1991 |
2657 |
Journal
Int J Pharm Compound 1997 : 60-63. |
Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets.
Alexander KS, Kothapalli MR, Dollimor D. |
1997 |
2401 |
Journal
Am J Health-Syst Pharm 2007 ; 64: 644-646. |
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
Cober MP, Johnson CE. |
2007 |
3420 |
Journal
J Oncol Pharm Practice 2014 ; 21, 3: 178-187. |
Stability of an extemporaneously prepared bleomycin-lidocaine-epinephrine intradermal admixture used in dermatology
El Kateb N, Chaussard M, Bellenger P, Petit A, Faure P. |
2014 |
3298 |
Journal
Am J Health-Syst Pharm 2012 ; 69: 592-594 |
Stability of an extemporaneously prepared tadalafil suspension
Pettit R.S, Johnson C.E, Caruthers R.L. |
2012 |
3269 |
Journal
Am J Health-Syst Pharm 2012 ; 69:56-58. |
Stability of an extemporaneously prepared thalidomide suspension.
Kraft S, . Johnson C.E, Tyler R.P. |
2012 |
1341 |
Journal
Pharm J 1983 ; 230: 495-497. |
Stability of an intrathecal morphine injection formulation.
Deeks T, Davis S, Nash S. |
1983 |
444 |
Journal
Am J Hosp Pharm 1992 ; 49: 2756-2760. |
Stability of an ofloxacin injection in various infusion fluids.
Bornstein M, Kao SH, Mercorelli M, Verma S. |
1992 |
4249 |
Journal
PeerJ 2018 |
Stability of an ophtalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multi dose eyedroppers.
Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V. |
2018 |
2833 |
Journal
Int J Pharm Compound 2001 ; 5, 6: 480-481. |
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets
Das Gupta V. |
2001 |
3336 |
Journal
EJHP 2013 ;20:46-49 |
Stability of an oral ranitidine suspension (15 mg/ml).
Petit-Jean E, Perello L, Hernandez C, Gairard Dory A.C, Gourieux B, Ubeaud-Sequier G. |
2013 |
2925 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 2518-2520. |
Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions.
Johnson CE, vanDe Koppel S, Myers E. |
2005 |
632 |
Journal
J Parenter Sci Technol 1985 ; 39: 220-222. |
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM. |
1985 |
573 |
Journal
Drug Intell Clin Pharm 1977 ; 11: 542-548. |
Stability of antibiotic admixtures frozen in minibags.
Dinel BA, Ayotte DL, Behme RJ, Black BL, Whitby JL. |
1977 |
3888 |
Journal
Perit Dial Int 2016 ; 36:421-426. |
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
Ranganathan D, Naicker S,. Wallis S.C, Lipman J, . Ratanjee S.K, Roberts J.A |
2016 |
574 |
Journal
Am J Hosp Pharm 1980 ; 37: 1087-1088. |
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ. |
1980 |
427 |
Journal
Am J Hosp Pharm 1986 ; 43: 3027-3030. |
Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states.
Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB. |
1986 |
960 |
Journal
Can J Hosp Pharm 1990 ; 43: 57-60. |
Stability of aqueous solutions of deferoxamine.
Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N. |
1990 |
2469 |
Journal
Am J Hosp Pharm 1981 ; 38: 363-364. |
Stability of aqueous suspensions of disulfiram
Das Gupta V. |
1981 |
2345 |
Journal
Can J Hosp Pharm 2009 ; 62, 3: 226-231. |
Stability of aseptically prepared Tazocin solutions in polyvinyl chloride bags.
Donnelly R.F. |
2009 |
3857 |
Journal
Int J Pharm Compound 2016 ; 20, 2: 167-174. |
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Polonini H.C, Sharlene L, Claudio L,Ferreira A.O,Brand?o M.A.F. |
2016 |
1093 |
Journal
Anesthesiology 1984 ; 61: 347-348. |
Stability of atracurium administered by infusion.
Fisher DM, Canfell, Miller RD. |
1984 |
1039 |
Journal
Am J Hosp Pharm 1984 ; 41: 1156-1159. |
Stability of azacitidine in infusion fluids.
Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP. |
1984 |
414 |
Journal
Am J Hosp Pharm 1989 ; 46: 2500-2505. |
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Den Hartigh J, Brandenburg HCR, Vermeij P. |
1989 |
3351 |
Journal
Can J Hosp Pharm 2012 ; 65, 5: 352-359 |
Stability of Azacitidine in Sterile Water for Injection.
Walker S.E, Charbonneau L.F, Law S, Earle C. |
2012 |
4227 |
Poster
Prof Practice Conference - Canadian Society of PH 2019 |
Stability of Azacitidine Solutions In Sterile Water for Injection.
Tyono I, Law S, Charbonneau L.F, Walker S.E. |
2019 |
3204 |
Journal
Ann Pharmacotherapy 2011 ;45, 4:546. |
Stability of Azacitidine Suspensions.
Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M. |
2011 |
4301 |
Journal
Oncotarget 2017 ;8, 63: 106249-106257. |
Stability of azasetron-dexamethasone mixture for chemotherapyinduced nausea and vomiting administration.
Fang B-X, Chen F-C, Zhu D, Guo J, Wang L-H. |
2017 |
4408 |
Journal
Int J Pharm Compound 2020 ;24,3:252-262 |
Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4.
Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E. |
2020 |
258 |
Journal
Am J Hosp Pharm 1994 ; 51: 901-904. |
Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
Belliveau PP, Nightingale CH, Quintiliani R. |
1994 |
1064 |
Journal
Pharm World Sci 1996 ; 18: 74-77. |
Stability of aztreonam in a portable pump reservoir used for home intravenous antibiotic treatement (HIVAT).
Vinks AATMM, Touw DJ, van Rossen RCJM, Heijeiman HGM, Bakker W. |
1996 |
2263 |
Journal
Il Farmaco 2005 ; 60: 599-603. |
Stability of aztreonam in AZACTAM.
Zajac M, Jelinska A, Cielecka-Piontek J, Osqczapowicz I. |
2005 |
2433 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2179-2184. |
Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids
Allen LV, Jr, Erickson MA, |
1996 |
3342 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:13-21 |
Stability of Bendamustine Solutions: Influence of Sodium Chloride Concentration, Temperature and Container.
Vigneron J, D'Huart E, Demoré B. |
2018 |
2056 |
Journal
J Antimicrob Chemother 2004 ; 53: 675-677. |
Stability of benzylpenicillin during continuous home intravenous therapy.
Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST. |
2004 |
3449 |
Journal
Ann Pharmacotherapy 2013 ; 47: 1237-1238. |
Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles.
Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J. |
2013 |
2421 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1804-1809. |
Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids
Allen LV, Jr, MA Erickson |
1998 |
4383 |
Journal
Crit Care Resusc 2020 ;22(1):83-85. |
Stability of bicarbonate in normal saline: a technical report.
Naorungroj T, Neto AS, Fujii T, Jude B, Udy A, Bellomo R. |
2020 |
252 |
Journal
Am J Hosp Pharm 1990 ; 47: 2528-2529. |
Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers.
Koberda M, Zieske PA, Raghavan NV, Payton RJ. |
1990 |
2010 |
Journal
Ann Pharmacotherapy 2005 ; 39: 1462-1466. |
Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial.
André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE. |
2005 |
3688 |
Journal
Can J Hosp Pharm 2014 ; 67, 2: 102-107 |
Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C).
Walker S.E, Charbonneau L.F, Law S. |
2014 |
3337 |
Journal
EJHP 2012 ; 19: 428-431. |
Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature.
Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z |
2012 |
2232 |
Journal
Can J Hosp Pharm 2008 ; 61, 1: 14-20. |
Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C)
Walker SE, Milliken D, Law S. |
2008 |
4590 |
Journal
J Pediatr Pharmacol Ther 2021 ; 51: 231-237. |
Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service.
Smith E.K, McWhinney MPhil B.C. |
2021 |
3702 |
Journal
J Pharm Pract and Res 2014 ; 44, 1: 26-28. |
Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy.
McDougall D.A.J, McWhinney. |
2014 |
3263 |
Journal
Can J Hosp Pharm 2011 ; 64, 4: 289-290. |
Stability of buffered lidocaine in glass vials.
Donnelly R.F. |
2011 |
42 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 422-423. |
Stability of bumetanide in 5% dextrose injection.
Cornish LA, Montgomery PA, Johnson CE. |
1997 |
306 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 170-173. |
Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Christen C, Johnson CE, Walters JR. |
1996 |
293 |
Journal
Am J Hosp Pharm 1993 ; 50: 2364-2365. |
Stability of bupivacaine hydrochloride in polypropylene syringes.
Jones JW, Davis AT. |
1993 |
512 |
Journal
Pharm World Sci 1995 ; 17: 87-92. |
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Barnes AR, Nash S. |
1995 |
217 |
Journal
Am J Hosp Pharm 1993 ; 50: 714-715. |
Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs.
Allen LV, Stiles ML, Wang DP, Tu YH. |
1993 |
2113 |
Journal
Pharm World Sci 1999 ; 21, 6: 272-274. |
Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.
Jäppinen A, Kokki H, Naaranlahti TJ, Rasi AS. |
1999 |
658 |
Journal
J Oncol Pharm Practice 1996 ; 2: 101-105. |
Stability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Xu QA, Zhang YP, Trissel LA, Martinez JF. |
1996 |
4033 |
Journal
Am J Health-Syst Pharm 2017 ;74,22:1887-1894 |
Stability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assay.
Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S. |
2017 |
668 |
Journal
Medicine 2015 ; 94(6):e432. |
Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use.
Chen, Fu-Chao; Shi, Xiao-Ya; Li, Peng; Yang, Jin-Guo; Zhou, Ben-Hong. |
2015 |
691 |
Journal
J Clin Pharm Ther 1989 ; 14: 53-55. |
Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE. |
1989 |
43 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 1106-1108. |
Stability of caffeine citrate injection in polypropylene syringes at room temperature.
Fraser BD, Berod T, Whitney HAK. |
1997 |
698 |
Journal
Ann Pharmacotherapy 1989 ; 23: 466-467. |
Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions.
Nahata MC, Zingarelli JR, Durell DE. |
1989 |
990 |
Journal
Ann Pharmacotherapy 1989 ; 23: 1035. |
Stability of caffeine injection stored in plastic and glass syringes.
Nahata MC, Zingarelli JR, Hipple TF. |
1989 |
2705 |
Journal
J Clin Pharm Ther 1994 ; 19, 6: 391-396. |
Stability of caffeine oral formulations for neonatal use.
Barnes AR, Hebron BS, Smith J. |
1994 |
2531 |
Journal
J Oncol Pharm Practice 2021 ; 27, 2: 288-296. |
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
Sanogo S, Silimbani P, Gaggeri R, Masini C. |
2021 |
4189 |
Journal
Am J Health-Syst Pharm 2022 ;79,12: 1011-1018 |
Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S, |
2022 |
3802 |
Journal
J Clin Pharm Ther 1998 ; 23: 451-456. |
Stability of captopril in invert sugar solution
Sam W.J, Ho P.C. |
1998 |
2522 |
Journal
Am J Hosp Pharm 1994 ; 51: 1707-1708. |
Stability of captopril in liquid containing ascorbic acid or sodium ascorbate
Nahata MC, Morosco RS, Hipple TF. |
1994 |
2488 |
Journal
Am J Hosp Pharm 1990 ; 47: 1799-1801. |
Stability of captopril in powder papers under three storage conditions
Taketomo CK, Chu SA, Cheng MH, Corpuz RP. |
1990 |
3436 |
Journal
Int J Pharm Compound 2013 ; 17, 4: 336-338. |
Stability of Captopril in SyrSPend SF.
Geiger C. M, Sorenson B, Whaley P. A. |
2013 |
2245 |
Journal
Int J Pharm 1996 ; 129: 275-277. |
Stability of carboplatin in 5% glucose solution exposed to light.
Torres F, Girona V, Puiol M, Prat J, de Bolos J. |
1996 |
2244 |
Journal
J Pharm Biomed Anal 1994 ; 12, 1: 81-84. |
Stability of carboplatin in 5% glucose solution in glass, polyethylene and polypropylene containers.
Prat J, Pujol M, Girona V, Munoz M, Sol? L-A. |
1994 |
4205 |
Journal
J Kor Soc Hosp Pharm 2006 ;23,3:219-224 |
Stability of Carboplatin in normal saline : dependence on initial dilution concentration and storage time.
Choi S, O La H, Kim K, Kim S, Hwangbo S. |
2006 |
486 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 602, 604. |
Stability of carboplatin in polyvinyl chloride bags.
Diaz Amador F, Sevilla Azzati E, Herreros de Tajeda y Lopez-Coterilla A. |
1998 |
4120 |
Journal
J Oncol Pharm Practice 2018 25,5:1076?1081 |
Stability of carboplatin infusion solutions used in desensitization protocol.
Vazquez-Sanchez R, Sanchez-Rubio-Ferrandez J, Cordoba-Diaz D, Cordoba-Diaz M, Molina-Garcia T. |
2018 |
3277 |
Journal
Int J Pharm Compound 2012 ; 16, 1 : 82-85. |
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Yang Z, Cameron S, Paul H. |
2012 |
837 |
Journal
Acta Pharm Suec 1986 ; 23: 115-124. |
Stability of carmustine - kinetics and compatibility during administration.
Fredriksson K, Lundgren P, Landersjo L. |
1986 |
1622 |
Journal
Am J Health-Syst Pharm 2001 ; 58: 238-241. |
Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers.
Favier M, De Casanove F, Coste A, Cherti N, Bressolle F. |
2001 |
715 |
Journal
Am J Hosp Pharm 1980 ; 37: 677-678. |
Stability of carmustine in the presence of sodium bicarbonate.
Colvin M, Hartner J, Summerfield M. |
1980 |
2486 |
Journal
Am J Hosp Pharm 1991 ; 48: 992-993. |
Stability of cefadroxil in reconstituted suspension under refrigeration and at room temperature
Nahata MC, Jackson DS. |
1991 |
612 |
Journal
Am J Hosp Pharm 1982 ; 39: 622-627. |
Stability of cefamandole nafate injection with parenteral solutions and additives.
Frable RA, Klink PR, Engel GL, Mundell EE. |
1982 |
1979 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 1537-1538. |
Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions.
Wu CC, Wang DP, Wong CY, Lin YF. |
2002 |
4247 |
Journal
Clin Ther 2018 ;40,4:664-667 |
Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices.
Patel R, Jacob J, Sedeeq M, Ming L.C, Wanandy T, Zaidi S.T.R, Peterson G.M. |
2018 |
582 |
Journal
Am J Hosp Pharm 1980 ; 37: 211-215. |
Stability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiation.
Tomecko GW, Kleinberg ML, Latiolais CL, Proior RB, Pesko LJ, Jones BC. |
1980 |
111 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1608,1610. |
Stability of cefazolin sodium and meperidine hydrochloride.
Lee DKT, Wong CY, Wang DP. |
1996 |
671 |
Journal
J Parenter Sci Technol 1993 ; 47: 135-137. |
Stability of cefazolin sodium and metronidazole at 8°C for use as an IV admixture.
Rivers TE, McBride HA, Trang JM. |
1993 |
2707 |
Journal
J Clin Pharm Ther 1998 ; 23, 1: 41-47. |
Stability of cefazolin sodium eye drops
How TH, Loo WY, Yow KL, Lim LY, Chan EW, Ho PC, Chan SY. |
1998 |
1805 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 2362-2364. |
Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution.
Lin YF, Wu CC, Lin SH, Wang DP, Wang CN. |
2002 |
2372 |
Journal
Am J Hosp Pharm 1991 ; 48: 291 - 292. |
Stability of cefazolin sodium in peritoneal dialysis solutions
Nahata MC, Ahalt PA. |
1991 |
3230 |
Journal
Can J Hosp Pharm 2011 ; 64, 4: 241-245. |
Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags
Donnelly RF. |
2011 |
2505 |
Journal
Am J Hosp Pharm 1987 ; 44: 2287-2290 |
Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles
Ahmed I, Day P. |
1987 |
440 |
Journal
Am J Hosp Pharm 1989 ; 46: 1408-1412. |
Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs.
Stiles ML, Tu YH, Allen LV. |
1989 |
1452 |
Journal
Eur Hosp Pharm 2000 ; 6: 17-23. |
Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*.
Muller HJ, Howe K, Frank C, Haker I. |
2000 |
1626 |
Journal
Int J Pharm Compound 2001 ; 5: 151-152. |
Stability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Ling J, Das Gupta V. |
2001 |
873 |
Journal
Int J Pharm Compound 1997 ; 1: 435-436. |
Stability of cefepime hydrochloride dextrose in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey RE. |
1997 |
1834 |
Journal
Ann Pharmacotherapy 2003 ; 37, 6: 804-807. |
Stability of cefepime hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA. |
2003 |
1068 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 457-459. |
Stability of cefepime hydrochloride in polypropylene syringes at -20°C, 4°C and 22-24°C.
Stewart JT, Warren FW, Maddox FC. |
1999 |
1046 |
Journal
Am J Health-Syst Pharm 1999 ; 56: 1134. |
Stability of cefepime hydrochloride in polypropylene syringes.
Stewart JT, Maddox FC, Warren FW. |
1999 |
1605 |
Journal
Hosp Pharm 2000 ; 35: 1057-1064. |
Stability of cefepime hydrochloride injection and metronidazole in polyvinyl chloride bags at 4°C and 22-24°C.
Stewart JT, Maddox FC, Warren FW. |
2000 |
3182 |
Journal
Pharmazie 2011 ; 66, 1: 17-23. |
Stability of cefepime in eye drops.
Kodym A, PawLowska M, Ruminski JK, Bartosinska A, Kieliba A. |
2011 |
1945 |
Journal
Ann Pharmacotherapy 2004 ; 38: 2041-2044. |
Stability of cefepime in icodextrin peritoneal dialysis solution.
Elwell RJ, Volino LR, Frye RF. |
2004 |
1290 |
Journal
Ann Pharmacotherapy 1999 ; 33: 906-909. |
Stability of cefepime in peritoneal dialysis solution.
Williamson JC, Volles DF, Lynch PLM, Rogers PD, Haverstick DM. |
1999 |
237 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 432. |
Stability of cefmetazole and famotidine.
Lee DKT, Wong CY, Wang DP, Chang LC, Wu KH. |
1996 |
652 |
Journal
Int J Pharm Compound 1997 ; 1: 208-209. |
Stability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injection.
Das Gupta V, Maswoswe J, Bailey R.E, County H. |
1997 |
1664 |
Journal
J Clin Pharm Ther 1994 ; 19: 317-325. |
Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections.
King AD, Stewart JT, Warren FW. |
1994 |
420 |
Journal
Am J Hosp Pharm 1985 ; 42: 1980-1983. |
Stability of cefonicid sodium in infusion fluids.
Wong WW, Maderich AB, Polli GP, Ravin LJ. |
1985 |
2374 |
Journal
Am J Hosp Pharm 1990 ; 47: 147 - 150. |
Stability of cefotaxime in two peritoneal dialysis solutions
CM Paap CM, Nahata MC. |
1990 |
1711 |
Journal
Int J Pharm Compound 2002 ; 6: 234-236. |
Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use.
Das Gupta V. |
2002 |
281 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1561-1563. |
Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags.
Belliveau PP, Nightingale CH, Quintiliani R. |
1995 |
593 |
Journal
J Pharm Sci 1984 ; 73: 565-567. |
Stability of cefotaxime sodium as determined by High-Performance Liquid Chromatography.
Das Gupta V. |
1984 |
3840 |
Journal
Acta Pol Pharm 2016 ; 73, 1: 23-27. |
Stability of cefpirome sulfate in aqueous solutions.
Zalewski P, Jelinska A, Paczkowska M, Garbacki P, Talaczynska A, Step-niak P, Cielecka- Piontek J. |
2016 |
280 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2427-2433. |
Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection.
Allen LV, Stiles ML, Prince SJ, Sylvestri MF. |
1995 |
443 |
Journal
Am J Hosp Pharm 1992 ; 49: 2761-2764. |
Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
Stiles ML, Allen LV, Fox JL. |
1992 |
287 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 1912-1914. |
Stability of ceftazidime (with arginine) in an elastomeric infusion device.
Bednar DA, Klutman NE, Henry DW, Fox JL, Strayer AH. |
1995 |
477 |
Journal
Am J Hosp Pharm 1992 ; 49: 2954-2956. |
Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures.
Nahata MC, Morosco RS, Fox JL. |
1992 |
4056 |
Journal
Perit Dial Int 2017 |
Stability of ceftazidime and heparine in four different types of peritoneal dialysis solutions.
Kandel S, Zaidi S, Wanandy T, Ming L, Castelino R, Sud K, Patel R. |
2017 |
2369 |
Journal
Am J Hosp Pharm 1992 ; 49: 1139 - 1142. |
Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution
Mason NA, Johnson CE, O'Brien MA. |
1992 |
3289 |
Journal
Acta Pol Pharm 2011 ; 68, 1: 99-107. |
Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method.
Kodym A, Hapka-Zmich D, Golab M, Gwizdala M. |
2011 |
2708 |
Journal
J Clin Pharm Ther 1999 ; 24: 299-302 |
Stability of ceftazidime in a viscous eye drop formulation
Barnes AR, Nash R. |
1999 |
445 |
Journal
Am J Hosp Pharm 1992 ; 49: 2765-2768. |
Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.
Stewart JT, Warren FW, Johnson SM, Fox JL, Mullaney J. |
1992 |
2450 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734. |
Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution
Manduru M, Fariello A, White RL, Fox JL, Bosso JA. |
1996 |
591 |
Journal
Can J Hosp Pharm 1993 ; 46: 13-16. |
Stability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chloride.
Knoppert DC, Freeman D, Webb D. |
1993 |
282 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2568-2570. |
Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags.
Rivers TE, Webster AA. |
1995 |
4378 |
Journal
Perit Dial Int 2020 ; 40, 5: 470-476. |
Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
Harmanjeet H, Jani H, Zaidi S.T.R, Wanandy T, Castelino R.L, Sud K, Peterson G.M, Patel R.P. |
2020 |
276 |
Journal
Am J Hosp Pharm 1994 ; 51: 92-94. |
Stability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixtures.
Parrish MA, Bailey LC, Medwick T. |
1994 |
11 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 424-427. |
Stability of ceftriaxone sodium and metronidazole hydrochloride.
Bailey LC, Orosz ST. |
1997 |
259 |
Journal
Am J Hosp Pharm 1993 ; 50: 2092-2094. |
Stability of ceftriaxone sodium in infusion-pump syringes.
Bailey LC, Tang KT, Medwick T. |
1993 |
279 |
Journal
Am J Hosp Pharm 1994 ; 51: 2159-2161. |
Stability of ceftriaxone sodium in injectable solutions stored frozen in syringes.
Bailey LC, Cappel KM, Orosz ST. |
1994 |
100 |
Journal
Am J Health-Syst Pharm 1996 ; 43: 2320-2323. |
Stability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20°C.
Plumridge RJ, Rieck AM, Annus TP, Langton SR. |
1996 |
649 |
Journal
Int J Pharm Compound 1997 ; 1: 280-281. |
Stability of ceftriaxone sodium when mixed with metronidazole injection.
Das Gupta V. |
1997 |
2491 |
Journal
Am J Hosp Pharm 1989 ; 46: 256. |
Stability of cefuroxime axetil in beverages
St Claire RL, Caudill WL. |
1989 |
2699 |
Journal
J Clin Pharm Ther 1991 ; 16, 5: 341-345. |
Stability of cefuroxime axetil in suspensions.
Pramar Y, Das Gupta V, Bethea C, Zerai T. |
1991 |
3290 |
Journal
Acta Pol Pharm 2011 ; 68, 4: 555-564. |
Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A, Wisniewski A, Kniola D, Olejniczak M. |
2011 |
2095 |
Journal
EJHP Science 2006 ; 12, 2: 32-34. |
Stability of cefuroxime infusion: the brand-name drug versus a generic product.
Rodenbach, MP, Hecq JD, Vanbeckbergen D, jamart J, Galanti L. |
2006 |
96 |
Journal
Am J Hosp Pharm 1994 ; 51: 809-811. |
Stability of cefuroxime sodium and aminophylline or theophylline.
Stewart JT, Warren FW, Johnson SM. |
1994 |
636 |
Journal
J Clin Hosp Pharm 1986 ; 11: 47-54. |
Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
Das Gupta V, Stewart KR. |
1986 |
3078 |
Journal
Can J Hosp Pharm 2009 ; 62, 6: 464-468. |
Stability of celecoxib oral suspensions.
Donnelly RF, Pascuet E, Ma C, Vaillancourt R. |
2009 |
3135 |
Journal
Am J Health-Syst Pharm 2010 ; 67, 3: 223-226. |
Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags.
Ikesue H, Vermeulen LC, Hoke R, Kolesar JM. |
2010 |
2206 |
Journal
Am J Health-Syst Pharm 2015 ; 72:1292-1297 |
Stability of chlorothiazide sodium in polypropylene syringes
McCluskey S.V, Gardner B, . Graner K.K, Nicole Vu N. |
2015 |
1 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1939-1943. |
Stability of cidofovir in 0.9% sodium chloride and in 5% dextrose injection.
Yuan LC, Samuels GJ, Visor GC. |
1996 |
71 |
Journal
Am J Health-Syst Pharm 1997 ; 54: 2204-2206. |
Stability of cidofovir in 0.9% sodium chloride injection for five days.
Ennis RD, Dahl TC. |
1997 |
1989 |
Journal
Am J Health-Syst Pharm 2005 ; 62: 506-509. |
Stability of cidofovir in extemporaneously prepared syringes.
Hennere G, Havard L, Bonan B, Prognon P. |
2005 |
3722 |
Journal
Acta Pol Pharm 2014 ; 71, 4: 661-666. |
Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska. |
2014 |
80 |
Journal
Am J Hosp Pharm 1993 ; 50: 2559-2561. |
Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1993 |
362 |
Journal
Am J Hosp Pharm 1985 ; 42: 2208-2210. |
Stability of cimetidine hydrochloride in a total nutrient admixture.
Baptista RJ, Palombo JD, Tahan SR, Valicenti AJ, Bistrian BR, Arkin CF, Blackburn GL. |
1985 |
1503 |
Journal
Am J Hosp Pharm 1983 ; 40: 1002-1006. |
Stability of cimetidine hydrochloride in admixtures after microwave thawing
Elliott GT, McKenzie MW, Curry SH, Pieper JA, Quinn SL. |
1983 |
1614 |
Journal
Hosp Pharm 2001 ; 36: 1170-1173. |
Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS. |
2001 |
666 |
Journal
J Clin Pharm Ther 1994 ; 19: 261-262. |
Stability of ciprofloxacin in 5% dextrose and normal saline injections.
Mathew M, Das Gupta V, Zerai T. |
1994 |
1740 |
Journal
Int J Pharm Compound 1998 ; 2, 4: 314-317. |
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V. |
1998 |
2676 |
Journal
Int J Pharm Compound 1998 ; 2: 314-317. |
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V. |
1998 |
2368 |
Journal
Am J Hosp Pharm 1992 ; 49: 2956 - 2959. |
Stability of ciprofloxacin in peritoneal dialysis solution
Mawhinney WM, Adair CG, Gorman SP, McClurg B. |
1992 |
3231 |
Journal
Can J Hosp Pharm 2011 ; 64, 4 : 252-256. |
Stability of Ciprofloxacin in Polyvinylchloride Minibags.
Donnelly RF. |
2011 |
4263 |
Journal
Am J Hosp Pharm 1994 ;51:373-377 |
Stability of ciprofloxacin injection in peritoneal dialysis solutions.
Kane MP, Bailie GR, Moon DG, Siu I. |
1994 |
533 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1037-1041. |
Stability of cisatracurium besylate in vials, syringes and infusion admixtures.
Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL. |
1998 |
1080 |
Journal
Am J Hosp Pharm 1985 ; 42: 2652. |
Stability of cisplatin admixtures in polyvinyl chloride bags.
La Folette JM, Arbus MH, Lauper RD. |
1985 |
417 |
Journal
Am J Hosp Pharm 1989 ; 46: 1400-1404. |
Stability of cisplatin and etoposide in intravenous admixtures.
Stewart CF, Hampton EM. |
1989 |
53 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2570-2573. |
Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
Henry DW, Marshall JL, Nazzar OD, Fox JL, Leff RD. |
1995 |
1729 |
Journal
Pharmazie 1998 ; 53: 490-492. |
Stability of cisplatin containing infusion.
Mittner A, Vincze Z, Jemnitz K. |
1998 |
742 |
Journal
Am J Hosp Pharm 1979 ; 36: 38-43. |
Stability of cisplatin in aqueous solution.
Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF. |
1979 |
149 |
Journal
J Clin Pharm Ther 1992 ; 17: 315-318. |
Stability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirs.
Rochard E, Barthes D, Courtois P. |
1992 |
147 |
Journal
Pharm World Sci 1993 ; 15: 34-36. |
Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s material.
Pujol Cubells M, Prat Aixela J, Girona Brumos V, Duran Pou S, Villaronga Flaque MV. |
1993 |
409 |
Journal
Am J Hosp Pharm 1987 ; 44: 124-130. |
Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP. |
1987 |
1604 |
Journal
Eur Hosp Pharm 2001 ; 7: 11-14. |
Stability of citalopram hydrochloride in polyvinyl chloride bag for I.V. solutions and compatibility in the presence of dipotassium clorazepate.
Gury C, Dolizy I, Aymard N, Sellali Y, Rochet S. |
2001 |
318 |
Journal
Am J Hosp Pharm 1994 ; 51: 512-514. |
Stability of citrated caffeine injectable solution in glass vials.
Donnelly RF, Tirona RG. |
1994 |
1354 |
Journal
Am J Hosp Pharm 1984 ; 41: 2405-2406. |
Stability of citrated caffeine solutions for injectable and enteral use.
Eisenberg MG, Kang N. |
1984 |
1505 |
Journal
Eur Hosp Pharm 1997 3,4: 154-6 |
Stability of cladribine in either polyethylene containers or polyvinylchloride bags.
Daouphars M, Vigneron J, Perrin A, Hoffman MA, Hoffman M. |
1997 |
3901 |
Journal
Int J Pharm Compound 2016 ; 20, 5 : 421-425. |
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A,Mandal Tarun K |
2016 |
567 |
Journal
Can J Hosp Pharm 1989 ; 42: 109-112. |
Stability of clindamycin phophate in dextrose and saline solutions.
Das Gupta V, Parasrampuria J, Bethea C, Wright W. |
1989 |
418 |
Journal
Am J Hosp Pharm 1985 ; 42: 2211-2214. |
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Bosso JA, Townsend RJ. |
1985 |
1815 |
Journal
Int J Pharm Compound 2003 ; 7, 2: 149-151. |
Stability of clindamycin phosphate in autodose infusion system bags.
Xu QA, Trissel LA. |
2003 |
432 |
Journal
Am J Hosp Pharm 1986 ; 43: 1732-1736. |
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
Marble DA, Bosso JA, Townsend RJ. |
1986 |
4630 |
Journal
J Pharm Health Care Sci 2021 ; 7:31 |
Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan.
Saito J, Hanawa T, Matsumoto T, Yoshikawa N, Harada T, Iwahashi K, Nakamura H, Yamatani A. |
2021 |
3649 |
Journal
Am J Health-Syst Pharm 2014 ; 71:657-661. |
Stability of clonidine suspension in oral plastic syringes.
Ma C, Decarie D, Ensom M.H.H. |
2014 |
2592 |
Journal
Can J Hosp Pharm 2005 ; 58, 5: 279-284. |
Stability of clozapine stored in oral suspension vehicles at room temperature.
Walker SE, Baker D, Law S. |
2005 |
2397 |
Journal
Am J Health-Syst Pharm 2007 Dentinger PJ, Swenson CF |
Stability of codeine phosphate in an extemporaneously compounded syrup
Dentinger PJ, Swenson CF. |
2007 |
2783 |
Journal
Int J Pharm 2015 ; 486; 1-2: 367-369. |
Stability of colistimethate sodium in a disposable elastomeric infusion device.
Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P. |
2015 |
3360 |
Journal
Antimicrob Agents Chemother 2012 ; 56:6432-6433. |
Stability of Colistimethate Sodium in Aqueous Solution.
Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J. |
2012 |
2285 |
Journal
Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051. |
Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.
Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL. |
2008 |
4607 |
Journal
Can J Hosp Pharm 2021 ;74(3):227-34 |
Stability of Compounded Clozapine 25 mg/mL and 50 mg/mL Suspensions in Plastic Bottles.
Walker SE, Sachedina H, Bichar K. |
2021 |
4690 |
Journal
Hosp Pharm 2022 ; 57, 2: 294-299. |
Stability of Compounded Digoxin Solution 0.05mg/mL for Injection.
Friciu M, Marcelin R.B, Bédard P, Forest J.M, Leclair G. |
2022 |
3202 |
Journal
Am J Health-Syst Pharm 2011 ; 68: 900-908. |
Stability of compounded thioguanine oral suspensions
Montazeri Aliabadi H, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A |
2011 |
4593 |
Journal
Int J Pharm Compound 2021 ;78,4:344-351 |
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases.
Teimouri A, Yeung P, Agu R. |
2021 |
4214 |
Journal
Int J Pharm Compound 2019 ;23,1:70-76 |
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A. |
2019 |
4089 |
Journal
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:23-30 |
Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units.
Godet M, Simar J, Closset M, Hecq J.D, Braibant M, Soumoy L, Gillet P, Jamart J, Bihin B, Galanti L. |
2018 |
2162 |
Journal
Perit Dial Int 1990 ; 10: 157-160. |
Stability of cotrimoxazole in peritoneal dialysis fluid.
Holmes SE, Aldous S. |
1990 |
1833 |
Journal
Ann Pharmacotherapy 2003 ; 37, 12: 1789-1792. |
Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
Menard C, Bourguignon C, Schlatter J, Vermerie N. |
2003 |
1728 |
Journal
Pharmazie 1999 ; 54: 224-225. |
Stability of cyclophosphamide containing infusions.
Mittner A, Vincze Z, Jemnitz. |
1999 |
3096 |
Journal
Ann Pharmacotherapy 2010 ;44:295-301. |
Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF. |
2010 |
3476 |
Journal
Am J Health-Syst Pharm 2013 ;70:1970-1972. |
Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers.
Li M, Coursol C, Leclair G. |
2013 |
471 |
Journal
Am J Hosp Pharm 1989 ; 46: 2053-2055. |
Stability of cyclosporine in 5% dextrose injection.
Shea BF, Ptachcinski RJ, O'Neill S, Cersosimo RJ, Sesin GP, Souney PF. |
1989 |
2444 |
Journal
Am J Health-Syst Pharm 1995 ; 52: 2204-2207. |
Stability of cyclosporine in an extemporaneously compounded paste
Ghnassia LT, Yau DF, Kaye KI, Duggin GG. |
1995 |
3229 |
Journal
Am J Health-Syst Pharm 2011 ;68:1646-1650. |
Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes.
Li M, Forest JM, Coursol C, Leclair G. |
2011 |
291 |
Journal
Am J Hosp Pharm 1993 ; 50: 470-472. |
Stability of cyclosporine with magnesium sulfate in 5% dextrose injection.
Nieforth KA, Shea BF, Souney PF, Scavone JM. |
1993 |
1028 |
Journal
Am J Hosp Pharm 1984 ; 41: 1802-1806. |
Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.
Cheung YW, Vishnuvajjala BR, Flora KP. |
1984 |
859 |
Journal
Nor Pharm Acta 1983 ; 45: 61-67. |
Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment.
Karlsen J, Thonnesen HH, Olsen IR, Sollien AH, Skobba TJ. |
1983 |
1635 |
Journal
Am J Health-Syst Pharm 2002 ; 59: 1351-1356. |
Stability of dacarbazine in amber glass vials and polyvinyl chloride bags.
El Aatmani M, Poujol S, Astre C, Malosse F, Pinguet F. |
2002 |
4031 |
Journal
Int J Pharm Compound 2017 ;21 , 5 : 426-429 |
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes.
Kirkham K, Munson J, McCluskey S, Graner K. |
2017 |
4106 |
Journal
Can J Hosp Pharm 2018 ;71,2/152-154 |
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions.
Alarie H, Friciu M, Leclair G. |
2018 |
2545 |
Journal
Ann Pharmacotherapy 2000 ;34:848-850. |
Stability of dapsone in two oral liquid dosage forms.
Nahata MC, Morosco RC, Trowbridge JM. |
2000 |
3665 |
Journal
Am J Health-Syst Pharm 2014 ; 71:956-959 |
Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and -20°C.
Ortega R, Salmer?n-Garc?a A, Cabeza J, Capit?n-Vallvey L.F, Navas N. |
2014 |
4074 |
Journal
EJHP 2018 ; 25: 107-110. |
Stability of daptomycin reconstituted vials and infusion solutions.
Ferrandez J, Sanchez R, Diaz D, Diaz M, Estevan M, Garcia T. |
2018 |
5 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1583-1588. |
Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes.
Stiles ML, Allen LV Jr, Prince SJ. |
1996 |
2156 |
Journal
Perit Dial Int 1994 ; 14: 396-398. |
Stability of deferoxamine peritoneal dialysate solutions.
Kane MP, Bailie GR, Moon DG, Siu I. |
1994 |
2961 |
Journal
Can J Hosp Pharm 2001 ; 54: 96-101. |
Stability of dexamethasone in extemporaneously prepared oral suspensions.
Wen-Lin Chow J, Decarie D, Dumont RJ. |
2001 |
24 |
Journal
Am J Hosp Pharm 1994 ; 51: 514-517. |
Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
Stiles ML, Allen LV Jr, Prince SJ, Holland JS. |
1994 |
3299 |
Journal
Am J Health-Syst Pharm 2012 ; 69:595-597. |
Stability of dexmedetomidine 4 µg/mL in polypropylene syringes.
Anderson C.R, Mackay M.W, Holley M, Kay B.A |
2012 |
4029 |
Journal
Int J Pharm Compound 2017 ; 21, 5: 436-439 |
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags.
Marquis K, Hohlfelder B, Szumita Paul. |
2017 |
3433 |
Journal
Am J Health-Syst Pharm 2013 ; 70:1336-1341 |
Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection.
Preslaski C.R, Mueller S.W, Wempe M.F, Robert MacLaren R. |
2013 |
779 |
Journal
J Pharm Pharmacol 1986 ; 38: 51P. |
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
Collins AJ, Abethell JA, Holmes SG, Rain R. |
1986 |
4533 |
Journal
Int J Pharm Compound 2021 ;25,5:427-430 |
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base.
Lopalco A, Lopedota A, Aurelio F, La Forgia F, Fontana S, Franco M, Denora N. |
2021 |
1199 |
Journal
Am J Hosp Pharm 1982 ; 1687-1690. |
Stability of diazepam injection repackaged in glass unit-dose syringes.
Smith FM, Nuessle NO. |
1982 |
4313 |
Journal
PlosOne 2017 |
Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
Friciu M, Zaraa S, Roullin G, Leclair G. |
2017 |
2840 |
Journal
Can J Hosp Pharm 2010 ; 63, 1 : 25-30. |
Stability of Diclofenac Sodium Oral suspensions Packaged in Amber Polyvinyl Chloride Bottles.
Donnell RF, Pascuet E, Ma C, Vaillancourt R. |
2010 |
618 |
Journal
Am J Hosp Pharm 1982 ; 39: 844-846. |
Stability of digoxin in common large-volume injections.
Shank WA, Coupal JJ. |
1982 |
3426 |
Journal
Journal of Addiction Medicine 2013 ; 7,2:113-115. |
Stability of Dilute Oral Morphine Solution for Neonatal Abstinence Syndrome.
Sauberan, Jason; Rossi, Steven; Kim, Jae H. |
2013 |
3422 |
Journal
Hosp Pharm 2013 ; 48, 6: 484-488. |
Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags.
Almagambetova E, Hutchinson D, Blais D.M, Zhao F. |
2013 |
3223 |
Journal
Am J Health-Syst Pharm 2011 ;68:1533-1536. |
Stability of diluted adenosine solutions in polyvinyl chloride infusion bags
Kaltenbach M, Hutchinson DJ, Bollinger JE, Zhao F. |
2011 |
546 |
Journal
Ann Pharmacotherapy 1994 ; 28: 1018-1019. |
Stability of diluted dexamethasone sodium phosphate injection at two temperatures.
Lugo RA, Nahata MC. |
1994 |
3309 |
Journal
EJHP 2012 ;19:378-380 |
Stability of diluted epinephrine in prefilled syringes for use in neonatology.
Zenoni D, Priori G, Bellan C, Invernizzi R.W. |
2012 |
1183 |
Journal
Am J Hosp Pharm 1981 ; 38: 1001-1004. |
Stability of diluted heparin sodium stored in plastic syringes.
Tunbridge LJ, Lloyd JV, Penhall RK, Wise AL, Maloney T. |
1981 |
3443 |
Journal
J Pharm Pract and Res 2013 ; 43: 112-116. |
Stability of Diluted Iron Polymaltose in PVC Infusion Bags.
Patel R.P, Wanandy T, Loring S, Johns C, Hutchinson J, Shastri M. |
2013 |
3435 |
Journal
Can J Hosp Pharm 2013 ; 66, 3 : 198. |
Stability of Diluted Ketamine Packaged in Glass Vials.
Donnelly R.F. |
2013 |
3243 |
Poster
ECCO Congress Stockholm 2011 |
Stability of diluted L-asparaginase in normal saline solution.
Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M. |
2011 |
212 |
Journal
Am J Hosp Pharm 1994 ; 51: 2157-2159. |
Stability of diluted methylprednisolone sodium succinate injection at two temperatures.
Nahata MC, Morosco RS, Hipple TF. |
1994 |
2310 |
Journal
EJHP Science 2008 ; 14, 6: 36-38. |
Stability of diluted nadroparin for the treatment of paediatric thrombosis.
Hunfeld N, Ypma P, Westerman E, Leebeck F, Touw D. |
2008 |
2132 |
Journal
Int J Pharm Compound 2015 ; 19, 4 : 344-347. |
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes.
Anderson Collin R, Halford Zachery, MacKay Mark. |
2015 |
2471 |
Journal
Am J Hosp Pharm 1982 ; 39: 309-310. |
Stability of disopyramide phosphate in cherry syrup
Mathur LK, Lai PK, Shively CD. |
1982 |
2765 |
Journal
Pharm World Sci 1999 ; 21: 275-277. |
Stability of dithranol in creams.
Wuis EW, Burger DM, Beelen M. |
1999 |
3293 |
Journal
EJHP 2012 ; 19: 52-56. |
Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service
Patel N, Taki M, Tunstell P, Forsey P, Forbes B. |
2012 |
1753 |
Journal
Int J Pharm Compound 1999 ; 3: 412-414. |
Stability of dobutamine hydrochloride 4 mg/ml in 5% dextrose injection at 5 and 23°C.
Webster AA, English BA, McGuire JM, Riggs RM, Lander V, Buckle T. |
1999 |
1045 |
Journal
Am J Hosp Pharm 1984 ; 41: 686-689. |
Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5 % dextrose injections.
Das Gupta V, Stewart KR. |
1984 |
2371 |
Journal
Am J Hosp Pharm 1991 ; 48: 1234 - 1237. |
Stability of dobutamine hydrochloride in peritoneal dialysis solutions
Gora ML, Seth S, Visconti JA, Shields B, Bay W. |
1991 |
628 |
Journal
Am J Hosp Pharm 1982 ; 39: 1923-1925. |
Stability of dobutamine hydrochloride in selected large-volume parenterals.
Kirschenbaum HL, Aronoff W, Perentesis GP, Piltz GW, Goldberg RJ, Cutie AJ. |
1982 |
4141 |
Journal
J Clin Pharm Ther 2018 : 530-535. |
Stability of dobutamine in continuous ambulatory delivery devices.
Al Madfai F, Valah B, Zaidi S.T.R, Wanandy T, Ming M.C, Peterson G.M, Patel R.P. |
2018 |
2210 |
Journal
Can J Hosp Pharm 2007 ; 60, 4: 231-237. |
Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Walker S.E, Charbonneau F, Law S. |
2007 |
1807 |
Journal
Can J Hosp Pharm 2003 ; 56, 2: 87-92. |
Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water.
Chan J, Walker SE, Law S. |
2003 |
3712 |
Journal
Pediatr Crit Care Med 2001 ; 2, 4: 315-317. |
Stability of dopamine and epinephrine solutions up to 84 hours.
Ghanayem N.S, Lee L, Nelson T, Wong S, Gordon G.B, Markdante K et al. |
2001 |
1820 |
Journal
J Clin Pharm Ther 2003 ; 28: 471-474. |
Stability of dopamine hydrochloride 0.5 mg/ml in polypropylene syringes.
Braenden JU, Stendal TL, Fagernaes CB. |
2003 |
206 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 186. |
Stability of dopamine hydrochloride and of dobutamine hydrochloride in plastic syringes and administration sets.
Sautou-Miranda V, Gremeau I, Chamard I, Cassagnes J, Chopineau J. |
1996 |
1249 |
Journal
Am J Hosp Pharm 1985 ; 42: 595-597. |
Stability of dopamine hydrochloride exposed to blue-light phototherapy.
Dandurand KR, Stennett DJ. |
1985 |
3145 |
Journal
Am J Health-Syst Pharm 2010 ; 67: 1539-1544. |
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.
Crandon JL, Sutherland C, Nicolau DP. |
2010 |
2316 |
Journal
Clin Ther 2008 ; 30, 11: 2075-2087. |
Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas P.A, Kuzmission A, Ikeda K, Yasuo S. |
2008 |
2256 |
Manufacturer
Ebewe Pharma 2007 |
Stability of doxorubicin "Ebewe" infusion solutions.
|
2007 |
32 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 1171-1173. |
Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs.
Nyhammar EK, Johansson SG, Seiving BE. |
1996 |
686 |
Journal
J Clin Pharm Ther 1990 ; 15: 279-289. |
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
Wood MJ, Irwin WJ, Scott DK. |
1990 |
3207 |
Journal
Int J Pharm Compound 2011 ; 15, 2: 170-173. |
Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes.
McCluskey Susan V, Lovely Jenna K . |
2011 |
2425 |
Journal
Am J Health-Syst Pharm 1998 ; 55: 1155-1157. |
Stability of enalapril maleate in three extemporaneously prepared oral liquids
Nahata MC, Morosco RS, Hipple TF. |
1998 |
1720 |
Journal
Int J Pharm Compound 2001 ; 5: 394-396. |
Stability of ephedrine sulfate at ambient temperature and 4°C in polypropylene syringes.
Storms ML, Stewart JT, Warren FW. |
2001 |
1292 |
Journal
Int J Pharm Pract 1995 ; 3: 174-177. |
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Grassby PF, Roberts DE. |
1995 |
3704 |
Journal
Can J Hosp Pharm 2014 ; 67, 3:179-202. |
Stability of Epinephrine at Standard Concentrations
Carr R.R, Decarie D, Ensom M.H.H |
2014 |
2437 |
Journal
Am J Health-Syst Pharm 1996 ; 53: 659-662. |
Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine
Larson TA, Uden DL, Schilling CG. |
1996 |
2077 |
Journal
Ann Emerg Med 1990 ; 19: 1242-1244. |
Stability of epinephrine in alkalinized solutions.
Bonhomme L, Benhamou D, Comoy E, Preaux N. |
1990 |
2257 |
Manufacturer
Ebewe Pharma 2007 |
Stability of epirubicin "Ebewe" infusion solutions.
|
2007 |
3891 |
Journal
Can J Hosp Pharm 2015 ; 68, 2: 121-126. |
Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Walker S.E, Law S, Perks W, Iazzetta J. |
2015 |
3717 |
Journal
Am J Health-Syst Pharm 2014 ; 71:1480-1484 |
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L. |
2014 |
3208 |
Journal
Int J Pharm Compound 2011 ; 15, 3: 252-254. |
Stability of Ertapenem in an Elastomeric Infusion Device.
Phipps Stephen D, Peacock Gina F, Smith Douglas L . |
2011 |
2178 |
Journal
J Pharm Biomed Anal 2007 ; 43: 445-449. |
Stability of ertapenem in aqueous solutions.
Zajac M, Cielecka-Piontek J, J |